
<html lang="en"     class="pb-page"  data-request-id="b74a7d10-a0d3-4c12-b965-d6b156cf1f3d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00272;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2020.63.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of 9-Cyclopropylethynyl-2-((S)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one (GLPG1205), a Unique GPR84 Negative Allosteric Modulator Undergoing Evaluation in a Phase II Clinical Trial" /></meta><meta name="dc.Creator" content="Frédéric  Labéguère" /></meta><meta name="dc.Creator" content="Sonia  Dupont" /></meta><meta name="dc.Creator" content="Luke  Alvey" /></meta><meta name="dc.Creator" content="Florilène  Soulas" /></meta><meta name="dc.Creator" content="Gregory  Newsome" /></meta><meta name="dc.Creator" content="Amynata  Tirera" /></meta><meta name="dc.Creator" content="Vanessa  Quenehen" /></meta><meta name="dc.Creator" content="Thi Thu Trang  Mai" /></meta><meta name="dc.Creator" content="Pierre  Deprez" /></meta><meta name="dc.Creator" content="Roland  Blanqué" /></meta><meta name="dc.Creator" content="Line  Oste" /></meta><meta name="dc.Creator" content="Sandrine  Le Tallec" /></meta><meta name="dc.Creator" content="Steve  De Vos" /></meta><meta name="dc.Creator" content="Annick  Hagers" /></meta><meta name="dc.Creator" content="Ann  Vandevelde" /></meta><meta name="dc.Creator" content="Luc  Nelles" /></meta><meta name="dc.Creator" content="Nele  Vandervoort" /></meta><meta name="dc.Creator" content="Katja  Conrath" /></meta><meta name="dc.Creator" content="Thierry  Christophe" /></meta><meta name="dc.Creator" content="Ellen  van der Aar" /></meta><meta name="dc.Creator" content="Emanuelle  Wakselman" /></meta><meta name="dc.Creator" content="Didier  Merciris" /></meta><meta name="dc.Creator" content="Céline  Cottereaux" /></meta><meta name="dc.Creator" content="Cécile  da Costa" /></meta><meta name="dc.Creator" content="Laurent  Saniere" /></meta><meta name="dc.Creator" content="Philippe  Clement-Lacroix" /></meta><meta name="dc.Creator" content="Laura  Jenkins" /></meta><meta name="dc.Creator" content="Graeme  Milligan" /></meta><meta name="dc.Creator" content="Stephen  Fletcher" /></meta><meta name="dc.Creator" content="Reginald  Brys" /></meta><meta name="dc.Creator" content="Romain  Gosmini" /></meta><meta name="dc.Description" content="GPR84 is a medium chain free fatty acid-binding G-protein-coupled receptor associated with inflammatory and fibrotic diseases. As the only reported antagonist of GPR84 (PBI-4050) that displays rela..." /></meta><meta name="Description" content="GPR84 is a medium chain free fatty acid-binding G-protein-coupled receptor associated with inflammatory and fibrotic diseases. As the only reported antagonist of GPR84 (PBI-4050) that displays rela..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 9, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00272" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00272" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00272" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00272" /></link>
        
    
    

<title>Discovery of 9-Cyclopropylethynyl-2-((S)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one (GLPG1205), a Unique GPR84 Negative Allosteric Modulator Undergoing Evaluation in a Phase II Clinical Trial | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00272" /></meta><meta property="og:title" content="Discovery of 9-Cyclopropylethynyl-2-((S)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one (GLPG1205), a Unique GPR84 Negative Allosteric Modulator Undergoing Evaluation in a Phase II Clinical Trial" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0020.jpeg" /></meta><meta property="og:description" content="GPR84 is a medium chain free fatty acid-binding G-protein-coupled receptor associated with inflammatory and fibrotic diseases. As the only reported antagonist of GPR84 (PBI-4050) that displays relatively low potency and selectivity, a clear need exists for an improved modulator. Structural optimization of GPR84 antagonist hit 1, identified through high-throughput screening, led to the identification of potent and selective GPR84 inhibitor GLPG1205 (36). Compared with the initial hit, 36 showed improved potency in a guanosine 5′-O-[γ-thio]triphosphate assay, exhibited metabolic stability, and lacked activity against phosphodiesterase-4. This novel pharmacological tool allowed investigation of the therapeutic potential of GPR84 inhibition. At once-daily doses of 3 and 10 mg/kg, GLPG1205 reduced disease activity index score and neutrophil infiltration in a mouse dextran sodium sulfate-induced chronic inflammatory bowel disease model, with efficacy similar to positive-control compound sulfasalazine. The drug discovery steps leading to GLPG1205 identification, currently under phase II clinical investigation, are described herein." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00272"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00272">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00272&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00272&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00272&amp;href=/doi/10.1021/acs.jmedchem.0c00272" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 13526-13545</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01193" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.0c00944" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 9-Cyclopropylethynyl-2-((<i>S</i>)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one (GLPG1205), a Unique GPR84 Negative Allosteric Modulator Undergoing Evaluation in a Phase II Clinical Trial</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Frédéric Labéguère</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Frédéric Labéguère</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fr%C3%A9d%C3%A9ric++Lab%C3%A9gu%C3%A8re">Frédéric Labéguère</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sonia Dupont</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sonia Dupont</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sonia++Dupont">Sonia Dupont</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luke Alvey</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luke Alvey</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luke++Alvey">Luke Alvey</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Florilène Soulas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Florilène Soulas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Floril%C3%A8ne++Soulas">Florilène Soulas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregory Newsome</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory Newsome</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory++Newsome">Gregory Newsome</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Amynata Tirera</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Amynata Tirera</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Amynata++Tirera">Amynata Tirera</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vanessa Quenehen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vanessa Quenehen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vanessa++Quenehen">Vanessa Quenehen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thi Thu Trang Mai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thi Thu Trang Mai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thi+Thu+Trang++Mai">Thi Thu Trang Mai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pierre Deprez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pierre Deprez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pierre++Deprez">Pierre Deprez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roland Blanqué</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roland Blanqué</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roland++Blanqu%C3%A9">Roland Blanqué</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Line Oste</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Line Oste</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Line++Oste">Line Oste</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sandrine Le Tallec</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sandrine Le Tallec</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sandrine++Le+Tallec">Sandrine Le Tallec</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Steve De Vos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Steve De Vos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Steve++De+Vos">Steve De Vos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Annick Hagers</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Annick Hagers</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Annick++Hagers">Annick Hagers</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ann Vandevelde</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ann Vandevelde</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ann++Vandevelde">Ann Vandevelde</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luc Nelles</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luc Nelles</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luc++Nelles">Luc Nelles</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nele Vandervoort</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nele Vandervoort</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nele++Vandervoort">Nele Vandervoort</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Katja Conrath</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Katja Conrath</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Katja++Conrath">Katja Conrath</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thierry Christophe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thierry Christophe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thierry++Christophe">Thierry Christophe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ellen van der Aar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ellen van der Aar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ellen++van+der+Aar">Ellen van der Aar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Emanuelle Wakselman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Emanuelle Wakselman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Emanuelle++Wakselman">Emanuelle Wakselman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Didier Merciris</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Didier Merciris</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Didier++Merciris">Didier Merciris</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Céline Cottereaux</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Céline Cottereaux</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9line++Cottereaux">Céline Cottereaux</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cécile da Costa</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cécile da Costa</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9cile++da+Costa">Cécile da Costa</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laurent Saniere</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laurent Saniere</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laurent++Saniere">Laurent Saniere</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Philippe Clement-Lacroix</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Philippe Clement-Lacroix</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Clement-Lacroix">Philippe Clement-Lacroix</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura Jenkins</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Jenkins</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Jenkins">Laura Jenkins</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Graeme Milligan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Graeme Milligan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Translational Pharmacology, Institute of Molecular, Cell and Systems Biology, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Graeme++Milligan">Graeme Milligan</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6946-3519" title="Orcid link">http://orcid.org/0000-0002-6946-3519</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stephen Fletcher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen Fletcher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Fletcher">Stephen Fletcher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Reginald Brys</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Reginald Brys</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos NV, Generaal De Wittelaan L11 A3, 2800 Mechelen, Belgium</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Reginald++Brys">Reginald Brys</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Romain Gosmini</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Romain Gosmini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Galapagos SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#3d4f52505c5453135a524e505453547d5a514d5a135e5250"><span class="__cf_email__" data-cfemail="2b5944464a4245054c4458464245426b4c475b4c05484446">[email protected]</span></a>. Telephone: +33149424778.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Romain++Gosmini">Romain Gosmini</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00272&amp;href=/doi/10.1021%2Facs.jmedchem.0c00272" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 13526–13545</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 9, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 February 2020</li><li><span class="item_label"><b>Published</b> online</span>9 September 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00272" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00272</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 <span class="NLM_copyright-holder">American Chemical Society</span></strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00272"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2957</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">4</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00272" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 9-Cyclopropylethynyl-2-((S)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one (GLPG1205), a Unique GPR84 Negative Allosteric Modulator Undergoing Evaluation in a Phase II Clinical Trial&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Frédéric&quot;,&quot;last_name&quot;:&quot;Labéguère&quot;},{&quot;first_name&quot;:&quot;Sonia&quot;,&quot;last_name&quot;:&quot;Dupont&quot;},{&quot;first_name&quot;:&quot;Luke&quot;,&quot;last_name&quot;:&quot;Alvey&quot;},{&quot;first_name&quot;:&quot;Florilène&quot;,&quot;last_name&quot;:&quot;Soulas&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;Newsome&quot;},{&quot;first_name&quot;:&quot;Amynata&quot;,&quot;last_name&quot;:&quot;Tirera&quot;},{&quot;first_name&quot;:&quot;Vanessa&quot;,&quot;last_name&quot;:&quot;Quenehen&quot;},{&quot;first_name&quot;:&quot;Thi&quot;,&quot;last_name&quot;:&quot;Thu Trang Mai&quot;},{&quot;first_name&quot;:&quot;Pierre&quot;,&quot;last_name&quot;:&quot;Deprez&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;Blanqué&quot;},{&quot;first_name&quot;:&quot;Line&quot;,&quot;last_name&quot;:&quot;Oste&quot;},{&quot;first_name&quot;:&quot;Sandrine&quot;,&quot;last_name&quot;:&quot;Le Tallec&quot;},{&quot;first_name&quot;:&quot;Steve&quot;,&quot;last_name&quot;:&quot;De Vos&quot;},{&quot;first_name&quot;:&quot;Annick&quot;,&quot;last_name&quot;:&quot;Hagers&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;Vandevelde&quot;},{&quot;first_name&quot;:&quot;Luc&quot;,&quot;last_name&quot;:&quot;Nelles&quot;},{&quot;first_name&quot;:&quot;Nele&quot;,&quot;last_name&quot;:&quot;Vandervoort&quot;},{&quot;first_name&quot;:&quot;Katja&quot;,&quot;last_name&quot;:&quot;Conrath&quot;},{&quot;first_name&quot;:&quot;Thierry&quot;,&quot;last_name&quot;:&quot;Christophe&quot;},{&quot;first_name&quot;:&quot;Ellen&quot;,&quot;last_name&quot;:&quot;van der Aar&quot;},{&quot;first_name&quot;:&quot;Emanuelle&quot;,&quot;last_name&quot;:&quot;Wakselman&quot;},{&quot;first_name&quot;:&quot;Didier&quot;,&quot;last_name&quot;:&quot;Merciris&quot;},{&quot;first_name&quot;:&quot;Céline&quot;,&quot;last_name&quot;:&quot;Cottereaux&quot;},{&quot;first_name&quot;:&quot;Cécile&quot;,&quot;last_name&quot;:&quot;da Costa&quot;},{&quot;first_name&quot;:&quot;Laurent&quot;,&quot;last_name&quot;:&quot;Saniere&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Clement-Lacroix&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Jenkins&quot;},{&quot;first_name&quot;:&quot;Graeme&quot;,&quot;last_name&quot;:&quot;Milligan&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Fletcher&quot;},{&quot;first_name&quot;:&quot;Reginald&quot;,&quot;last_name&quot;:&quot;Brys&quot;},{&quot;first_name&quot;:&quot;Romain&quot;,&quot;last_name&quot;:&quot;Gosmini&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;13526-13545&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00272&quot;},&quot;abstract&quot;:&quot;GPR84 is a medium chain free fatty acid-binding G-protein-coupled receptor associated with inflammatory and fibrotic diseases. As the only reported antagonist of GPR84 (PBI-4050) that displays relatively low potency and selectivity, a clear need exists for an improved modulator. Structural optimization of GPR84 antagonist hit 1, identified through high-throughput screening, led to the identification of potent and selective GPR84 inhibitor GLPG1205 (36). Compared with the initial hit, 36 showed improved potency in a guanosine 5′-O-[γ-thio]triphosphate assay, exhibited metabolic stability, and lacked activity against phosphodiesterase-4. This novel pharmacological tool allowed investigation of the therapeutic potential of GPR84 inhibition. At once-daily doses of 3 and 10 mg/kg, GLPG1205 reduced disease activity index score and neutrophil infiltration in a mouse dextran sodium sulfate-induced chronic inflammatory bowel disease model, with efficacy similar to positive-control compound sulfasalazine. The drug disc&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00272&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00272" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00272&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00272" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00272&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00272" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00272&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00272&amp;href=/doi/10.1021/acs.jmedchem.0c00272" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00272" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00272" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00272%26sid%3Dliteratum%253Aachs%26pmid%3D32902984%26genre%3Darticle%26aulast%3DLab%25C3%25A9gu%25C3%25A8re%26date%3D2020%26atitle%3DDiscovery%2Bof%2B9-Cyclopropylethynyl-2-%2528%2528S%2529-1-%255B1%252C4%255Ddioxan-2-ylmethoxy%2529-6%252C7-dihydropyrimido%255B6%252C1-a%255Disoquinolin-4-one%2B%2528GLPG1205%2529%252C%2Ba%2BUnique%2BGPR84%2BNegative%2BAllosteric%2BModulator%2BUndergoing%2BEvaluation%2Bin%2Ba%2BPhase%2BII%2BClinical%2BTrial%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D22%26spage%3D13526%26epage%3D13545%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/jmcmar.2020.63.issue-22/20201125/jmcmar.2020.63.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">GPR84 is a medium chain free fatty acid-binding G-protein-coupled receptor associated with inflammatory and fibrotic diseases. As the only reported antagonist of GPR84 (PBI-4050) that displays relatively low potency and selectivity, a clear need exists for an improved modulator. Structural optimization of GPR84 antagonist hit <b>1</b>, identified through high-throughput screening, led to the identification of potent and selective GPR84 inhibitor GLPG1205 (<b>36</b>). Compared with the initial hit, <b>36</b> showed improved potency in a guanosine 5′-<i>O</i>-[γ-thio]triphosphate assay, exhibited metabolic stability, and lacked activity against phosphodiesterase-4. This novel pharmacological tool allowed investigation of the therapeutic potential of GPR84 inhibition. At once-daily doses of 3 and 10 mg/kg, GLPG1205 reduced disease activity index score and neutrophil infiltration in a mouse dextran sodium sulfate-induced chronic inflammatory bowel disease model, with efficacy similar to positive-control compound sulfasalazine. The drug discovery steps leading to GLPG1205 identification, currently under phase II clinical investigation, are described herein.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">GPR84 is a G-protein-coupled receptor (GPCR) that couples almost exclusively to pertussis-toxin sensitive G<sub>i/o</sub> pathways.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Whereas GPR84 has no unanimously accepted cognate ligand, medium-chain free fatty acids (MCFAs, carbon chain lengths of 9–14) have been known as agonists for over a decade<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> with decanoic acid (C10), undecanoic acid (C11), and lauric acid (C12) being the most effective.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> An increasing range of synthetic GPR84 agonist ligands have been described, including embelin, 3,3′-diindolylmethane (DIM), 6-<i>n</i>-octylaminouracil (6-OAU),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and 2-(hexylthiol)pyrimidine-4,6 diol (2-HTP)<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). These synthetic GPR84 ligands are more potent than the MCFAs, with particular derivatives and structural relatives of 6-OAU being the most potent agonists of GPR84 to date.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of known GPR84 agonists MCFA C10, embelin, 2-HTP, and DIM derivatives and the GPR84 antagonists PBI-4050 and 6-OAU. Abbreviations: 2-HTP, 2-(hexylthiol)pyrimidine-4,6 diol; 6-OAU, 6-<i>n</i>-octylaminouracil; DIM, 3,3′-diindolylmethane; MCFA, medium-chain free fatty acids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">GPR84 is primarily expressed in innate immune cells (neutrophils,<a onclick="showRef(event, 'ref1 ref7'); return false;" href="javascript:void(0);" class="ref ref1 ref7">(1,7)</a> monocytes,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> macrophages,<a onclick="showRef(event, 'ref1 ref8'); return false;" href="javascript:void(0);" class="ref ref1 ref8">(1,8)</a> dendritic cells,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and microglia<a onclick="showRef(event, 'ref8 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref10">(8,10)</a>) and splenic T and B cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Expression of GPR84 is highly upregulated by inflammatory stimuli in these innate immune cells and adipocytes,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> suggesting an immunoregulatory role for the receptor.<a onclick="showRef(event, 'ref1 ref7 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref1 ref7 ref10 ref11 ref12 ref13">(1,7,10−13)</a> In polymorphonuclear leukocytes and macrophages, activation of GPR84 results in chemotactic responses and enhances the release of cytokines (interleukin [IL]-8, IL-12, and tumor necrosis factor α [TNF-α]).<a onclick="showRef(event, 'ref1 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref3">(1,3)</a> In addition, activation of this receptor in neutrophils and macrophages triggers the release of reactive oxygen species.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">GPR84 is suspected to be involved in inflammatory bowel disease (IBD), as increased levels of GPR84 messenger RNA (mRNA) have been observed in intestinal mucosal biopsies of patients with IBD (either ulcerative colitis or Crohn’s disease).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Additionally, GPR84 may be involved in fibrotic processes, as one recent study observed that GPR84 knock-out mice display significantly reduced kidney fibrosis when compared with wild-type mice in an adenine-induced chronic kidney disease model.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Moreover, in a mouse bleomycin-induced pulmonary fibrosis model, treatment with the nonspecific GPR84 antagonist PBI-4050 reduced histological lesions in the lung by 47% compared with vehicle.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Other animal disease models have indicated a role for GPR84 in chronic pain,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> reflux esophagitis,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> acute myeloid leukemia,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> obesity,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and Alzheimer’s disease.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> As such, GPR84 has emerged as a potential drug target, particularly for inflammatory and fibrotic diseases.</div><div class="NLM_p last">To date, only one low potency, nonspecific antagonist of GPR84 has been reported (PBI-4050), which inhibits GPR84 G<sub>α/i</sub> activation initiated by either sodium decanoate or embelin.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In this article, we describe the discovery of GLPG1205 (<b>36</b>), a potent and selective GPR84 modulator, which demonstrates efficacy in <i>in vivo</i> IBD models and has been progressed in phase IIa clinical trials for the treatment of ulcerative colitis.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01616" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01616" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">During the course of our investigations, there was limited structural information available to provide support with molecular modeling tools for identifying GPR84 antagonists. The closest homologs of GPR84 with resolved structures had sequence identities below 30%, thereby preventing homology models being developed with sufficient accuracy to enable structure-based design. Furthermore, ligand-based approaches were limited due to the absence of reference antagonists. These issues led us to rely on a high-throughput screen (HTS) approach to identify GPR84 antagonists.</div><div class="NLM_p">A functional assay based on measurement of cyclic adenosine 3′,5′-monophosphate (cAMP) was selected to detect antagonists from a collection of approximately 200 000 diverse compounds. The comparison of assay robustness between the cAMP assay and the orthogonal assay ([<sup>35</sup>S]guanosine 5′-<i>O</i>-[γ-thio]triphosphate (GTPγS) binding) led us to use the GTPγS for hit confirmation and concentration–response determination. The GTPγS assay measures the level of G protein activation following agonist occupancy of a GPCR by determining the binding of the nonhydrolyzable analogue [<sup>35</sup>S]GTPγS to Gα subunits using membranes derived from a HEK293 cell line stably overexpressing human GPR84.</div><div class="NLM_p">Through HTS, the commercially available compound 2-(benzylamino)-9,10-dimethoxy-6,7-dihydro-4<i>H</i>-pyrimido[6,1-<i>a</i>]isoquinolin-4-one (<b>1</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) was identified as an appropriate starting point with submicromolar potency (IC<sub>50</sub> = 735 nM) combined with favorable druglikeness properties,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> such as moderate lipophilicity (XlogP3 = 2.4), polar surface area (PSA = 63.2), and molecular weight (MW = 363.4).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Properties of Hit Compound <b>1</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0007.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hGPR84 GTPγS IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">735</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE4A IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">553</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">aqueous solubility 2% DMSO (μg/mL)</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 3/pH 7.4</td><td class="colsep0 rowsep0" align="left">>73/24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver microsomal stability</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>int</sub> MIC scaled (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">mouse: 10.4 (<i>n</i> = 2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">human: 1.9 (<i>n</i> = 2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatocyte stability</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>int</sub> HEP scaled (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">mouse: 10.6 (<i>n</i> = 2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">human: 1 (<i>n</i> = 2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intestinal permeability Caco-2 cells</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> A<sub>2</sub>B (10<sup>–6</sup> cm/s)/ER</td><td class="colsep0 rowsep0" align="left">15/2.0 (<i>n</i> = 2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hCYP inhibition</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% inhibition at 10 μM</td><td class="colsep0 rowsep0" align="left"><33 with CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 (midazolam and testosterone)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat PK 5 mg/kg po</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">1269</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–inf</sub> (ng·h/mL)</td><td class="colsep0 rowsep0" align="left">2588</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat PK 1 mg/kg iv</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (L h<sup>–1</sup> kg<sup>–1</sup>); CL (% LBF)</td><td class="colsep0 rowsep0" align="left">1.06; 21.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">1.27</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: AUC<sub>0–inf</sub>, area under curve (from time 0 to infinity); CL<sub>int</sub>, intrinsic clearance; <i>C</i><sub>max</sub>, maximum plasma concentration; DMSO, dimethyl sulfoxide; ER, efflux ratio; hCYP, human cytochrome P450; <i>F</i>, oral bioavailability; GTPγS, guanosine 5′-<i>O</i>-[γ-thio]triphosphate; HEP, hepatocyte; hGPR84, human G-protein-coupled receptor 84; IC<sub>50</sub>, half maximal inhibitory concentration; iv, intravenous; LBF, liver blood flow; MIC, microsomal; MW, molecular weight; <i>P</i><sub>app</sub> A<sub>2</sub>B, apparent permeability from apical to basal chambers; PDE4A, phosphodiesterase 4; PK, pharmacokinetics; po, per os; PSA, polar surface area; <i>T</i><sub>1/2</sub>, half-life; <i>V</i><sub>ss</sub>, apparent volume of distribution at steady state.</p></div></div></div><div class="NLM_p">Compound <b>1</b> showed moderate <i>in vitro</i> metabolic clearance in both mouse and human microsomes and hepatocytes (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). <i>In vivo</i> intravenous (iv) dosing at 1 mg/kg in Sprague Dawley rats confirmed a moderate plasma clearance and revealed a moderate volume of distribution and short terminal half-life (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_p">The favorable physicochemical parameters of <b>1</b> translated into high apparent permeability in Caco-2 cells with a low efflux ratio (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). When administered orally to Sprague Dawley rats at 5 mg/kg in polyethylene glycol (PEG) 200/H<sub>2</sub>O (60/40; v/v), high plasma exposure (<i>C</i><sub>max</sub> = 1269 ng/mL and AUC<sub>0–inf</sub> = 2588 ng·h/mL) was obtained for <b>1</b> with a 50% oral bioavailability (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The hit series did not show marked inhibition of either cytochrome P450 (CYP) or human ether-à-go-go-related gene (hERG).</div><div class="NLM_p">At the start of our investigations, the presence of two methoxy groups in the 9 and 10 positions of the isoquinoline moiety raised some concerns, as such groups might play the role of the catechol ether structural motif common to most of the phosphodiesterase 4 (PDE4A) inhibitors<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21,22)</a> and introduce a PDE4A inhibitory component to the hit series already reported for 9 and 10 substituted dialkoxy analogues of pyrimido[6,1-<i>a</i>]isoquinolin-4-ones.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">PDE4 inhibitors possess a broad range of anti-inflammatory effects but have pronounced nausea and emesis side effects. As the aim of this project was to generate selective antagonists allowing us to unequivocally assess the therapeutic potential of GPR84, we wanted to show less than 50% inhibition over PDE4A at 10 μM. PDE4A inhibitory activity of <b>1</b> was confirmed (IC<sub>50</sub> = 553 nM; <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). This led us to implement a PDE4A biochemical assay to assess the inhibitory activity of the compounds and gain SAR (structure–activity relationship) understanding to remove this residual PDE4A activity.</div><div class="NLM_p">Initial SAR investigations focused on modifications of the benzyl amine moiety. Potency was abolished by either replacement of the nitrogen atom by a carbon atom (<b>2</b>) or introduction of a carbon–carbon double bond in place of the amino-methyl linker (<b>3</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). A more favorable replacement was identified with the introduction of an oxygen atom, leading to an encouraging 5-fold increase in potency (<b>4</b>), compared with <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). We decided to consolidate the investigations with the oxygen atom in place.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. hGPR84 GTPγS, PDE4A, Human Neutrophil Migration, and Solubility Profiles of <b>1</b> Derivatives<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0008.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0009.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: ASOL, aqueous solubility; Cap, capric acid; Compd, compound; hGTPγS, human guanosine 5′-<i>O</i>-[γ-thio]triphosphate; Hum neutro, human neutrophil migration assay; IC<sub>50</sub>, half maximal inhibitory concentration; IP1, inositol monophosphate; PDE4A, phosphodiesterase 4.</p></div></div><div></div></div><div class="NLM_p">Improved potency (IC<sub>50</sub> = 21 nM, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) was observed with the introduction of an aliphatic chain that is common to the MCFA endogenous ligands (<b>5</b>), although solubility was drastically reduced by the lipophilic side chain (aqueous solubility [ASOL] pH 7.4 = 3 μg/mL).</div><div class="NLM_p">Various lipophilic spacers were introduced (<b>6</b> and <b>7</b>) and showed decreased potency compared with <b>4</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). With this ether linkage in place, introduction of a fluorine in the ortho position (<b>8</b>) had limited impact on potency, compared with <b>4</b>. Further assessment of PDE4A inhibitory activity showed no selectivity improvement. Moreover, <b>8</b> showed decreased metabolic stability in mouse microsomes (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), compared with <b>1</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. hGTPγS, PDE4A, and Mouse Liver Microsomal Stability of Substructural Derivatives<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0010.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0011.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: Compd, compound; CL<sub>int</sub>, intrinsic clearance; hGTPγS, human guanosine 5′-<i>O</i>-[γ-thio]triphosphate; IC<sub>50</sub>, half maximal inhibitory concentration; LMS, liver microsomal stability; Me, methyl group; PDE4A, phosphodiesterase 4.</p></div></div><div></div></div><div class="NLM_p">We probed the scope of polarity introduction which, if tolerated, could be beneficial for further improvement of metabolic stability. The addition of an ethylene glycol spacer (<b>9</b>) restored good potency (IC<sub>50</sub> = 63 nM) and gave a 150-fold increase compared with the match paired analogue (<b>7</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This disparity indicated a strong contribution from the oxygen atom introduced, possibly resulting from an H-bond interaction. Compound <b>9</b> showed a reduced inhibitory activity on PDE4A (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), leading to a 30-fold ratio selectivity. Internal investigations identified that GPR84 agonists such as embelin, DIM, and sodium decanoate were able to induce human neutrophil migration. GPR84 antagonists were able to specifically block neutrophil chemotaxis induced by GPR84 agonists (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00272/suppl_file/jm0c00272_si_001.pdf" class="ext-link">Supplemental Figure 4</a>). The embelin-induced neutrophil chemotaxis assay was used as an inflammatory disease relevant cell assay to determine the inhibitory activity of our GPR84 antagonists. Assessment of <b>9</b> showed a good translation of the antagonist effect on a target based GTPγS assay toward the human neutrophil migration assay (IC<sub>50</sub> = 128 nM; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Comparing the matched pairs <b>10</b> and <b>8</b> showed that the introduction of one nitrogen atom had only a moderate impact on potency; however, a positive impact was observed on metabolic stability (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) and its selectivity toward PDE4A (IC<sub>50</sub> = 1088; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">Replacement of the phenyl ring with a more polar tetrahydrofuran was tolerated for the 2-substituted heterocycle (<b>11</b>) and found inactive for the 3-substituted analogue (<b>12</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). This result is associated with the favorable impact observed on potency with the oxygen introduction (<b>9</b>) and may be indicative of a specific interaction of GPR84 with an oxygen atom in this position. In addition to increased potency, the position of oxygen in <b>11</b> improved selectivity against PDE4A (IC<sub>50</sub> = 2165 nM; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) and solubility (<b>9</b>, ASOL pH 7.4 = 26 μg/mL and <b>11</b>, ASOL pH 7.4 = 72 μg/mL). The potency of <b>9</b>, in the human neutrophil assay (IC<sub>50</sub> = 128 nM; <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), prompted investigation into the tolerance of further polarity. Replacement of the phenyl ring of <b>9</b> with a 2-pyridyl ring increased both the potency toward the target and the selectivity ratio over PDE4A (<b>13</b>, GTPγS IC<sub>50</sub> = 8 nM and selectivity ratio = 73).</div><div class="NLM_p">Sequence differences between human and mouse GPR84 (mouse GPR84 shares 85% with its human ortholog at the amino acid level) prompted us to assess activity of the hit series on mouse GPR84 receptor assays. At this stage of investigation, no cell line stably overexpressing the mouse receptor for the GTPγS assay was available. An assay measuring inositol monophosphate (IP1) using transiently transfected HEK293 cells with either the human or mouse recombinant GPR84 and a variant of a chimeric Gq protein was developed to allow direct comparison on mouse and human receptor under similar assay conditions. We confirmed the high inhibitory activity of <b>13</b> in the IP1-based hGPR84 assay (hGPR84 IP1 IC<sub>50</sub> = 11 nM) and observed an approximate 60-fold reduction in the IP1-based mouse GPR84 assay (mGPR84 IP1 IC<sub>50</sub> = 636 nM).</div><div class="NLM_p">Initial investigations demonstrated that a high potency in the nanomolar range could be reached in the human GTPγS assay, which translated into potent inhibition of human neutrophil migration. Further optimization comprised the consolidation of the attractive profile of the series, with the aim to improve the selectivity ratio by producing a compound that was inactive in the PDE4A assay or had at least a 100-fold selectivity.</div><div class="NLM_p">The presence of the catechol ether moiety in known potent inhibitors of PDE4A suggested a key role for this functional group in the enzyme pharmacophore, prompting further investigation of the impact of modifications in this region. The presence of the two methoxy substituents was found to be crucial to PDE4A activity but not mandatory for maintaining GPR84 inhibitory activity, as illustrated with the unsubstituted analogue <b>14</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Removal of either methoxy group markedly decreased PDE4A activity for the corresponding analogues (<b>15</b> and <b>16</b>; <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Of particular interest were the 9-methoxy substituted analogues, which showed a less than 10-fold loss of GPR84 activity in three matched pairs (<b>17</b> and <b>10</b>; <b>18</b> and <b>11</b>; <b>15</b> and <b>8</b>; <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The favorable selectivity trend was found to be well conserved when applied to the 2-fluoropyridine analogue (<b>17</b> and <b>10</b>; <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Despite decreased metabolic stability in mouse liver microsomes observed for the 9-substituted analogue <b>17</b> compared with the dimethoxy substituted analogue <b>10</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>), the gain in selectivity and the attractiveness of the undocumented 9-methoxy derivatives led us to continue in this direction.</div><div class="NLM_p">Introduction of the phenoxyethyl group (<b>19</b>) led to a 20-fold increase in potency compared with the moderately potent starting point <b>18</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), a marked improvement from the previous 6-fold increase in potency for the dimethoxy substituted matched pair analogues <b>11</b> and <b>9</b>. Additionally, <b>19</b> achieved good selectivity with an inhibitory activity above 10 μM in the PDE4A assay (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Within the chemical series, the preliminary results observed from liver microsomal stability data and the lipophilicity of the compounds seemed to point toward a favorable XlogP3 threshold below 3. Subsequent SAR optimization aimed to keep lipophilicity with XlogP3 below 3, retain the key β-oxygen, and determine the most suitable moieties for demonstrating a good metabolic profile while maintaining acceptable potency and selectivity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. hGTPγS, PDE4A, Liver Microsomal Stability, Hepatocyte Stability, PPB, and XlogP3 Profiles for Substructural Derivatives<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0012.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0013.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: CL<sub>int</sub>, intrinsic clearance; H, human; HEP, hepatocyte; hGTPγS, human guanosine 5′-<i>O</i>-[γ-thio]triphosphate; IC<sub>50</sub>, half maximal inhibitory concentration; M, mouse; MIC, microsomal; PPB, plasma protein binding; PDE4A, phosphodiesterase 4; R, rat.</p></div></div><div></div></div><div class="NLM_p">Replacement of the 2-tetrahydrofuryl with the homologous tetrahydro-2<i>H</i>-pyranyl moiety improved potency (<b>20</b>; <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) with a moderate increase in lipophilicity. However, a significant reduction in lipophilicity was achieved with the introduction of the 1,4-dioxane (<b>21</b>) with similar potency compared with <b>20</b> and improved metabolic stability in mouse and human liver microsomes and hepatocytes. The attractive absorption, distribution, metabolism, and excretion (ADME) profile obtained by introduction of the dioxane moiety prompted attempts to mitigate the associated reduced potency by adding moderate lipophilicity with fused heterocycles on the dioxane. This was achieved through fusion of a phenyl ring to produce <b>22</b> with increased potency (IC<sub>50</sub> = 50 nM; <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) but with severely reduced stability in mouse, rat, and human liver microsomes.</div><div class="NLM_p">To reduce the lipophilicity, a 2-pyridyl ring was fused to the dioxane to give <b>23</b>. However, the introduction of the nitrogen in the ortho position of the key β-oxygen resulted in reduced potency compared with <b>22</b>. Introducing the nitrogen to the ortho position of the other oxygen in the dioxane ring had a positive impact on potency (<b>24</b>) but was accompanied by a high intrinsic liver microsomal clearance in mice (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Assessment of the metabolic stability of compounds <b>18</b>–<b>24</b> in hepatocytes showed a good correlation of intrinsic clearance between liver microsomes and both mouse and human hepatocytes, indicating a major contribution in phase I metabolism (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_p">With the high potency of <b>24</b>, further optimization investigations focused on modifications of the 9 position with opportunistic introduction in one step of diverse and exotic commercially available moieties (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Assessment of the tolerability of this region to substantial modulation was investigated through the introduction of a negatively charged chain and a very bulky moiety. Interestingly, substitution of the methyl group with an acetic acid group from the potent compound <b>22</b> led only to a moderate 5-fold decrease in potency (<b>25</b>; <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Replacement of the methoxy group with 2-cyanophenyl (<b>26</b>) was neutral (IC<sub>50</sub> = 212 nM; <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) when compared with <b>21</b>. The compound was unstable in dog, monkey, and human liver microsomes, but moderate clearance was observed in rodents. Furthermore, <b>26</b> demonstrated good permeability in Caco-2 cells with low efflux and high systemic exposure in rat at 5 mg/kg (AUC<sub>0–Z</sub> of 2645 ng·h/mL [6.37 μM·h] following oral dosing in PEG200/water [60/40; v/v]) providing an interesting opportunity to evaluate the capability of the lead series to modulate inflammatory bowel disease (IBD).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. hGTPγS, XlogP3, Metabolic Stability, and Permeability Profiles of <b>25</b>, <b>26</b>, and <b>27</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0014.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0015.gif" alt="" id="fx9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: CL<sub>int</sub>, intrinsic clearance; Compd, compound; ER, efflux ratio; hGTPγS, human guanosine 5′-<i>O</i>-[γ-thio]triphosphate; IC<sub>50</sub>, half maximal inhibitory concentration; MIC, minimum inhibitory concentration; <i>P</i><sub>app</sub> A<sub>2</sub>B, apparent permeability from apical to basal chambers.</p></div></div><div></div></div><div class="NLM_p">To assess <i>in vivo</i> efficacy, <b>26</b> was studied in a mouse chronic dextran sodium sulfate (DSS)-induced colitis model, a well-validated model for IBD.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> The DSS treatment significantly increased the disease activity index (DAI) score (sum of scores for weight loss, stool consistency, and fecal blood) reflecting active colitis. As expected, once-daily treatment with the positive control cyclosporine (administered at 25 mg/kg, once daily [qd]) diminished the DAI score in diseased mice. Once-daily treatment with <b>26</b> at 10 mg/kg qd reduced the DAI score at 8–11 days (<i>p</i> < 0.05 at day 9 versus diseased mice) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Encouraged by these <i>in vivo</i> data, subsequent optimization of the lead series was aimed at improving <i>in vivo</i> potency and metabolic stability in dog and human.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Disease activity index score in a mouse DSS-induced chronic colitis model. Diseased mice were administered with 4% DSS in drinking water for 4 days, followed by 3 days of regular drinking water and a new cycle of DSS. In addition they were orally administered <b>26</b> at 10 mg/kg once daily (qd), cyclosporine at 25 mg/kg qd (positive control), or vehicle for 11 consecutive days. Control mice were administered water alone as a negative control. Data are the mean ± SEM. No scores were measured on days 5 and 6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A 33-fold gain in potency was achieved by the addition of a bulky phenylpro-2-yn-1-ol moiety to the highly potent compound <b>24</b> to produce <b>27</b> with a subnanomolar potency on GPR84 (IC<sub>50</sub> = 0.6 nM; <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). This result confirmed the option of replacing the oxygen linker at the 9 position with a carbon atom, as with <b>26</b>. These additions, of both the negatively charged chain and bulky moiety, indicated a broad SAR tolerance in this region of the molecule. Further modification of this region was pursued with the aim of maintaining overall lipophilicity below the defined threshold for the series while benefiting from a gain in potency.</div><div class="NLM_p">The high potency of <b>27</b> was associated with increased lipophilicity (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), so further modifications aimed to achieve a good balance of these properties. The moderately potent <b>21</b> (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>) was selected as a starting compound as it afforded a 2 log margin for lipophilicity and required only an approximate 10-fold gain in potency to produce an attractive target molecule. Removal of the 9-methoxy substituent (<b>28</b>; <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) had a minor impact on the lipophilicity and the inhibitory activity (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Introduction of groups with growing size to maintain lipophilicity in the targeted range improved the potency (<b>29</b>, <b>30</b>, and <b>31</b>; <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). Introduction of a 2 ethylpyridyl moiety maintained a moderate lipophilicity and gave a remarkable potency (<b>32</b>) in human GTPγS and IP1 assays and reduced orthology shift in the mouse IP1 assay. However, while the compound showed low clearance in human microsomes (intrinsic clearance (CL<sub>int</sub>) scaled of 1.5 L h<sup>–1</sup> kg<sup>–1</sup>), it was highly cleared in mouse liver microsomes (CL<sub>int</sub> scaled of 31 L h<sup>–1</sup> kg<sup>–1</sup>) precluding further <i>in vivo</i> evaluation of the compound.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. hGTPγS, XlogP3, PDE4A, IP1, Liver Microsomal Stability, and Human Neutrophil Migration Profiles of Substructural Derivatives<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0016.gif" alt="" id="fx10" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0017.gif" alt="" id="fx11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: CL<sub>int</sub>, intrinsic clearance; Compd, compound; D, dog; H, human; hGTPγS, human guanosine 5′-<i>O</i>-[γ-thio]triphosphate; Hum neutro, human neutrophil migration; IC<sub>50</sub>, half maximal inhibitory concentration; IP1, inositol monophosphate; LMS, liver microsomal stability; M, mouse; MIC, microsomal; PDE4A, phosphodiesterase; R, rat.</p></div></div><div></div></div><div class="NLM_p">We decided to further exploit the initial path identified with compound <b>27</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Starting from a decreased level of lipophilicity, due to the removal of the fused pyridyl moiety, the phenyl ring linked to the secondary alcohol was replaced with an isobutyl group limiting the lipophilicity at XlogP3 = 2.3. Compound <b>33</b> showed good potency (IC<sub>50</sub> = 25 nM; <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>); however, in spite of a moderate lipophilicity, the compound was found to be insufficiently stable in rat liver microsomes (CL<sub>int</sub> scaled of 15.3 L h<sup>–1</sup> kg<sup>–1</sup>). Compound <b>34</b> was designed to remove the propargylic alcohol as a putative metabolite site and introduce a basic benzyl amine moiety. These modifications retained potency (IC<sub>50</sub> = 22 nM; <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), but <b>34</b> showed elevated liver microsomal clearances in both mouse and human (in mouse, CL<sub>int</sub> scaled of 26 L h<sup>–1</sup> kg<sup>–1</sup> and in human, CL<sub>int</sub> scaled of 5.3 L h<sup>–1</sup> kg<sup>–1</sup>).</div><div class="NLM_p">The addition of a simple cyclopropyl ring into the alkyne moiety maintained both acceptable lipophilicity and potency (IC<sub>50</sub> = 55 nM; <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>), and the resulting compound <b>35</b> was devoid of PDE4A activity. The high potency of the compound was confirmed in a human IP1 assay (IC<sub>50</sub> = 2 nM) and was found to be 10-fold less potent in the same assay in mice (IC<sub>50</sub> = 21 nM). In accordance with previous data, the high potency of <b>35</b> in GPR84 functional assays corresponded to high potency in human neutrophil migration assays (IC<sub>50</sub> = 17; <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>). A rat neutrophil migration assay was successfully developed and confirmed the high inhibitory activity of the compound (IC<sub>50</sub> = 119 nM) and the shift in activity from human to rodent. Additionally, <b>35</b> showed acceptable metabolic stability in human, rat, and mouse liver microsomes (CL<sub>int</sub> scaled of 2.2, 1.4 and 9.7, respectively).</div><div class="NLM_p">The attractive profile of <b>35</b>, with good potency in rat and human <i>in vitro</i> assays and improved metabolic stability in human liver microsomes, led to further <i>in vivo</i> studies. High plasma exposure was observed following oral administration at 5 mg/kg in rats with an AUC<sub>0–inf</sub> of 10246 ng·h/mL and a <i>C</i><sub>max</sub> of 2423 ng/mL at 1.7 h. In a mouse DSS-induced chronic IBD model, once-daily treatment with <b>35</b> at 1, 3, or 10 mg/kg dose-dependently reduced the DAI score; <b>35</b> at 10 mg/kg was found to have similar efficacy as cyclosporine at 25 mg/kg, the positive control (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Disease activity index score in a mouse DSS-induced chronic colitis model. Diseased mice were administered with 4% DSS in drinking water for 4 days, followed by 3 days of regular drinking water and a new cycle of DSS. In addition they were orally administered <b>35</b> at 1*, 3<sup>†</sup> or 10<sup>‡</sup> mg/kg qd, cyclosporine at 25 mg/kg qd (positive control), or vehicle, for 11 consecutive days. Control mice were administered water alone as a negative control. Data are the mean ± SEM. No scores were measured on days 5 and 6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The attractive profile of the compound instigated efforts to isolate and characterize the two enantiomers of <b>35</b> (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). When profiled in terms of ADME and biological assays, the two enantiomers (<i>S</i>) <b>36</b> and (<i>R</i>) <b>37</b> showed moderate differences favoring the (<i>S</i>) enantiomer <b>36</b> (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Compound <b>36</b> was approximately 5-fold more potent in human neutrophil migration assays (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>) but only slightly more potent in human GTPγS and rat and dog neutrophil migration assays (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Both enantiomers appeared stable in hepatocytes when incubated at 1 μM, with a low predicted hepatic clearance for rat, mouse, dog, and human (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). The two enantiomers did not show marked differences in binding to plasma protein when assessed in four different species in an <i>in vitro</i> equilibrium dialysis PPB assay (tested at 5 μM) (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). The assessment of the CYP inhibitory potential of the two enantiomers was markedly more favorable for <b>36</b>. The IC<sub>50</sub> was determined using human liver microsomes with probe substrates for CYP1A2, 2C9, 2C19, 2D6, and 3A4 (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). The IC<sub>50</sub> value for <b>36</b> for each of the CYP isoenzymes was >33 μM (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>), whereas the (<i>R</i>) enantiomer showed micromolar inhibition of the CYP2C9 isoform (IC<sub>50</sub> = 1.85 μM; <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>) and moderate inhibition of CYP2C19 (IC<sub>50</sub> = 18 μM; <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). In addition, there was no evidence for time-dependent inhibition of CYP3A4 by <b>36</b> (human liver microsomes, midazolam, and testosterone used as probe substrates to assess remaining enzyme activity) and the IC<sub>50</sub> was >50 μM, both with and without preincubation.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Profiles of the Two Enantiomers of <b>35</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0018.gif" alt="" id="GRAPHIC-d7e1800-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>36</b> (<i>S</i>)</th><th class="colsep0 rowsep0" align="center"><b>37</b> (<i>R</i>)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hGPR84 (GTPγS IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">54</td><td class="colsep0 rowsep0" align="left">102</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human neutrophil assay (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat neutrophil assay (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">111</td><td class="colsep0 rowsep0" align="left">153</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog neutrophil assay (IC<sub>50</sub>, nM)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">aqueous solubility 2% DMSO (μg/mL)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 3/pH 7.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">113/113</td><td class="colsep0 rowsep0" align="left">113/113</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">thermodynamic solubility (μg/mL)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 3/pH 7.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">12.6/7.75</td><td class="colsep0 rowsep0" align="left">17.6/9.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">liver microsomal stability 1 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>int</sub> MIC scaled (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">5.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">4.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">5.34</td><td class="colsep0 rowsep0" align="left">3.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left"><1.16</td><td class="colsep0 rowsep0" align="left">0.962</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">hepatocyte stability 1 μM</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (min)/CL<sub>int</sub> HEP scaled (L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">>200/<4.37</td><td class="colsep0 rowsep0" align="left">>200/<4.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">>200/<2.0</td><td class="colsep0 rowsep0" align="left">>188/<2.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">>200/<1.45</td><td class="colsep0 rowsep0" align="left">>151/<1.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">>200/<1.28</td><td class="colsep0 rowsep0" align="left">>200/<1.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="left">intestinal permeability Caco-2 cells</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>P</i><sub>app</sub> A<sub>2</sub>B (×10<sup>–6</sup> cm/s)/ER</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">41.9/1.05</td><td class="colsep0 rowsep0" align="left">31.2/1.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhibition HLM IC<sub>50</sub> (μM)</td><td class="colsep0 rowsep0" align="left">1A2</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C19</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">18.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2D6</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">31.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2C9</td><td class="colsep0 rowsep0" align="left">34.6</td><td class="colsep0 rowsep0" align="left">1.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3A4 mid</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3A4 test</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB % bound</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">97.8</td><td class="colsep0 rowsep0" align="left">98.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">97.7</td><td class="colsep0 rowsep0" align="left">96.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">97.2</td><td class="colsep0 rowsep0" align="left">94.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">93.5</td><td class="colsep0 rowsep0" align="left">96.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: CL<sub>int</sub>, intrinsic clearance; CYP, cytochrome P450; DMSO, dimethyl sulfoxide; ER, efflux ratio; GTPγS, guanosine 5′-<i>O</i>-[γ-thio]triphosphate; HEP, hepatocyte; HLM, human liver microsome; IC<sub>50</sub>, half maximal inhibitory concentration; IP1, inositol monophosphate; MIC, microsomal; <i>P</i><sub>app</sub> A<sub>2</sub>B, apparent permeability from apical to basal chambers; PPB, plasma protein binding.</p></div></div></div><div class="NLM_p">The pharmacokinetic profile (PK) of <b>36</b> was assessed in three species (mouse, rat, and dog) after an iv administration at 1 mg/kg (in mouse) or 0.5 mg/kg (in rat and dog) and an oral administration in fasted animals at 5 mg/kg (in mouse) or 2.5 mg/kg (in rat and dog). PEG200/NaCl 0.9% (60/40; v/v) was used as formulation for the iv route and PEG200/water (60/40; v/v) for the po route. A high oral exposure was obtained in all three species (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>), giving a bioavailability of 100%. A high total clearance was observed in dogs but did not preclude its progression owing to acceptable clearances in other species. The use of the recently introduced unbound clearance parameter shows that this is due to the lower PPB in dog (93.5% of binding) compared with mouse, rat, and human, leading to a lower unbound clearance (CL<sub>unb</sub> = 18.5). The volume of distribution was low in mice and high in dogs.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Pharmacokinetic Parameters of <b>36</b> in Different Species<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">mouse</th><th class="rowsep1 colsep0" colspan="2" align="center">rat</th><th class="rowsep1 colsep0" colspan="2" align="center">dog</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">1 mg/kg iv (<i>n</i> = 3)</th><th class="colsep0 rowsep0" align="center">5 mg/kg po (<i>n</i> = 3)</th><th class="colsep0 rowsep0" align="center">0.5 mg/kg iv (<i>n</i> = 3)</th><th class="colsep0 rowsep0" align="center">2.5 mg/kg po (<i>n</i> = 3)</th><th class="colsep0 rowsep0" align="center">0.5 mg/kg iv (<i>n</i> = 3)</th><th class="colsep0 rowsep0" align="center">2.5 mg/kg po (<i>n</i> = 3)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>0</sub> or <i>C</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">(ng/mL)</td><td class="colsep0 rowsep0" align="left">1227</td><td class="colsep0 rowsep0" align="left">4593</td><td class="colsep0 rowsep0" align="left">395</td><td class="colsep0 rowsep0" align="left">1164</td><td class="colsep0 rowsep0" align="left">NC</td><td class="colsep0 rowsep0" align="left">558</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">(h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–24h)</sub></td><td class="colsep0 rowsep0" align="left">(ng·h/mL)</td><td class="colsep0 rowsep0" align="left">1054</td><td class="colsep0 rowsep0" align="left">15349</td><td class="colsep0 rowsep0" align="left">710</td><td class="colsep0 rowsep0" align="left">4469</td><td class="colsep0 rowsep0" align="left">410</td><td class="colsep0 rowsep0" align="left">2232</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL</td><td class="colsep0 rowsep0" align="left">(L h<sup>–1</sup> kg<sup>–1</sup>)/(% LBF)</td><td class="colsep0 rowsep0" align="left">0.9/11</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.7/14</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.2/48</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>unb</sub></td><td class="colsep0 rowsep0" align="left">(L h<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">40.9</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">30.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">18.5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub></td><td class="colsep0 rowsep0" align="left">(L/kg)</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">(h)</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i></td><td class="colsep0 rowsep0" align="left">(%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: AUC, area under curve; CL, clearance; CL<sub>unb</sub>, clearance unbound calculated using PPB data (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>); <i>C</i><sub>max</sub>, maximum plasma concentration; <i>C</i><sub>0</sub>, concentration extrapolated at <i>T</i><sub>0</sub> after a bolus iv dose; <i>F</i>, bioavailability; LBF, liver blood flow; <i>t</i><sub>1/2</sub>, half-life; <i>T</i><sub>max</sub>, time at <i>C</i><sub>max</sub>; <i>V</i><sub>ss</sub>, volume of distribution.</p></div></div></div><div class="NLM_p">In competition studies, <b>36</b> was found to block agonist effects of both modulators considered as orthosteric ligands, such as C10 and embelin, and allosteric ligands, such as PSB-16671 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). In parallel to the progression of <b>36</b>, additional potent compounds with modified substitutions in position 9 and different side chains in the northern region of the compound were identified. Compound <b>38</b>, with a phenethyl chain in position 9 and a 2-ethoxypyrazine moiety in the northern region (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B), reached a high potency level in the hGTPγS assay (IC<sub>50</sub> = 5 nM). In addition to being one of the most potent analogues in the GTPγS assay, the straightforward synthetic introduction of a tritium atom into the molecule from the corresponding 3-chlorophenetyl derivative guided the selection of <b>38</b> as a target for generating a radiolabeled ligand ([<sup>3</sup>H]<b>38</b> was prepared by Quotient Bioresearch). Compound <b>36</b> competed well with its analogue [<sup>3</sup>H]<b>38</b> with a p<i>K</i><sub>i</sub> of 7.52. Increasing concentrations of C10 were unable to displace the [<sup>3</sup>H]<b>38</b> ligand, suggesting an allosteric binding site for the GPR84 antagonists (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). In the same competition experiment, PSB-16671, an allosteric agonist from the DIM series, showed only moderate displacement at a very high dose (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). In a Schild experiment, further characterization of the interaction between the two ligands showed <b>36</b> to act dose-dependently as a noncompetitive and reversible blocker of PSB-16671, with a decreased maximum effect rather than markedly increasing the half maximal effective concentration (EC<sub>50</sub>) (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D). These results, combined with previous studies showing that [<sup>3</sup>H]<b>38</b> binding was not affected by mutation of key residue Arg172,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> indicate that <b>36</b> acts as a negative allosteric modulator of the known GPR84 agonists.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Effect of increasing concentrations of <b>36</b> on effects of orthosteric and allosteric GPR84 agonists (GTPyS assay with agonists used at EC<sub>80</sub>). (B) Structure of tritiated ligand <b>38</b>. (C) Ability of various concentrations of C10, PSB-16671, and <b>36</b> to compete for binding with [<sup>3</sup>H]<b>38</b> to GPR84 (competition binding + 0.2 nM [<sup>3</sup>H]<b>38</b>). (D) Schild analysis showing inhibition of PSB-16671 activity with <b>36</b> at concentrations of 10 nM, 30 nM, 100 nM, and 300 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a mouse DSS-induced chronic IBD model, once-daily treatment with <b>36</b> at 3 or 10 mg/kg reduced the DAI score (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). In the colon, compound <b>36</b> also reduced neutrophil infiltration induced by DSS, a pharmacodynamics marker in relation to <i>in vitro</i> neutrophil chemotaxis activity (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). The pharmacodynamics marker was reversed by <b>36</b> at 3 mg/k and 10 mg/kg, with a similar dose effect to DAI. This provides a mechanistic insight, clearly indicating the capacity of <b>36</b> to reduce neutrophil migration toward the inflamed colonic tissue. This activity was associated with a <i>C</i><sub>max</sub> of 1837 ng/mL and an exposure level (AUC<sub>0–24h</sub>) of 5556 ng·h/mL (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>).</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Diseased mice (DSS-induced chronic colitis model) were administered with 4% DSS in drinking water for 4 days, followed by 3 days of regular drinking water and a new cycle of DSS. In addition they were orally administered <b>36</b> at 3* and 10<sup>†</sup> mg/kg qd, sulfasalazine 20 mg/kg qd (positive control) or vehicle, for 11 consecutive days. Control mice were administered water alone as a negative control. (A) Disease activity index score. Data are the mean ± SEM. No scores were measured on days 5 and 6. (B) Neutrophil density (number of cells per square millimeter of colon area, as determined by immunohistochemistry assay with anti-Ly6G/Ly6C antibodies).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Pharmacokinetic Parameters of <b>36</b> at Steady State in Female BALB/c Mice after Multiple Oral Doses of 3 or 10 mg kg<sup>–1</sup> day<sup>–1</sup> <a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">3 mg kg<sup>–1</sup> day<sup>–1</sup> (<i>n</i> = 2 or 3)</th><th class="colsep0 rowsep0" align="center">10 mg kg<sup>–1</sup> day<sup>–1</sup> (<i>n</i> = 2 or 3)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">(ng/mL)</td><td class="colsep0 rowsep0" align="left">1837</td><td class="colsep0 rowsep0" align="left">8140</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub>/dose</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">612</td><td class="colsep0 rowsep0" align="left">814</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">(h)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–24h)</sub></td><td class="colsep0 rowsep0" align="left">(ng·h/mL)</td><td class="colsep0 rowsep0" align="left">5556</td><td class="colsep0 rowsep0" align="left">50387</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>(0–24h)</sub>/dose</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1852</td><td class="colsep0 rowsep0" align="left">5039</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">(h)</td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">2.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Abbreviations: AUC, area under curve; <i>C</i><sub>max</sub>, maximum plasma concentration; <i>T</i><sub>max</sub>, time to <i>C</i><sub>max</sub>; <i>t</i><sub>1/2</sub>, half-life.</p></div></div></div><div class="NLM_p">Compound <b>36</b> was tested in three independent mouse DSS-induced chronic IBD studies at 1, 3, or 10 mg/kg to confirm the efficacy and to define the minimal efficacious dose (MED). The dose of 1 mg/kg dose was inactive; however the dose of 3 mg/kg was constantly found active in all three studies and thus was considered as the MED.</div><div class="NLM_p last">Compound <b>36</b> was further profiled in a diverse set of selectivity assays. Compound <b>36</b> was fully selective over close homologs GPR43 (FFA2R) and GPR41 (FFA3R) (no inhibition up to 10 μM in [Ca<sup>2+</sup>]<sub>i</sub> flux assay) and >100-fold selective over 123 other GPCRs on a Millipore GPCR Profiler panel. Compound <b>36</b> was remarkably selective over a kinase panel, displaying only weak inhibitory activity against maternal embryonic leucine zipper kinase (MELK; 57% inhibition at a concentration of 10 μM) out of a selection of 152 kinases (Reaction Biology, Malvern, PA, USA); this inhibitory activity was not considered to be clinically relevant. Similar high selectivity was also observed against a diverse panel of 67 enzymes focusing mostly on ion channels and transporters. Compound <b>36</b> was considered to present a low cardiovascular risk due to the minimal impact observed on the amplitude of the IKr current in the <i>in vitro</i> hERG manual patch clamp assay and the lack of effect on hemodynamic and electrocardiographic parameters in telemetered monkeys. Compound <b>36</b> was assessed in the full Ames test, up to concentrations of 5000 μg/plate, in the presence and absence of S9 fraction, leading to the conclusion that <b>36</b> is not mutagenic in the <i>Salmonella typhimurium</i> reverse mutation assay and in the <i>Escherichia coli</i> reverse mutation assay. Compound <b>36</b> did not have any genotoxic effect <i>in vitro</i> in the mouse lymphoma assay or <i>in vivo</i> in the bone marrow micronucleus test in rats. Compound <b>36</b> did not show any teratogenic or embryotoxic effects in rats, up to the highest tolerated maternal dose of 50 mg kg<sup>–1</sup> day<sup>–1</sup>. In addition, no phototoxic effects with <b>36</b> have been observed <i>in vivo</i> in rats and mice.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> GLPG1205 Synthesis</h3><div class="NLM_p">GLPG1205 (<b>36</b>) was synthesized in nine linear steps that all proceeded with yields higher than 70% and involved readily available starting material (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (<i>S</i>)-GLPG1205 (<b>36</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) urea, AcOH, conc HCl, water, reflux; (b) conc HBr, reflux; (c) AllylBr, K<sub>2</sub>CO<sub>3</sub>, DMF; (d) Na, EtOH, diethyl malonate, reflux; (e) POCl<sub>3</sub>, 50 °C; (f) [(2<i>R</i>)-1,4-dioxan-2-yl]methanol, <i>t</i>BuOK, DCM; (g) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, MeOH/THF; (h) PhN(SO<sub>3</sub>CF<sub>3</sub>)<sub>2</sub>, Et<sub>3</sub>N, DCM; (i) ethynylcyclopropane, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, Et<sub>3</sub>N, DMF.</p></p></figure><div class="NLM_p last">Starting from 3-methoxyphenethylamine, refluxing urea in acetic acid overnight led to the urea analogue. Demethylation was carried out upon overnight reflux with hydrogen bromide to lead to the corresponding phenol derivative which was further protected by introduction of an allyl group. Condensation with diethyl malonate afforded the hexahydropyrimidine-2,4,6-trione which underwent regioselective cyclization reaction with treatment with POCl<sub>3</sub>. Subsequent O-alkylation with commercially available or easily prepared (<i>R</i>)-(1,4-dioxan-2-yl)methanol<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> followed by deprotection of the allyl group led to the phenol intermediate. The phenol intermediate was converted into the corresponding triflate for further use in Sonogashira coupling reaction with ethynylcyclopropane, providing GLPG1205. The purity of all compounds was determined by liquid chromatography–mass spectrometry (LCMS) and <sup>1</sup>H NMR. Minor adaptations of this synthetic route afforded 9,10-dimethoxy derivatives starting from 3,4-dimethoxyphenethylamine.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The progression of the commercially available hit compound <b>1</b> to the clinical candidate <b>36</b> was achieved by structure optimization to improve potency (GTPγS assay), metabolic stability, lipophilicity, and selectivity against PDE4A. In a mouse DSS-induced chronic IBD model, treatment with <b>36</b> reduced both the DAI score and neutrophil infiltration at oral doses of 3 and 10 mg/kg qd, with an efficacy similar to the positive control compound sulfasalazine. A phase I first-in-human study<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and a phase IIa study in IBD (ulcerative colitis; NCT02337608)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> confirmed favorable PK, safety, and tolerability profiles for <b>36</b>, but the compound failed to meet the primary efficacy end point in the latter, and as GLPG1205 is the first in class GPR84 antagonist tested in clinical study, additional translational studies would contribute to the further understanding of results.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The biology of GPR84 has been further investigated and a potential role in fibrosis described in different organs including the kidney<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and liver.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Moreover, GLPG1205 (<b>36</b>) has demonstrated reduced lung fibrosis in two mouse models in a therapeutic setting.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> GLPG1205 (<b>36</b>) is currently being evaluated in a phase II study in patients with idiopathic pulmonary fibrosis. Additional safety, pharmacological, PK, and clinical data will be reported in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83688" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83688" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry. Methods</h3><div class="NLM_p last">All reagents were of commercial grade and were used as received without further purification unless otherwise stated. Commercially available anhydrous solvents were used for reactions conducted under inert atmosphere. Reagent grade solvents were used in all other cases unless otherwise specified. Column chromatography was performed on silica gel 60 (35–70 μm). Thin layer chromatography was carried out using precoated silica gel F-254 plates (thickness 0.25 mm). Microwave heating was performed with a Biotage Initiator apparatus (Biotage, Uppsala, Sweden). Celpure P65 (Merck KgaA, Darmstadt, Germany) is a filtration aid and commercial product (CAS number 61790-53-2). <sup>1</sup>H NMR spectra were recorded on a Bruker DPX 400 NMR spectrometer (400 MHz) (Bruker, Billerica, MA, USA) or a Bruker Avance 300 NMR spectrometer (300 MHz) (Bruker, Billerica, MA, USA). Chemical shifts (δ) for <sup>1</sup>H NMR spectra are reported in parts per million (ppm) relative to tetramethylsilane (δ 0.00) or the appropriate residual solvent peak, i.e., CHCl<sub>3</sub> (δ 7.27), as internal reference. Multiplicities are given as singlet (s), doublet (d), triplet (t), quartet (q), quintuplet (quin), multiplet (m), and broad (br). Waters Acquity UPLC (Waters, Elstree, U.K.) with Waters Acquity PDA detector (Waters, Elstree, U.K.) and SQD mass spectrometer (Waters, Elstree, U.K.) were used to generate UV and MS chromatograms as well as MS spectra. Columns used were the following: UPLC BEH C18 1.7 μm, 2.1 mm × 5 mm, VanGuard Precolumn (Waters, Elstree, U.K.) with Acquity UPLC BEH C18 1.7 μm, 2.1 mm × 30 mm column or Acquity UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm column. LC–MS analyses were conducted using the following two methods. Method 1: solvent A, H<sub>2</sub>O–0.05% NH<sub>4</sub>OH; solvent B, MeCN–0.05% NH<sub>4</sub>OH; flow rate, 0.8 mL/min; start 5% B, final 95% B in 1.55 min, linear gradient. Method 2: solvent A, H<sub>2</sub>O–0.1% HCO<sub>2</sub>H; solvent B, MeCN–0.1% HCO<sub>2</sub>H; flow rate, 0.8 mL/min; start 5% B, final 95% B in 1.55 min, linear gradient. All final compounds reported were analyzed using one of these analytical methods, and purity is greater than 95% or otherwise indicated in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00272/suppl_file/jm0c00272_si_001.pdf" class="ext-link">Supporting Information</a>. Autopurification system from Waters was used for LC–MS purification. LC–MS columns used: Waters XBridge Prep OBD C18 5 μm, 30 mm × 100 mm (preparative column) and Waters XBridge BEH C18 5 μm, 4.6 mm × 100 mm (analytical column) (Waters, Elstree, U.K.). All the methods used MeCN/H<sub>2</sub>O gradients. MeCN and H<sub>2</sub>O contained either 0.1% formic acid or 0.1% diethylamine.</div></div><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-(3-Methoxyphenyl)ethylurea</h3><div class="NLM_p last">A solution of 3-methoxyphenethylamine (100 g, 661.3 mmol), urea (157.3 g, 2619.0 mmol), glacial AcOH (36 mL), and concentrated HCl (12 mL) in H<sub>2</sub>O (800 mL) was heated under reflux for 5 days. The reaction mixture was cooled to room temperature (RT), and the precipitate obtained was filtered off, washed with water, and dried under vacuum to give 2-(3-methoxyphenyl)ethylurea as a white solid (92 g, 72% yield). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.18 (t, <i>J</i> = 8.1 Hz, 1H), 6.83–6.71 (m, 3H), 3.77 (s, 3H), 3.37–3.31 (m, 2H), 2.74 (t, <i>J</i> = 7.2 Hz, 2H).</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-(3-Hydroxyphenyl)ethylurea</h3><div class="NLM_p last">A solution of 2-(3-methoxyphenyl)ethylurea (92 g, 473.6 mmol) in concentrated HBr (600 mL) was heated under reflux overnight. The reaction was cooled to RT and basified by addition of NaHCO<sub>3</sub> and extracted with EtOAc. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to give crude 2-(3-hydroxyphenyl)ethylurea as a light brown solid (67 g) which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.25 (s, 1H), 7.07 (td, <i>J</i> = 7.2, 1.8 Hz, 1H), 6.65–6.55 (m, 3H), 5.89 (t, <i>J</i> = 5.8 Hz, 1H), 3.16 (dt, <i>J</i> = 7.7, 6.3 Hz, 2H), 2.57 (t, <i>J</i> = 7.3 Hz, 2H). LCMS: <i>m</i>/<i>z</i> 181 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-(3-Allyloxyphenyl)ethylurea</h3><div class="NLM_p last">To a solution of crude 2-(3-hydroxyphenyl)ethylurea (67 g, 371.0 mmol) and K<sub>2</sub>CO<sub>3</sub> (154 g, 1115.0 mmol) in DMF (400 mL) was added allyl bromide (75 mL, 743.6 mmol), and the reaction was stirred for 2.5 days. DMF was concentrated under reduced pressure and then the residue was dissolved in EtOAc, washed with a saturated aqueous solution of Na<sub>2</sub>CO<sub>3</sub> followed by brine, then dried over MgSO<sub>4</sub>. Concentration under reduced pressure gave crude 2-(3-allyloxyphenyl)ethylurea as a colorless solid (79 g) which was used in the next step without further purification. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.97 (s, 1H), 7.22–7.13 (m, 1H), 6.84–6.71 (m, 3H), 6.13–5.97 (m, 1H), 5.39 (dq, <i>J</i> = 17.3, 1.7 Hz, 1H), 5.23 (dq, <i>J</i> = 10.6, 1.6 Hz, 1H), 4.52 (ddt, <i>J</i> = 5.1, 3.5, 1.6 Hz, 2H), 3.34 (d, <i>J</i> = 7.0 Hz, 2H), 2.98 (d, <i>J</i> = 0.6 Hz, 2H), 2.74 (t, <i>J</i> = 7.3 Hz, 2H). LCMS: <i>m</i>/<i>z</i> 221 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 1-[2-(3-Allyloxyphenyl)ethyl]hexahydropyrimidine-2,4,6-trione</h3><div class="NLM_p last">To a stirred solution of sodium (16 g, 718.0 mmol) in EtOH (1.0 L), diethyl malonate (109.1 mL, 718.0 mmol) was added, and the reaction mixture was heated under reflux for 1 h. Crude 2-(3-allyloxyphenyl)ethylurea (72 g, 359.0 mmol) in EtOH (200 mL) was added, and the reaction mixture was heated under reflux for 12 h. The reaction was cooled to RT, 1 M aq HCl was added, and the precipitate obtained was filtered off, washed with water, and dried under vacuum to give 1-[2-(3-allyloxyphenyl)ethyl]hexahydropyrimidine-2,4,6-trione as a yellow solid (82 g, 79% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.36 (s, 1H), 7.25–7.16 (m, 1H), 6.87–6.72 (m, 3H), 6.05 (ddt, <i>J</i> = 17.3, 10.5, 5.3 Hz, 1H), 5.41 (dq, <i>J</i> = 17.3, 1.6 Hz, 1H), 5.28 (dq, <i>J</i> = 10.5, 1.4 Hz, 1H), 4.53 (dt, <i>J</i> = 5.3, 1.5 Hz, 2H), 4.15–4.04 (m, 2H), 3.61 (s, 2H), 2.92–2.82 (m, 2H). LCMS: <i>m</i>/<i>z</i> 289 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 9-Allyloxy-2-chloro-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one</h3><div class="NLM_p last">A solution of 1-[2-(3-allyloxyphenyl)ethyl]hexahydropyrimidine-2,4,6-trione (50 g, 173.4 mmol) in POCl<sub>3</sub> (100 mL) was stirred at 50 °C for 3 days. POCl<sub>3</sub> was concentrated under pressure, and the residue was dissolved in dichloromethane (DCM) and quenched with a saturated aqueous solution of NaHCO<sub>3</sub>. The organic layer was washed with water, dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to give crude 9-allyloxy-2-chloro-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one as a yellow solid (46 g, 92% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.67 (d, <i>J</i> = 8.8 Hz, 1H), 6.94 (dd, <i>J</i> = 8.8, 2.6 Hz, 1H), 6.85–6.80 (m, 1H), 6.67 (s, 1H), 6.04 (ddt, <i>J</i> = 17.2, 10.5, 5.2 Hz, 1H), 5.43 (dq, <i>J</i> = 17.3, 1.6 Hz, 1H), 5.34 (dq, <i>J</i> = 10.5, 1.4 Hz, 1H), 4.62 (dt, <i>J</i> = 5.3, 1.5 Hz, 2H), 4.26–4.19 (m, 2H), 3.01 (t, <i>J</i> = 6.7 Hz, 2H). LCMS: <i>m</i>/<i>z</i> 289 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 9-Allyloxy-2-[[(2<i>S</i>)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one</h3><div class="NLM_p last">To a solution of (<i>R</i>)-2-hydroxymethyl[1,4]dioxane (1.82 g, 15.4 mmol) in anhydrous DCM (100 mL) under N<sub>2</sub> at 0 °C, NaH (618 mg, 15.4 mmol, 60% in mineral oil) was added and stirred for 15 min. 9-Allyloxy-2-chloro-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one (3.43 g, 11.9 mmol) was added, and the reaction mixture was stirred and warmed up to RT overnight. Saturated NH<sub>4</sub>Cl was added, and the organic layer was washed with water, dried over MgSO<sub>4</sub>, and concentrated under reduced pressure. The crude product was purified by flash chromatography on silica gel eluting with 5% MeOH in DCM to afford 9-allyloxy-2-[[(2<i>S</i>)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one as a yellow solid (2.90 g, 66% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.95 (d, <i>J</i> = 8.7 Hz, 1H), 7.02–6.93 (m, 2H), 6.54 (s, 1H), 6.06 (ddt, <i>J</i> = 17.3, 10.5, 5.2 Hz, 1H), 5.42 (dq, <i>J</i> = 17.3, 1.7 Hz, 1H), 5.29 (dq, <i>J</i> = 10.6, 1.5 Hz, 1H), 4.67 (dt, <i>J</i> = 5.3, 1.5 Hz, 2H), 4.30–4.20 (m, 2H), 4.06–3.98 (m, 2H), 3.85 (dddd, <i>J</i> = 10.0, 5.9, 4.4, 2.6 Hz, 1H), 3.78 (td, <i>J</i> = 10.7, 10.1, 2.8 Hz, 2H), 3.70–3.56 (m, 2H), 3.49 (td, <i>J</i> = 10.8, 2.7 Hz, 1H), 3.38 (dd, <i>J</i> = 11.4, 9.9 Hz, 1H), 2.97 (t, <i>J</i> = 6.5 Hz, 2H). LCMS: <i>m</i>/<i>z</i> 371 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 2-[[(2<i>S</i>)-1,4-Dioxan-2-yl]methoxy]-9-hydroxy-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one</h3><div class="NLM_p last">To a suspension of 9-allyloxy-2-[[(2<i>S</i>)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one (31.2 g, 84.2 mmol) in a mixture of DCM/MeOH (300 mL/300 mL), K<sub>2</sub>CO<sub>3</sub> (23.27 g, 168.4 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (4.86 g, 4.21 mmol) were added, and the reaction mixture was degassed before stirring at RT overnight. After completion, the reaction was quenched with H<sub>2</sub>O, the aqueous layer was separated, and the pH was adjusted to pH 1 with 2 M aq HCl, and the precipitate formed was filtered off, washed with water, and dried to afford 2-[[(2<i>S</i>)-1,4-dioxan-2-yl]methoxy]-9-hydroxy-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one as a yellow solid (18.62 g, 67% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (s, 1H), 7.83 (d, <i>J</i> = 8.6 Hz, 1H), 6.77 (dd, <i>J</i> = 8.6, 2.5 Hz, 1H), 6.74 (d, <i>J</i> = 2.4 Hz, 1H), 6.44 (s, 1H), 4.28–4.18 (m, 2H), 4.03–3.94 (m, 2H), 3.89–3.72 (m, 3H), 3.69–3.56 (m, 2H), 3.49 (td, <i>J</i> = 10.8, 2.7 Hz, 1H), 3.37 (dd, <i>J</i> = 11.4, 9.9 Hz, 1H), 2.91 (t, <i>J</i> = 6.5 Hz, 2H). LCMS: <i>m</i>/<i>z</i> 331 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> [2-[[(2<i>S</i>)-1,4-Dioxan-2-yl]methoxy]-4-oxo-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-9-yl] Trifluoromethanesulfonate</h3><div class="NLM_p last">A solution of 2-[[(2<i>S</i>)-1,4-dioxan-2-yl]methoxy]-9-hydroxy-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one (23.25 g, 70.5 mmol), <i>N</i>-phenyl-bis(trifluoromethanesulfonimide) (27.69 g, 77.5 mmol), and Et<sub>3</sub>N (17.5 mL, 126.8 mmol) in DCM (800 mL) under N<sub>2</sub> was stirred at RT for 5 h. The reaction mixture was concentrated, and the crude product was purified by recrystallization from <i>i</i>PrOH to afford [2-[[(2<i>S</i>)-1,4-dioxan-2-yl]methoxy]-4-oxo-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-9-yl] trifluoromethanesulfonate as a white solid (24.5 g, 75% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.79 (d, <i>J</i> = 8.7 Hz, 1H), 7.31 (dd, <i>J</i> = 8.7, 2.6 Hz, 1H), 7.27–7.23 (m, 1H), 6.37 (s, 1H), 4.50–4.35 (m, 2H), 4.24 (dd, <i>J</i> = 7.1, 5.8 Hz, 2H), 4.02–3.93 (m, 1H), 3.90–3.69 (m, 4H), 3.65 (ddd, <i>J</i> = 11.7, 10.6, 3.0 Hz, 1H), 3.48 (dd, <i>J</i> = 11.5, 10.1 Hz, 1H), 3.07 (t, <i>J</i> = 6.5 Hz, 2H). LCMS: <i>m</i>/<i>z</i> 463 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 9-(2-Cyclopropylethynyl)-2-[[(2<i>S</i>)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one (<b>36</b>)</h3><div class="NLM_p last">To a solution of [2-[[(2<i>S</i>)-1,4-dioxan-2-yl]methoxy]-4-oxo-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-9-yl] trifluoromethanesulfonate (42 g, 90.8 mmol) in anhydrous DMF (840 mL), cyclopropylacetylene (15.38 mL, 181.6 mmol) was added followed by Et<sub>3</sub>N (31.5 mL, 227.0 mmol), and the mixture was degassed. Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (3.19g, 4.5 mmol) was added with CuI (3.46 g, 18.2 mmol), and the reaction mixture was heated at 50 °C overnight. The reaction mixture was concentrated and the crude was purified by flash chromatography on silica gel eluting with 1–3% MeOH in DCM to afford 9-(2-cyclopropylethynyl)-2-[[(2<i>S</i>)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-<i>a</i>]isoquinolin-4-one as a light brown solid (30.2 g, 88% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.57 (d, <i>J</i> = 8.2 Hz, 1H), 7.32 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 6.31 (s, 1H), 4.45–4.32 (m, 2H), 4.16 (dd, <i>J</i> = 7.0, 5.9 Hz, 2H), 4.00–3.90 (m, 1H), 3.87–3.57 (m, 5H), 3.45 (dd, <i>J</i> = 11.5, 10.1 Hz, 1H), 2.93 (t, <i>J</i> = 6.5 Hz, 2H), 1.45 (tt, <i>J</i> = 8.2, 5.0 Hz, 1H), 0.94–0.85 (m, 2H), 0.85–0.75 (m, 2H). LCMS: 0.70 min, <i>m</i>/<i>z</i> 379.5 [M + H]<sup>+</sup>. Chromatographic conditions: Waters Alliance HPLC, column Daicel Chiralpak (Chiral Technologies, West Chester, PA, USA) IG 4.6 mm i.d. × 250 mm, 5 μm particle size, wavelength 330 nm, flow rate 0.8 mL/min, column temperature 25 °C, injection volume 10 μL, run time 65 min, isocratic elution (85/15) <i>tert</i>-butyl methyl ether/ethanol, retention time 32.87 min.</div></div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Biology. HTS</h3><div class="NLM_p last">The cAMP assay measures the level of Gi protein activation following agonist occupancy of GPR84, in the presence of forskolin to stimulate production of cAMP, and adenylate cyclase and 3-isobutyl-1-methylxanthine (IBMX) to block phosphodiesterase activity. HEK293T samples stably transfected with recombinant human GPR84 (Multiscreen; Multispan, Hayward, CA, USA) were seeded at a density of 2500 cells/well in a 384-well plate in suspension on the day of the assay in assay buffer (1× Hanks’ balanced salt solution [HBSS]), 20 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 0.5 mM IBMX). GPR84 was stimulated with capric acid as the natural ligand at EC<sub>85</sub> (30.5 μM), and tested compounds were added simultaneously for 30 min before the addition of 1.5 μM forskolin for 30 min. Cells were lysed and analyzed for cAMP level using a competitive immunoassay in homogeneous time-resolved fluorescence (HTRF) format (Cisbio, Bedford, MA, USA). Fluorescence signals were read on a PerkinElmer ViewLux1430 microplate imager (PerkinElmer, Boston, MA, USA).</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Recombinant Human GPR84 GTPγS Binding Assay</h3><div class="NLM_p last">The assay was performed in a 96-well plate where the following reagents were added. First, 50 μL of hit compound from HTS was added into the assay plate, followed by addition of 20 μL of DIM at EC<sub>80</sub> concentration (concentration which gives 80% of the activity of GPR84) and was incubated with 30 μL of mixture consisting of membranes derived from stable cell line overexpressing recombinant human GPR84, [<sup>35</sup>S]GTPγS, and scintillation proximity assay (SPA) beads (PerkinElmer, Boston, MA, USA; RPNQ0001). All components were diluted in assay buffer containing 20 mM HEPES, pH 7.4; 5 mM MgCl<sub>2</sub>; 250 mM NaCl; 0.05% bovine serum albumin (BSA); 75 μg/mL saponin. Reactions were incubated at room temperature for 90 min followed by centrifugation. Plates were read on a Topcount reader (Molecular Devices, Sunnyvale, CA, USA) immediately after centrifugation.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> IP1 Assay</h3><div class="NLM_p">The IP1 assay using transiently transfected cells allowed the development of similar assays with overexpression of either mouse or human GPR84. IP1 activity was measured in HEK293T cells transiently transfected with a variant of Gq protein (GNAO1 transcription variant 1) and GPR84 using the Cisbio IP-One assay, which detected the accumulation of IP1, a stable downstream metabolite of IP3 induced by activation of a phospholipase C (PLC) cascade.</div><div class="NLM_p last">HEK293T cells were transiently transfected in suspension with a variant of Gq protein and recombinant mouse or human GPR84 using Jet-PEI (Polyplus-transfection, Sebastien Brant, France) and seeded at a density of 25 000 cells/well in a 384-well plate. After overnight incubation, the transfection mix was removed and replaced by cell culture medium for 24 h. The cells were then treated with test compounds for 30 min before addition of capric acid at EC<sub>80</sub> for 1 h for the human assay. As transfection of mouse GPR84 resulted in IP1 activity in the absence of capric acid stimulation, compounds were tested in inverse agonist mode without addition of capric acid. IP1 was measured using competitive immunoassay in HTRF format (Cisbio, Bedford, CA, USA) according to manufacturer’s instructions. Fluorescence signal was read on PerkinElmer EnVision (PerkinElmer, Boston, MA, USA).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> PDE4A Inhibition</h3><div class="NLM_p last">The IC<sub>50</sub> value for human PDE4A was determined in a HTRF based cAMP assay. PDE4A present in a HEK293 cell lysate containing overexpressed PDE4A hydrolyzes cAMP into 5′AMP. The amount of cAMP present is measured in a competitive immunoassay, which is based on competition between native cAMP and d2-labeled cAMP for binding to an anti-cAMP monoclonal antibody labeled with cryptate. The specific signal (i.e., energy transfer) is inversely proportional to the concentration of cAMP.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Human Neutrophil Migration</h3><div class="NLM_p last">Freshly isolated human neutrophils were diluted in a suspension of 8.9 × 10<sup>6</sup> cells per mL. 20 μL of compound solution in chemotaxis buffer was added to the 180 μL cell suspension. The mixture was incubated at 37 °C for 30 min with intermediate resuspension of the cells after 15 min. Following this, 70 μL of cell suspension was transferred to the upper compartment of a Corning HTS Transwell 96 permeable support system with 5.0 μm pore size polycarbonate membrane (Corning, Corning, NY, USA; catalog no. 3387). The receiver well of the Transwell system was then filled with 200 μL of chemotaxis buffer containing compound and chemotactic agent (embelin). After incubation at 37 °C in 5% CO<sub>2</sub> for 1 h, the upper plate of the Transwell system was removed and the cell suspension in the receiver plate is transferred to a 96-well V-bottom plate. 50 μL of DPBS was added to the receiver plate to prevent remaining cells from drying out. The V-bottom plate was centrifuged for 6 min at 1500 rpm. The supernatant was removed, and the cells were resuspended in 50 μL DPBS. The cells were then transferred back to the receiver plate of the Transwell system. After this, 100 μL of ATPlite solution (PerkinElmer, Boston, MA, USA; catalog no. 436110) was added to the cells. The plate was incubated for 10 min in the dark while shaking. 170 μL of cell lysate was then transferred to a white 96-well plate, and luminescence was measured. The detected luminescent signal was considered as linearly related to the number of cells having migrated from the upper well to the receiver well.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Rat Neutrophil Migration</h3><div class="NLM_p last">Freshly isolated rat neutrophils were diluted in a suspension of 8.9 × 10<sup>6</sup> cells per mL. 10 μL of compound solution in chemotaxis buffer was added to the 90 μL cell suspension. The mixture was incubated at 37 °C for 30 min with intermediate resuspension of the cells after 15 min. Following this, 75 μL of cell suspension was transferred to the upper compartment of a Corning HTS Transwell 96 permeable support system with 5.0 μm pore size polycarbonate membrane (Corning, Corning, NY, USA; catalog no. 3387). The receiver well of the Transwell system was then filled with 200 μL of chemotaxis buffer containing compound and chemotactic agent (embelin). After incubation at 37 °C in 5% CO<sub>2</sub> for 1 h, the upper plate of the Transwell system was removed and 70 μL of CellTiter-Glo substrate (Promega, Madison, WI, USA; catalog no. G755B) was added to a 96-well V-bottom plate. The plate was incubated for 10 min in the dark while shaking. 180 μL of cell lysate was then transferred to a white 96-well plate, and luminescence was measured. The detected luminescent signal was considered as linearely related to the number of cells having migrated from the upper well to the receiver well.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Liver Microsomal Stability (LMS) Assay</h3><div class="NLM_p">The microsomal stability assay was performed by incubation of test compound at 1 μM, 0.2% DMSO in phosphate buffer with microsomes (0.5 mg/mL) from mouse, rat, dog, or human (Xeno-Tech, Kansas City, KS, USA), and cofactors with final concentrations of 0.6 U/mL glucose-6-phosphate dehydrogenase, 3.3 mM MgCl<sub>2</sub>, 3.3 mM glucose-6-phosphate, and 1.3 mM nicotinamide adenine dinucleotide phosphate (NADP)<sup>+</sup>. Before addition of the microsomes (time zero) and after 30 min of incubation at 37 °C with shaking, the reaction was stopped and proteins were precipitated with an excess of acetonitrile containing an internal standard. The samples were mixed, centrifuged, and filtered, and the supernatant was analyzed by liquid chromatography–mass spectrometry/mass spectrometry (LC–MS/MS). The instrument responses (peak areas/IS peak area) were referenced to the zero-time point samples (considered as 100%) in order to determine the percentage of compound remaining. Verapamil (1 μM) and warfarin (1 μM) were used as reference compounds, as unstable and stable compounds, respectively.</div><div class="NLM_p last"><i>In vitro</i> scaled intrinsic clearance (CL<sub>int</sub> scaled) was calculated from the half-life using the following equations:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Intrinsic clearance equation:</p></td></tr></table><span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_m001.gif" alt="" id="_i35" /></img></span><table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Scaled intrinsic clearance equation:</p></td></tr></table><span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_m002.gif" alt="" id="_i36" /></img></span></div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Hepatocyte Stability Assay</h3><div class="NLM_p">The hepatocyte stability assay was performed by incubation of test compound at 1 μM, 0.03% DMSO in modified Krebs–Henseleit buffer with suspension of pooled cryopreserved hepatocytes (BioIVT, Hicksville, NY, USA) from mouse, rat, dog, or human (BioIVT, Hicksville, NY, USA) at 0.5 million viable hepatocytes/mL.</div><div class="NLM_p">Before adding the hepatocytes (time zero) and after 10, 20, 45, 90, 120, and 180 min of incubation (<i>n</i> = 2) at 37 °C while gently shaking, the reaction was stopped and proteins were precipitated with an excess of acetonitrile containing an internal standard. The samples were mixed, centrifuged, and filtered, and the supernatant was analyzed by liquid chromatography–mass spectrometry/mass spectrometry (LC–MS/MS). The instrument responses (peak areas/IS peak area) were referenced to the zero-time point samples (considered as 100%) in order to determine the percentage of compound remaining. Testosterone (1 μM) and 7-hydroxycoumarin (1 μM) were used as phase I and phase II reaction controls, while caffeine was used as a negative control.</div><div class="NLM_p last"><i>In vitro</i> intrinsic clearance (CL<sub>int</sub>) was calculated from half-life using the following equations:<span class="NLM_disp-formula" id="ueq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_m003.gif" alt="" id="_i38" /></img></span><span class="NLM_disp-formula" id="ueq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_m004.gif" alt="" id="_i39" /></img></span></div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Plasma Protein Binding Assay</h3><div class="NLM_p last">Plasma protein binding was determined by equilibrium dialysis using the Pierce Red device plate with inserts (Thermo Fisher Scientific, Waltham, MA, USA). Test compound at 5 μM (0.5% DMSO) spiked in freshly thawed human, rat, mouse, or dog plasma (Bioreclamation INC, Westbury, NY, USA) was dialyzed against phosphate-buffered saline (PBS, pH 7.4) at 37 °C under shaking for 4 h. Proteins were precipitated with an excess of methanol, and samples were mixed and centrifuged, and the supernatant was analyzed by liquid chromatography–mass spectrometry/mass spectrometry (LC–MS/MS). Addition of compound peak areas in the buffer chamber and the plasma chamber was considered to be 100% compound. The percentage bound to plasma proteins was derived from these results with the formula<span class="NLM_disp-formula" id="ueq5"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_m005.gif" alt="" id="_i41" /></img></span>Acebutolol and nicardipine are included in the assay design as low and high binding controls.</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Intestinal Permeability on Caco-2 Cells</h3><div class="NLM_p">Caco-2 cells were obtained from European Collection of Cell Cultures (ECACC) and used after a 21-day cell culture in 24-well Transwell plates.</div><div class="NLM_p">GLPG1205 and the references (vinblastine and propranolol) were prepared in protein-free Hanks’ balanced salt solution containing 25 mM HEPES (pH 7.4) at a concentration of 10 μM and added to either the apical or basolateral chambers of a Transwell plate assembly.</div><div class="NLM_p">Before the experiment, the integrity of the monolayer was checked by measuring the transepithelial resistance. Lucifer yellow (LY) was added to the donor buffer in all wells to assess integrity of the cell layers by monitoring LY permeation. As LY cannot freely permeate lipophilic barriers, a high degree of LY transport indicates poor integrity of the cell layer.</div><div class="NLM_p">After a 1 h incubation at 37 °C, aliquots were taken from both apical (A) and basolateral (B) chambers and added to acetonitrile containing analytical internal standard (carbamazepine) in a 96-well plate. Concentrations of compound in the samples were measured by LC–MS/MS.</div><div class="NLM_p last">Apparent permeability (<i>P</i><sub>app</sub>) values were calculated from the relationship<span class="NLM_disp-formula" id="ueq6"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_m006.gif" alt="" id="_i43" /></img></span>where <i>V</i><sub>donor</sub> is the volume of the apical chamber at 125 μL, <i>V</i><sub>acceptor</sub> is the volume of the basolateral chamber at 600 μL, <i>T</i><sub>inc</sub> is the incubation time of 3600 s, and the surface area for the 24-well Transwell is 0.33 cm<sup>2</sup>. The efflux ratios, as an indication of active efflux from the apical cell surface, were calculated using the ratio of <i>P</i><sub>app</sub>(B → A)/<i>P</i><sub>app</sub>(A → B).</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> CYP Direct Inhibition Assay</h3><div class="NLM_p">A 5 mM stock solution of compound was prepared in methanol. This stock was serially diluted 1:3 in methanol and then added in duplicates to a mixture containing 50 mM potassium phosphate buffer, pH 7.4, and human liver microsomes (BD Gentest, BD, Wokingham, U.K.). A total of seven different concentrations (0.14–100 μM in final reaction mixture; 2% methanol) of compound were prepared in duplicates.</div><div class="NLM_p">After prewarming for 5 min at 37 °C, the 20 min preincubation was started by adding a probe substrate to the first concentration range (first replica) and a cofactor mix (7. 65 mg/mL glucose-6-phosphate, 1.7 mg/mL NADP, 6 U/mL of glucose-6-phosphate dehydrogenase) to the second replica. Final concentrations of cofactor mix components were as follows: 1.56 mg/mL glucose-6-phosphate, 0.34 mg/mL NADP, 1.2 U/mL of glucose-6-phosphate dehydrogenase.</div><div class="NLM_p">After preincubation, the reaction was finally started by adding the cofactor mix to the first replica and adding the probe substrate to second replica (opposite from preincubation).</div><div class="NLM_p">After incubation at 37 °C, the reaction (aliquot of 50 μL) was terminated with 150 μL of acetonitrile/methanol (2:1) solution with internal standard (diclofenac). Samples were centrifuged and the supernatant fractions analyzed by LC–MS/MS.</div><div class="NLM_p">The instrument responses (ratio of compound and internal standard peak areas) were referenced to those for solvent controls (assumed as 100%) in order to determine the percentage reduction in probe metabolism.</div><div class="NLM_p last">Percent of control activity versus concentration plots were generated and fitted using GraphPad Prism software to determine IC<sub>50</sub> for both substrate- and cofactor preincubations, as well as the IC<sub>50</sub> fold shift.</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> hERG Manual Patch Clamp Assay</h3><div class="NLM_p">Whole-cell patch-clamp recordings were performed using an EPC10 amplifier controlled by Pulse version 8.77 software (HEKA, Ludwigshafen, Germany). The external bathing solution contained 135 mM NaCl, 5 mM KCl, 1.8 mM CaCl<sub>2</sub>, 5 mM glucose, 10 mM HEPES, pH 7.4. The internal patch pipet solution contained 100 mM K gluconate, 20 mM KCl, 1 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 5 mM Na<sub>2</sub>ATP, 2 mM glutathione, 11 mM ethylene glycol-bis(β-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid (EGTA), 10 mM HEPES, pH 7.2. Compound was perfused using an automate scientific pressurized superfusion system coupled to a Biologic micromanifold.</div><div class="NLM_p last">All recordings were performed on HEK293 cells stably expressing hERG channels. Cells were cultured on 12 mm round coverslips (German glass; Bellco, Vineland, NJ, USA) anchored in the recording chamber using two platinum rods (Goodfellow, Coraopolis, PA, USA). hERG currents were evoked using an activating pulse to +40 mV for 1000 ms followed by a tail current pulse to −50 mV for 2000 ms, and holding potential was −80 mV. Pulses were applied every 15 s, and all experiments were performed at room temperature. For the concentration response, peak tail current amplitude was measured during the voltage step to −50 mV.</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> PK Mouse</h3><div class="NLM_p">This study was performed with 42 naïve male CD1 mice, weighing 18–20 g upon arrival (4–5 weeks old). The first group of mice were dosed iv via a bolus in the tail vein with a dose level of 1 mg/kg, and the second group of mice was dosed orally as a single esophageal gavage with a dose level of 5 mg/kg.</div><div class="NLM_p">Formulations were prepared the day before administration and kept at room temperature, protected from light. For the iv route, compound was formulated in PEG 200 and saline (60/40; v/v) as a clear solution. For the oral route, compound was formulated in PEG 200/purified water (60/40; v/v) as a homogeneous suspension. Before the oral dosing, the animals were deprived of food for at least 12 h before compound administration and 4 h after administration. All animals had free access to tap water.</div><div class="NLM_p">From all animals, approximately 500 μL blood samples were collected by intracardiac puncture and placed into tubes containing Li-heparin as anticoagulant. Blood samples were collected at the following time points: iv, 0.05, 0.25, 0.5, 1, 3, 5, and 8 h after dosing (<i>n</i> = 3 mice per sampling time); po, 0.25, 0.5, 1, 3, 5, 8, and 24 h after dosing (<i>n</i> = 3 mice per sampling time). Each mouse was sampled once and then euthanized.</div><div class="NLM_p">Blood was kept on ice. Within 1 h after sampling, blood was centrifuged at 5000 rpm for 10 min at 4 °C. Immediately after centrifugation, the resulting plasma samples were collected into polypropylene tubes and were kept frozen at −20 °C pending bioanalysis.</div><div class="NLM_p">Plasma samples were assayed by LC–MS/MS with a non-good-laboratory-practice (non-GLP)-validated method. Compound <b>36</b> plasma concentrations were calculated against a calibration curve consisting of eight levels with a 3 log amplitude. Back-calculated values for quality control (three levels prepared in duplicate) were used for accepting or rejecting the entire batch. The lower limit of quantification was 4 ng/mL with a plasma volume of 25 μL.</div><div class="NLM_p">Plasma proteins were precipitated with an excess of methanol containing the internal standard, and the corresponding supernatant was injected onto a C18 column. Analytes were eluted out of the HPLC system by increasing the percentage of the organic mobile phase. An API5500 QTrap mass spectrometer (AB Sciex, Sciex, Warrington, U.K.) was used for the simultaneous detection and quantification of <b>36</b>.</div><div class="NLM_p last">PK parameters were calculated from the mean of individual plasma concentrations by noncompartmental analysis using WinNonlin software (Pharsight, version 5.2; Certara, Princeton, NJ, USA).</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> PK Rat</h3><div class="NLM_p">This study was performed with six naïve male Sprague Dawley rats, weighing 180–200 g upon arrival (6–8 weeks old). Catheterized rats (in the jugular vein) were used to avoid interindividual variability. Three rats per group was a sufficient number to carry out statistical calculations.</div><div class="NLM_p">For the iv route, compound was formulated in PEG 200 and NaCl for injection (60/40; v/v) as a clear solution. For the oral route, compound was formulated in PEG 200 and purified water (60/40; v/v) as a clear solution.</div><div class="NLM_p">Rats (<i>n</i> = 3) were dosed iv via a bolus in the tail vein. Three additional rats were dosed orally as a single gavage. The iv bolus and the oral administration were given with a dose volume of 5 mL/kg. Actual dose volumes were based on the individual body weights.</div><div class="NLM_p">From all animals, approximately 200 μL blood samples were collected via a catheter into the jugular vein and placed into tubes containing Li-heparin as anticoagulant. Blood samples were collected at the following time points: iv, 0.05, 0.25, 0.5, 1, 3, 5, 8, and 24 h after dosing; po, 0.25, 0.5, 1, 3, 5, 8, and 24 h after dosing. Each rat was sampled seven or eight times (at each sampling time), depending on the route of administration. Just after each sampling, the same volume of physiological serum with sodium heparin (50 UI/mL) was injected into the catheter to avoid blocking.</div><div class="NLM_p">Blood was kept on ice. Within 1 h after sampling, blood was centrifuged at 5000 rpm for 10 min at 4 °C. Immediately after centrifugation, the resulting plasma samples were collected into polypropylene tubes and were kept frozen at −20 °C pending bioanalysis.</div><div class="NLM_p">Plasma samples were assayed by LC–MS/MS with a non-GLP-validated method. Plasma concentrations were calculated against a calibration curve consisting of eight levels with a 3 log amplitude. Back-calculated values for quality control (three levels prepared in duplicate) were used for accepting or rejecting the whole batch.</div><div class="NLM_p">Plasma proteins were precipitated with an excess of methanol containing the internal standard, and the corresponding supernatant was injected on a C18 column. Analytes were eluted out the HPLC system by increasing the percentage of the organic mobile phase. An API5500 QTrap mass spectrometer (ABSciex, Sciex, Warrington, U.K.) was used.</div><div class="NLM_p last">PK parameters were calculated for each individual rat by noncompartmental analysis using WinNonlin software (Pharsight, version 5.2; Certara, Princeton, NJ, USA).</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> PK Dog</h3><div class="NLM_p">This study was performed with three non-naïve male Beagle dogs. Formulations were prepared the day of administration.</div><div class="NLM_p">Dogs <i>(n</i> = 3) were dosed iv via a 10 min infusion via a catheter with a dose level of 0.5 mg/kg (12 mL kg<sup>–1</sup> h<sup>–1</sup>). After a washout of 3 days, they were dosed orally as a single gavage with a dose level of 2.5 mg/kg in PEG200/water. The oral dose of 2.5 mg/kg was given with a dose volume of 5 mL/kg. Actual dose volumes were based on the individual body weights. Approximately 250 g of Harlan Teklad 2027 diet was distributed daily to each animal. The food was given 4 h after the iv administration. Before administration by the po route, animals were fasted for a period of at least 12 h before treatment, and food was given just after the 4 h blood sampling. All animals had free access to tap water.</div><div class="NLM_p">From all animals approximately 0.5 mL blood samples were taken without anesthetic from a jugular or cephalic vein into tubes containing lithium heparin as anticoagulant. Blood samples were collected at the following time points: iv, at predose, 0.083, 0.167 (end of infusion), 0.5, 1, 2, 4, 6, 8, 10, and 24 h after start of infusion; po, at predose and then 0.25, 0.5, 1, 2, 3, 4, 6, 8, 10, and 24 h after dose administration.</div><div class="NLM_p">Plasma samples were assayed by LC–MS/MS with a non-GLP-validated method. Compound <b>36</b> plasma concentrations were calculated against a calibration curve consisting of eight levels with a 3 log amplitude. Back-calculated values of the quality control samples (three levels prepared in duplicate) were used for accepting or rejecting the whole batch. The lower limit of quantification was 4 ng/mL with a plasma volume of 25 μL.</div><div class="NLM_p">Plasma proteins were precipitated with an excess of methanol containing the internal standard, and the corresponding supernatant was injected on a C18 column. Analytes were eluted out the high-performance liquid chromatography (HPLC) system by increasing the percentage of the organic mobile phase. An API5500 QTrap mass spectrometer (ABSciex, Sciex, Warrington, U.K.) was used for the detection and quantification of <b>36</b>.</div><div class="NLM_p last">PK parameters were calculated for each individual dog by noncompartmental analysis using WinNonlin software (Pharsight, version 5.2; Certara, Princeton, NJ, USA).</div></div><div id="sec5_2_16_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> Negative Allosteric Modulation of Known GPR84 Agonists by GLPG1205. Membrane Preparation</h3><div class="NLM_p last">Membranes were generated from Flp-In T-REx 293 cells treated with 100 ng/mL doxycycline to induce expression of FLAG-GPR84-Gαi2.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Cells were washed with ice-cold phosphate buffered saline, removed from dishes by scraping, and centrifuged at 3000 rpm for 5 min at 4 °C. Pellets were resuspended in TE buffer (10 mM Tris-HCl, 0.1 mM EDTA; pH 7.5) containing a protease inhibitor mixture (Roche Applied Science, West Sussex, U.K.) and homogenized with a 5 mL hand-held homogenizer. This material was centrifuged at 1500 rpm for 5 min at 4 °C, and the supernatant was further centrifuged at 50 000 rpm for 30 min at 4 °C. The resulting pellet was resuspended in TE buffer, and protein content was assessed using a BCA protein assay kit (Pierce, Fisher Scientific, Loughborough, U.K.).</div></div><div id="sec5_2_16_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Competition Binding Assay</h3><div class="NLM_p last">Assays were performed using 0.2 nM [<sup>3</sup>H]<b>38</b>, binding buffer (phosphate-buffered saline with 0.5% fatty acid free bovine serum albumin; pH 7.4) and the indicated concentrations of test compounds, in a total assay volume of 500 μL. Binding was initiated by the addition of membranes (5 μg of protein per tube), and incubations were carried out at 25 °C for 1 h. Reactions were terminated by the addition of ice-cold phosphate buffered saline and vacuum filtration through GF/C glass filters using a 24-well Brandel cell harvester (Alpha Biotech, Glasgow, U.K.). Each reaction tube was washed three times with ice-cold PBS. The filters were allowed to dry for 2–3 h and then placed in 3 mL of Ultima Gold XR. Radioactivity was quantified by liquid scintillation spectrometry.</div></div><div id="sec5_2_16_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Reaction Biology Kinase Selectivity Profiling</h3><div class="NLM_p last">Inhibition of 152 kinases by 10 μM compound was determined in a Reaction Biology proprietary nanoliter radioactive HotSpot assay in duplicate. The principle of the assay consists of the measurement of incorporated <sup>33</sup>P into a specific substrate for each kinase when the substrate is phosphorylated by the enzyme using [<sup>33</sup>P]-γ-ATP and ATP.</div></div><div id="sec5_2_16_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Millipore GPCR Profiler Selectivity Profiling</h3><div class="NLM_p last">Free intracellular [Ca<sup>2+</sup>] flux assays were conducted to test compound agonist and antagonist activities against 123 GPCRs selected to cover as many GPCR families as possible. Percentage activation was determined upon initial addition of compound followed by 10 min incubation at 25 °C (in absence of agonist). Following this initial incubation, reference agonists were added at EC<sub>80</sub> concentration allowing determination of percentage inhibition of the agonist induced signal caused by compound.</div></div><div id="sec5_2_16_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Dextran Sulfate Sodium (DSS)-Induced Colitis Model</h3><div class="NLM_p last">Balb/cJ female mice (Janvier Labs, Le Genest-Saint-Isle, France) were housed in a dedicated in house animal facility under specific pathogen-free conditions according to the Federation for Laboratory Animal Science Associations guidelines. The study was performed according to ethical guidelines approved by the Animal Institutional Care and Use Committee of Galapagos controlled by the French Authorities (Agreement No. C93-063-06, DDPP, Seine Saint Denis). Animals were housed in filter top cages, provided with filtered tap water and standard chow ad libitum, and maintained at 22 ± 2 °C in 55 ± 10% humidity on a 12 h light/dark cycle. The randomization of mice in the different groups was based on body weight (BW) at study commencement. A model of chronic colitis was induced in 8-week-old mice (BW 25 g) with three cycles, each consisting of 4% DSS administered in drinking water for 4 days, followed by 3 days of regular drinking water. The mice (<i>n</i> = 10 per group) were orally administered vehicle (PEG200/H<sub>2</sub>0 [60/40; v/v]) or 1, 3, or 10 mg/kg of compounds <b>26</b>, <b>35</b>, <b>36</b> qd from day 1 of DSS administration and throughout the dosing period. Compound <b>36</b> was tested in three independent experiments. Two positive controls were used in these different studies: cyclosporine (CsA) at 25 mg/kg qd po in PEG200/water (60/40; v/v) or sulfazalazine at 20 mg/kg qd po in 0.5% methylcellulose. Clinical parameters were measured every other day. DAI (a combined score of body weight loss, stool consistency, and rectal bleeding scores) was recorded daily. Each criterion was graded from 0 to 4. Animals were decapitated after brief isoflurane anesthesia. At necropsy at day 17 of the experiment, the complete colon was removed and rinsed with sterile PBS. A segment of 5 mm of distal colon was collected for histology analysis. Histology was performed on formalin-fixed (4% buffered formaldehyde for 3 h). After fixation, samples were transferred into a sucrose solution prior to being frozen in isopentane. Three series of cryosections within a distance of 1 mm were performed in duplicate. One series of sections were stained with a Goldner trichrome for colon lesion evaluation, and scoring was performed. Neutrophil cell infiltration was assayed by immunohistochemistry using anti-Ly6G/Ly6C (clone NIMP-R14, Santa Cruz, Dallas, TX, USA). Neutrophil identification was followed by manual quantification of cell number per surface. The neutrophil density was expressed as a number of cells per mm<sup>2</sup> of colon area. Blood was sampled at day 4 at four time points: 0, 1, 3, and 6 h (and assuming 24 h is equal to the predose sample). Plasma was prepared and <b>36</b> was quantified using LC–MS to assess steady state PK. Statistical analysis was performed with Prism 5.03 software (GraphPad, San Diego, CA, USA) with a one-way ANOVA performed on the arcsinh(log)-transformed neutrophil density data and a two-way ANOVA performed on the arcsinh(log)-transformed DAI data. Dunnett’s post-hoc multiplicity correction procedure was applied to the neutrophil density data, and Bonferonni post-hoc multiplicity correction procedure was applied to the DAI data.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00272" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61344" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61344" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00272?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00272</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">General methods and synthetic routes used in the investigation of compounds; synthetic procedures and analytical data for all compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00272/suppl_file/jm0c00272_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00272/suppl_file/jm0c00272_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00272/suppl_file/jm0c00272_si_001.pdf">jm0c00272_si_001.pdf (1.06 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00272/suppl_file/jm0c00272_si_002.csv">jm0c00272_si_002.csv (8.92 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00272" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08804" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08804" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romain Gosmini</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c0e13111d1512521b130f111512153c1b100c1b521f1311"><span class="__cf_email__" data-cfemail="eb9984868a8285c58c849886828582ab8c879b8cc5888486">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frédéric Labéguère</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span>; 
    <span>Present Address:
                        F.L.: Evotec SAS, 195 Route d’Espagne, 1036 Toulouse CEDEX, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonia Dupont</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luke Alvey</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florilène Soulas</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory Newsome</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Amynata Tirera</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vanessa Quenehen</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thi Thu Trang Mai</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre Deprez</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland Blanqué</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Line Oste</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandrine Le Tallec</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steve De Vos</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Annick Hagers</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann Vandevelde</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luc Nelles</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nele Vandervoort</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Katja Conrath</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thierry Christophe</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ellen van der Aar</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Emanuelle Wakselman</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Didier Merciris</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Céline Cottereaux</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cécile da Costa</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurent Saniere</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Clement-Lacroix</span> - <span class="hlFld-Affiliation affiliation">Galapagos
SASU, 102 Avenue Gaston Roussel, 93230 Romainville, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Jenkins</span> - <span class="hlFld-Affiliation affiliation">Centre
for Translational Pharmacology, Institute of Molecular, Cell and Systems
Biology, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graeme Milligan</span> - <span class="hlFld-Affiliation affiliation">Centre
for Translational Pharmacology, Institute of Molecular, Cell and Systems
Biology, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, United Kingdom</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6946-3519" title="Orcid link">http://orcid.org/0000-0002-6946-3519</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Fletcher</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reginald Brys</span> - <span class="hlFld-Affiliation affiliation">Galapagos
NV, Generaal De Wittelaan
L11 A3, 2800 Mechelen, Belgium</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors’ provided substantial contributions to the design or the acquisition, analysis, or interpretation of data. Authors critically reviewed the manuscript for important intellectual content. All authors read and approved the final version of the manuscript.</p></li><li><span class="author-information-subsection-header">Funding</span><p>This study and the medical writing support were funded by Galapagos.</p></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): S. Dupont, L. Alvey, G. Newsome, A. Tirera, V. Quenehen, T. T. T. Mai, P. Deprez, R. Blanque, E. Wakselman, S. Le Tallec, D. Merciris, C. Cottereaux, C. da Costa, L. Saniere, P. Clement-Lacroix, and R. Gosmini are employees of Galapagos SASU, France. S. De Vos, A. Hagers, A. Vandevelde, L. Nelles, N. Vandervoort, K. Conrath, T. Christophe, E. van der Aar, L. Oste, and R. Brys are employees of Galapagos NV, Belgium. F. Labeguere, F. Soulas, and S. Fletcher are former employees of Galapagos. G. Milligan has received funding and support from Galapagos NV, Belgium. L. Jenkins has no conflicts of interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e4468-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Medical writing assistance in the preparation of this manuscript was provided by Emily Fisher, Alexander Bowen and Samuel McCracken of CircleScience (an Ashfield Company, part of UDG Healthcare plc) and funded by Galapagos. The authors thank Sebastien Richard for his support in the development of the analytical chemistry section.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion</p></td></tr><tr><td class="NLM_term">ASOL</td><td class="NLM_def"><p class="first last">aqueous solubility</p></td></tr><tr><td class="NLM_term">AUC<sub>0–inf</sub></td><td class="NLM_def"><p class="first last">area under the curve (from time 0 to infinity)</p></td></tr><tr><td class="NLM_term">BEH</td><td class="NLM_def"><p class="first last">ethylene bridged hybrid</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">BW</td><td class="NLM_def"><p class="first last">body weight</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine 3′,5′-monophosphate</p></td></tr><tr><td class="NLM_term">Cap</td><td class="NLM_def"><p class="first last">capric acid</p></td></tr><tr><td class="NLM_term">CAS</td><td class="NLM_def"><p class="first last">Chemical Abstracts Service</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CL<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">CL<sub>unb</sub></td><td class="NLM_def"><p class="first last">unbound clearance</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum plasma concentration</p></td></tr><tr><td class="NLM_term">compd</td><td class="NLM_def"><p class="first last">compound</p></td></tr><tr><td class="NLM_term">cpm</td><td class="NLM_def"><p class="first last">counts per minute</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>0</sub></td><td class="NLM_def"><p class="first last">concentration extrapolated at time 0 after a bolus intravenous dose</p></td></tr><tr><td class="NLM_term">D</td><td class="NLM_def"><p class="first last">dog</p></td></tr><tr><td class="NLM_term">DAI</td><td class="NLM_def"><p class="first last">disease activity index</p></td></tr><tr><td class="NLM_term">DIM</td><td class="NLM_def"><p class="first last">3,3′-diindolylmethane</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DSS</td><td class="NLM_def"><p class="first last">dextran sodium sulfate</p></td></tr><tr><td class="NLM_term">ECACC</td><td class="NLM_def"><p class="first last">European Collection of Cell Cultures</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal effective concentration</p></td></tr><tr><td class="NLM_term">EC<sub>80</sub></td><td class="NLM_def"><p class="first last">concentration of agonist leading to 80% maximal response</p></td></tr><tr><td class="NLM_term">EGTA</td><td class="NLM_def"><p class="first last">ethylene glycol-bis(β-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">F</td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">GTPγS</td><td class="NLM_def"><p class="first last">guanosine 5′-<i>O</i>-[γ-thio]triphosphate</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hour</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hanks’ balanced salt solution</p></td></tr><tr><td class="NLM_term">hCYP</td><td class="NLM_def"><p class="first last">human cytochrome P450</p></td></tr><tr><td class="NLM_term">HEP</td><td class="NLM_def"><p class="first last">hepatocyte</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-à-go-go-related gene</p></td></tr><tr><td class="NLM_term">hGPR84</td><td class="NLM_def"><p class="first last">human G-protein-coupled receptor 84</p></td></tr><tr><td class="NLM_term">hGTPγS</td><td class="NLM_def"><p class="first last">human guanosine 5′-<i>O</i>-[γ-thio]triphosphate</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screen</p></td></tr><tr><td class="NLM_term">Hum neutro</td><td class="NLM_def"><p class="first last">human neutrophil migration assay</p></td></tr><tr><td class="NLM_term">H</td><td class="NLM_def"><p class="first last">human</p></td></tr><tr><td class="NLM_term">IBD</td><td class="NLM_def"><p class="first last">inflammatory bowel disease</p></td></tr><tr><td class="NLM_term">IBMX</td><td class="NLM_def"><p class="first last">3-isobutyl-1-methylxanthine</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">IL</td><td class="NLM_def"><p class="first last">interleukin</p></td></tr><tr><td class="NLM_term">IP1</td><td class="NLM_def"><p class="first last">inositol monophosphate</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">LCMS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry/mass spectrometry</p></td></tr><tr><td class="NLM_term">LMS</td><td class="NLM_def"><p class="first last">liver microsomal stability</p></td></tr><tr><td class="NLM_term">M</td><td class="NLM_def"><p class="first last">mouse</p></td></tr><tr><td class="NLM_term">MCFA</td><td class="NLM_def"><p class="first last">medium-chain free fatty acid</p></td></tr><tr><td class="NLM_term">Me</td><td class="NLM_def"><p class="first last">methyl group</p></td></tr><tr><td class="NLM_term">MED</td><td class="NLM_def"><p class="first last">minimal efficacious dose</p></td></tr><tr><td class="NLM_term">MELK</td><td class="NLM_def"><p class="first last">maternal embryonic leucine zipper kinase</p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">microsomal</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minute</p></td></tr><tr><td class="NLM_term">mRNA</td><td class="NLM_def"><p class="first last">messenger ribonucleic acid</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">OBD</td><td class="NLM_def"><p class="first last">optical bed density</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub> A<sub>2</sub>B</td><td class="NLM_def"><p class="first last">apparent permeability from apical to basal chambers</p></td></tr><tr><td class="NLM_term">PDA</td><td class="NLM_def"><p class="first last">photodiode array</p></td></tr><tr><td class="NLM_term">PDE4A</td><td class="NLM_def"><p class="first last">phosphodiesterase 4</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">polyethylene glycol</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term">POCl<sub>3</sub></td><td class="NLM_def"><p class="first last">phosphoryl chloride</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">qd</td><td class="NLM_def"><p class="first last">once daily</p></td></tr><tr><td class="NLM_term">R</td><td class="NLM_def"><p class="first last">rat</p></td></tr><tr><td class="NLM_term">rpm</td><td class="NLM_def"><p class="first last">revolutions per minute</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SPA</td><td class="NLM_def"><p class="first last">scintillation proximity assay</p></td></tr><tr><td class="NLM_term">SQD</td><td class="NLM_def"><p class="first last">single quadrupole detection</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time at maximum plasma concentration</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor α</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultraperformance liquid chromatography</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">ultraviolet</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">apparent volume of distribution at steady state</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonavicius, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, L.</span></span> <span> </span><span class="NLM_article-title">Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">34457</span>– <span class="NLM_lpage">34464</span>, <span class="refDoi"> DOI: 10.1074/jbc.M608019200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1074%2Fjbc.M608019200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=16966319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKgur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=34457-34464&issue=45&author=J.+Wangauthor=X.+Wuauthor=N.+Simonaviciusauthor=H.+Tianauthor=L.+Ling&title=Medium-chain+fatty+acids+as+ligands+for+orphan+G+protein-coupled+receptor+GPR84&doi=10.1074%2Fjbc.M608019200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Medium-chain Fatty Acids as Ligands for Orphan G Protein-coupled Receptor GPR84</span></div><div class="casAuthors">Wang, Jinghong; Wu, Xiaosu; Simonavicius, Nicole; Tian, Hui; Ling, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">34457-34464</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Free fatty acids (FFAs) play important physiol. roles in many tissues as an energy source and as signaling mols. in various cellular processes.  Elevated levels of circulating FFAs are assocd. with obesity, dyslipidemia, and diabetes.  Here we show that GPR84, a previously orphan G protein-coupled receptor, functions as a receptor for medium-chain FFAs with carbon chain lengths of 9-14.  Medium-chain FFAs elicit calcium mobilization, inhibit 3',5'-cAMP prodn., and stimulate [35S]guanosine 5'-O-(3-thiotriphosphate) binding in a GPR84-dependent manner.  The activation of GPR84 by medium-chain FFAs couples primarily to a pertussis toxin-sensitive Gi/o pathway.  In addn., we show that GPR84 is selectively expressed in leukocytes and markedly induced in monocytes/macrophages upon activation by lipopolysaccharide.  Furthermore, we demonstrate that medium-chain FFAs amplify lipopolysaccharide-stimulated prodn. of the proinflammatory cytokine interleukin-12 p40 through GPR84.  Our results indicate a role for GPR84 in directly linking fatty acid metab. to immunol. regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-BrABfXO2grVg90H21EOLACvtfcHk0lhTBozLoFsieQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKgur%252FI&md5=2bbe13a202723f62e59eab0b08a25878</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608019200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608019200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DSimonavicius%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLing%26aufirst%3DL.%26atitle%3DMedium-chain%2520fatty%2520acids%2520as%2520ligands%2520for%2520orphan%2520G%2520protein-coupled%2520receptor%2520GPR84%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D45%26spage%3D34457%26epage%3D34464%26doi%3D10.1074%2Fjbc.M608019200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mpamhanga, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmar, A. J.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">986</span>, <span class="refDoi"> DOI: 10.1124/pr.112.007179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1124%2Fpr.112.007179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=23686350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyrtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=967-986&issue=3&author=A.+P.+Davenportauthor=S.+P.+Alexanderauthor=J.+L.+Sharmanauthor=A.+J.+Pawsonauthor=H.+E.+Bensonauthor=A.+E.+Monaghanauthor=W.+C.+Liewauthor=C.+P.+Mpamhangaauthor=T.+I.+Bonnerauthor=R.+R.+Neubigauthor=J.+P.+Pinauthor=M.+Speddingauthor=A.+J.+Harmar&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXXVIII.+G+protein-coupled+receptor+list%3A+recommendations+for+new+pairings+with+cognate+ligands&doi=10.1124%2Fpr.112.007179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands</span></div><div class="casAuthors">Davenport, Anthony P.; Alexander, Stephen P. H.; Sharman, Joanna L.; Pawson, Adam J.; Benson, Helen E.; Monaghan, Amy E.; Liew, Wen Chiy; Mpamhanga, Chidochangu P.; Bonner, Tom I.; Neubig, Richard R.; Pin, Jean Philippe; Spedding, Michael; Harmar, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">967-986</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  In 2005, the International Union of Basic and Clin. Pharmacol. Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR) published a catalog of all of the human gene sequences known or predicted to encode G protein-coupled receptors (GPCRs), excluding sensory receptors.  This review updates the list of orphan GPCRs and describes the criteria used by NC-IUPHAR to recommend the pairing of an orphan receptor with its cognate ligand(s).  The following recommendations are made for new receptor names based on 11 pairings for class A GPCRs: hydroxycarboxylic acid receptors [HCA1 (GPR81) with lactate, HCA2 (GPR109A) with 3-hydroxybutyric acid, HCA3 (GPR109B) with 3-hydroxyoctanoic acid]; lysophosphatidic acid receptors [LPA4 (GPR23), LPA5 (GPR92), LPA6 (P2Y5)]; free fatty acid receptors [FFA4 (GPR120) with omega-3 fatty acids]; chemerin receptor (CMKLR1; ChemR23) with chemerin; CXCR7 (CMKOR1) with chemokines CXCL12 (SDF-1) and CXCL11 (ITAC); succinate receptor (SUCNR1) with succinate; and oxoglutarate receptor [OXGR1 with 2-oxoglutarate].  Pairings are highlighted for an addnl. 30 receptors in class A where further input is needed from the scientific community to validate these findings.  Fifty-seven human class A receptors (excluding pseudogenes) are still considered orphans; information has been provided where there is a significant phenotype in genetically modified animals.  In class B, six pairings have been reported by a single publication, with 28 (excluding pseudogenes) still classified as orphans.  Seven orphan receptors remain in class C, with one pairing described by a single paper.  The objective is to stimulate research into confirming pairings of orphan receptors where there is currently limited information and to identify cognate ligands for the remaining GPCRs.  Further information can be found on the IUPHAR Database website.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm8TAKeZwHO7Vg90H21EOLACvtfcHk0lhTBozLoFsieQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyrtLvN&md5=561149f6eb486cf3aea0bb255a9cbf39</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.112.007179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.112.007179%26sid%3Dliteratum%253Aachs%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26aulast%3DAlexander%26aufirst%3DS.%2BP.%26aulast%3DSharman%26aufirst%3DJ.%2BL.%26aulast%3DPawson%26aufirst%3DA.%2BJ.%26aulast%3DBenson%26aufirst%3DH.%2BE.%26aulast%3DMonaghan%26aufirst%3DA.%2BE.%26aulast%3DLiew%26aufirst%3DW.%2BC.%26aulast%3DMpamhanga%26aufirst%3DC.%2BP.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DHarmar%26aufirst%3DA.%2BJ.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXXVIII.%2520G%2520protein-coupled%2520receptor%2520list%253A%2520recommendations%2520for%2520new%2520pairings%2520with%2520cognate%2520ligands%26jtitle%3DPharmacol.%2520Rev.%26date%3D2013%26volume%3D65%26issue%3D3%26spage%3D967%26epage%3D986%26doi%3D10.1124%2Fpr.112.007179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onozawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iino, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, T.</span></span> <span> </span><span class="NLM_article-title">Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">10684</span>– <span class="NLM_lpage">10691</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.420042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1074%2Fjbc.M112.420042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=23449982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvFSisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=10684-10691&issue=15&author=M.+Suzukiauthor=S.+Takaishiauthor=M.+Nagasakiauthor=Y.+Onozawaauthor=I.+Iinoauthor=H.+Maedaauthor=T.+Komaiauthor=T.+Oda&title=Medium-chain+fatty+acid-sensing+receptor%2C+GPR84%2C+is+a+proinflammatory+receptor&doi=10.1074%2Fjbc.M112.420042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Medium-chain Fatty Acid-sensing Receptor, GPR84, Is a Proinflammatory Receptor</span></div><div class="casAuthors">Suzuki, Masakatsu; Takaishi, Sachiko; Nagasaki, Miyuki; Onozawa, Yoshiko; Iino, Ikue; Maeda, Hiroaki; Komai, Tomoaki; Oda, Tomiichiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">10684-10691</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">G protein-coupled receptor 84 (GPR84) is a putative receptor for medium-chain fatty acids (MCFAs), whose pathophysiol. roles have not yet been clarified.  Here, the authors show that GPR84 was activated by MCFAs with the hydroxyl group at the 2- or 3-position more effectively than nonhydroxylated MCFAs.  The authors also identified a surrogate agonist, 6-n-octylaminouracil (6-OAU), for GPR84.  These potential ligands and the surrogate agonist, 6-OAU, stimulated [35S]GTP binding and accumulated phosphoinositides in a GPR84-dependent manner.  The surrogate agonist, 6-OAU, internalized GPR84-EGFP from the cell surface.  Both the potential ligands and 6-OAU elicited chemotaxis of human polymorphonuclear leukocytes (PMNs) and macrophages and amplified LPS-stimulated prodn. of the proinflammatory cytokine IL-8 from PMNs and TNFα from macrophages.  Furthermore, the i.v. injection of 6-OAU raised the blood CXCL1 level in rats, and the inoculation of 6-OAU into the rat air pouch accumulated PMNs and macrophages in the site.  The results indicate a proinflammatory role of GPR84, suggesting that the receptor may be a novel target to treat chronic low grade inflammation assocd.-disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTeAePnQZYFrVg90H21EOLACvtfcHk0liWm1kwmgDxBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvFSisr8%253D&md5=63a395e01eb2083bfb7d4a1195c88b1a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.420042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.420042%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTakaishi%26aufirst%3DS.%26aulast%3DNagasaki%26aufirst%3DM.%26aulast%3DOnozawa%26aufirst%3DY.%26aulast%3DIino%26aufirst%3DI.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DKomai%26aufirst%3DT.%26aulast%3DOda%26aufirst%3DT.%26atitle%3DMedium-chain%2520fatty%2520acid-sensing%2520receptor%252C%2520GPR84%252C%2520is%2520a%2520proinflammatory%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D15%26spage%3D10684%26epage%3D10691%26doi%3D10.1074%2Fjbc.M112.420042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nan, F. J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of 2-alkylpyrimidine-4,6-diol and 6-alkylpyridine-2,4-diol as potent GPR84 agonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFGht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=579-583&issue=6&author=Y.+Liuauthor=Q.+Zhangauthor=L.+H.+Chenauthor=H.+Yangauthor=W.+Luauthor=X.+Xieauthor=F.+J.+Nan&title=Design+and+synthesis+of+2-alkylpyrimidine-4%2C6-diol+and+6-alkylpyridine-2%2C4-diol+as+potent+GPR84+agonists&doi=10.1021%2Facsmedchemlett.6b00025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 2-Alkylpyrimidine-4,6-diol and 6-Alkylpyridine-2,4-diol as Potent GPR84 Agonists</span></div><div class="casAuthors">Liu, Yang; Zhang, Qing; Chen, Lin-Hai; Yang, Hui; Lu, Wei; Xie, Xin; Nan, Fa-Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-583</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of alkylpyrimidine-4,6-diol derivs. were designed and synthesized as novel GPR84 agonists based on a high-throughput screening (HTS) hit I. 6-Nonylpyridine-2,4-diol was identified as the most potent agonist of GPR84 reported so far, with an EC50 of 0.189 nM.  These novel GPR84 agonists will provide valuable tools for the study of the physiol. functions of GPR84.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyEcxh2lX2Q7Vg90H21EOLACvtfcHk0lhHqrSrLfOGSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFGht7c%253D&md5=52f50ffae4ab4bbfd79f9eeda0bb063b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00025%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DL.%2BH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DNan%26aufirst%3DF.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202-alkylpyrimidine-4%252C6-diol%2520and%25206-alkylpyridine-2%252C4-diol%2520as%2520potent%2520GPR84%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D6%26spage%3D579%26epage%3D583%26doi%3D10.1021%2Facsmedchemlett.6b00025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a novel small-molecule agonist for medium-chain free fatty acid receptor G protein-coupled receptor 84</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>357</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.232033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1124%2Fjpet.116.232033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=26962172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWhu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2016&pages=337-344&issue=2&author=Q.+Zhangauthor=H.+Yangauthor=J.+Liauthor=X.+Xie&title=Discovery+and+characterization+of+a+novel+small-molecule+agonist+for+medium-chain+free+fatty+acid+receptor+G+protein-coupled+receptor+84&doi=10.1124%2Fjpet.116.232033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of a novel small-molecule agonist for medium-chain free fatty acid receptor G protein-coupled receptor 84</span></div><div class="casAuthors">Zhang, Qing; Yang, Hui; Li, Jing; Xie, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-344</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">G protein-coupled receptor 84 (GPR84) is a free fatty acid receptor activated by medium-chain free fatty acids with 9-14 carbons.  It is expressed mainly in the immune-related tissues, such as spleen, bone marrow, and peripheral blood leukocytes.  GPR84 plays significant roles in inflammatory processes and may represent a novel drug target for the treatment of immune-mediated diseases.  However, the lack of potent and specific ligands for GPR84 hindered the study of its functions and the development of potential clin. applications.  Here, we report the screen of 160,000 small- mol. compds. with a calcium mobilization assay using a human embryonic kidney 293 cell line stably expressing GPR84 and Ga16, and the identification of 2-(hexylthio)pyrimidine-4,6-diol (ZQ-16) as a potent and selective agonist of GPR84 with a novel structure.  ZQ-16 activates several GPR84-mediated signaling pathways, including calcium mobilization, inhibition of cAMP accumulation, phosphorylation of extracellular signal-regulated protein kinase 1/2, receptor desensitization and internalization, and receptor-β-arrestin interaction.  This compd. may be a useful tool to study the functions of GPR84 and a potential candidate for further structural optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjdl6EN67bhbVg90H21EOLACvtfcHk0lhHqrSrLfOGSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWhu7fE&md5=8a2f4113fddcb35cdd39f99b9470e0c7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.232033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.232033%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520novel%2520small-molecule%2520agonist%2520for%2520medium-chain%2520free%2520fatty%2520acid%2520receptor%2520G%2520protein-coupled%2520receptor%252084%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D357%26issue%3D2%26spage%3D337%26epage%3D344%26doi%3D10.1124%2Fjpet.116.232033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pillaiyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvester, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thimm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kugelgen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C. E.</span></span> <span> </span><span class="NLM_article-title">6-(Ar)alkylamino-substituted uracil derivatives: lipid mimetics with potent activity at the orphan G protein-coupled receptor 84 (GPR84)</span>. <i>ACS omega</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">3365</span>– <span class="NLM_lpage">3383</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b02092</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b02092" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVyqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=3365-3383&issue=3&author=T.+Pillaiyarauthor=M.+Koseauthor=V.+Namasivayamauthor=K.+Sylvesterauthor=G.+Borgesauthor=D.+Thimmauthor=I.+von+Kugelgenauthor=C.+E.+Muller&title=6-%28Ar%29alkylamino-substituted+uracil+derivatives%3A+lipid+mimetics+with+potent+activity+at+the+orphan+G+protein-coupled+receptor+84+%28GPR84%29&doi=10.1021%2Facsomega.7b02092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">6-(Ar)Alkylamino-Substituted Uracil Derivatives: Lipid Mimetics with Potent Activity at the Orphan G Protein-Coupled Receptor 84 (GPR84)</span></div><div class="casAuthors">Pillaiyar, Thanigaimalai; Koese, Meryem; Namasivayam, Vigneshwaran; Sylvester, Katharina; Borges, Gleice; Thimm, Dominik; von Kuegelgen, Ivar; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">3365-3383</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR84, a Gi protein-coupled receptor that is activated by medium-chain (hydroxy)fatty acids, appears to play an important role in inflammation, immunity, and cancer.  Recently, 6-octylaminouracil has been reported to act as an agonist at GPR84.  Here, we describe the synthesis of 69 derivs. and analogs which represent new compds.  They were evaluated in (a) cyclic adenosine monophosphate accumulation and (b) β-arrestin assays in human GPR84-expressing cells.  Potent nonbiased as well as G protein-biased agonists were developed, e.g., 6-hexylamino-2,4(1H,3H)-pyrimidinedione (PSB-1584, EC50 5.0 nM (a), 3.2 nM (b), bias factor: 0) and 6-((p-chloro- and p-bromo-phenylethyl)amino)-2,4(1H,3H)-pyrimidinedione (PSB-16434, EC50 7.1 nM (a), 520 nM (b), bias factor: 1.9 = 79-fold Gi pathway-selective; I, PSB-17365, EC50 2.5 nM (a), 100 nM (b), bias factor 1.3 = 20-fold selective), which were selective vs. other free fatty acid-activated receptors.  Compds. II and I were found to be metabolically stable upon incubation with human liver microsomes.  A pharmacophore model was created on the basis of structurally diverse lipidlike GPR84 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc4TDL4U0tF7Vg90H21EOLACvtfcHk0lgVsT_t-WEOFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVyqu7g%253D&md5=184964bac823f7cd34d4de98da0cef53</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b02092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b02092%26sid%3Dliteratum%253Aachs%26aulast%3DPillaiyar%26aufirst%3DT.%26aulast%3DKose%26aufirst%3DM.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DSylvester%26aufirst%3DK.%26aulast%3DBorges%26aufirst%3DG.%26aulast%3DThimm%26aufirst%3DD.%26aulast%3Dvon%2BKugelgen%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DC.%2BE.%26atitle%3D6-%2528Ar%2529alkylamino-substituted%2520uracil%2520derivatives%253A%2520lipid%2520mimetics%2520with%2520potent%2520activity%2520at%2520the%2520orphan%2520G%2520protein-coupled%2520receptor%252084%2520%2528GPR84%2529%26jtitle%3DACS%2520omega%26date%3D2018%26volume%3D3%26issue%3D3%26spage%3D3365%26epage%3D3383%26doi%3D10.1021%2Facsomega.7b02092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yousefi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarai, G.</span></span> <span> </span><span class="NLM_article-title">Cloning and expression analysis of a novel G-protein-coupled receptor selectively expressed on granulocytes</span>. <i>Journal Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1045</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1189/jlb.69.6.1045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1189%2Fjlb.69.6.1045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=11404393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslWrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=1045-1052&issue=6&author=S.+Yousefiauthor=P.+R.+Cooperauthor=S.+L.+Potterauthor=B.+Mueckauthor=G.+Jarai&title=Cloning+and+expression+analysis+of+a+novel+G-protein-coupled+receptor+selectively+expressed+on+granulocytes&doi=10.1189%2Fjlb.69.6.1045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and expression analysis of a novel G-protein-coupled receptor selectively expressed on granulocytes</span></div><div class="casAuthors">Yousefi, Shida; Cooper, Paul R.; Potter, Suzanne L.; Mueck, Beatrice; Jarai, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1045-1052</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The migration of neutrophils into sites of acute and chronic inflammation is mediated by chemokines.  The authors used degenerate-primer reverse transcriptase-polymerase chain reaction (RT-PCR) to analyze chemokine receptor expression in neutrophils and identify novel receptors.  RNA was isolated from human peripheral blood neutrophils and from neutrophils that had been stimulated for 5 h with granulocyte-macrophage colony-stimulating factor or by coculturing with primary human bronchial epithelial cells.  Amplification products were cloned, and clone redundancy was detd.  Seven known G-protein-coupled receptors were identified among 38 clones-CCR1, CCR4, CXCR1, CXCR2, CXCR4, HM63, and FPR1-as well as a novel gene, EX33.  The full-length EX33 clone was obtained, and an in silico approach was used to identify the putative murine homolog.  The EX33 gene encodes a 396-amino-acid protein with limited sequence identity to known receptors.  Expression studies of several known chemokine receptors and EX33 revealed that resting neutrophils expressed higher levels of CXCRs and EX33 compared with activated neutrophils.  Northern blot expts. revealed that EX33 is expressed mainly in bone marrow, lung, and peripheral blood leukocytes.  Using RT-PCR anal., the authors showed more abundant expression of EX33 in neutrophils and eosinophils, in comparison with that in T- or B-lymphocytes, indicating cell-specific expression among leukocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAMqeieaewbrVg90H21EOLACvtfcHk0lgVsT_t-WEOFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslWrurs%253D&md5=03d1eb21f619cdd4790ace3c2b571d23</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1189%2Fjlb.69.6.1045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.69.6.1045%26sid%3Dliteratum%253Aachs%26aulast%3DYousefi%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DP.%2BR.%26aulast%3DPotter%26aufirst%3DS.%2BL.%26aulast%3DMueck%26aufirst%3DB.%26aulast%3DJarai%26aufirst%3DG.%26atitle%3DCloning%2520and%2520expression%2520analysis%2520of%2520a%2520novel%2520G-protein-coupled%2520receptor%2520selectively%2520expressed%2520on%2520granulocytes%26jtitle%3DJournal%2520Leukocyte%2520Biol.%26date%3D2001%26volume%3D69%26issue%3D6%26spage%3D1045%26epage%3D1052%26doi%3D10.1189%2Fjlb.69.6.1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lattin, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltshire, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saijo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hume, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet, M. J.</span></span> <span> </span><span class="NLM_article-title">Expression analysis of G protein-coupled receptors in mouse macrophages</span>. <i>Immunome Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/1745-7580-4-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1186%2F1745-7580-4-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=18442421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A280%3ADC%252BC3czktlyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=5&author=J.+E.+Lattinauthor=K.+Schroderauthor=A.+I.+Suauthor=J.+R.+Walkerauthor=J.+Zhangauthor=T.+Wiltshireauthor=K.+Saijoauthor=C.+K.+Glassauthor=D.+A.+Humeauthor=S.+Kellieauthor=M.+J.+Sweet&title=Expression+analysis+of+G+protein-coupled+receptors+in+mouse+macrophages&doi=10.1186%2F1745-7580-4-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Expression analysis of G Protein-Coupled Receptors in mouse macrophages</span></div><div class="casAuthors">Lattin Jane E; Schroder Kate; Su Andrew I; Walker John R; Zhang Jie; Wiltshire Tim; Saijo Kaoru; Glass Christopher K; Hume David A; Kellie Stuart; Sweet Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Immunome research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Monocytes and macrophages express an extensive repertoire of G Protein-Coupled Receptors (GPCRs) that regulate inflammation and immunity.  In this study we performed a systematic micro-array analysis of GPCR expression in primary mouse macrophages to identify family members that are either enriched in macrophages compared to a panel of other cell types, or are regulated by an inflammatory stimulus, the bacterial product lipopolysaccharide (LPS).  RESULTS:  Several members of the P2RY family had striking expression patterns in macrophages; P2ry6 mRNA was essentially expressed in a macrophage-specific fashion, whilst P2ry1 and P2ry5 mRNA levels were strongly down-regulated by LPS.  Expression of several other GPCRs was either restricted to macrophages (e.g.  Gpr84) or to both macrophages and neural tissues (e.g.  P2ry12, Gpr85).  The GPCR repertoire expressed by bone marrow-derived macrophages and thioglycollate-elicited peritoneal macrophages had some commonality, but there were also several GPCRs preferentially expressed by either cell population.  CONCLUSION:  The constitutive or regulated expression in macrophages of several GPCRs identified in this study has not previously been described.  Future studies on such GPCRs and their agonists are likely to provide important insights into macrophage biology, as well as novel inflammatory pathways that could be future targets for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrwQCcalOvk2gRQsDqrjW_fW6udTcc2eY_nh_tnU-4R7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czktlyjtw%253D%253D&md5=d0f33a92e85b59309930de7b0bfb36ec</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2F1745-7580-4-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1745-7580-4-5%26sid%3Dliteratum%253Aachs%26aulast%3DLattin%26aufirst%3DJ.%2BE.%26aulast%3DSchroder%26aufirst%3DK.%26aulast%3DSu%26aufirst%3DA.%2BI.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWiltshire%26aufirst%3DT.%26aulast%3DSaijo%26aufirst%3DK.%26aulast%3DGlass%26aufirst%3DC.%2BK.%26aulast%3DHume%26aufirst%3DD.%2BA.%26aulast%3DKellie%26aufirst%3DS.%26aulast%3DSweet%26aufirst%3DM.%2BJ.%26atitle%3DExpression%2520analysis%2520of%2520G%2520protein-coupled%2520receptors%2520in%2520mouse%2520macrophages%26jtitle%3DImmunome%2520Res.%26date%3D2008%26volume%3D4%26spage%3D5%26doi%3D10.1186%2F1745-7580-4-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Audoy-Remus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozoyan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecours, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacroix, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivest, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallieres, L.</span></span> <span> </span><span class="NLM_article-title">GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer’s disease</span>. <i>Brain, Behav., Immun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.bbi.2015.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.bbi.2015.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=25637481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFCntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2015&pages=112-120&author=J.+Audoy-Remusauthor=L.+Bozoyanauthor=A.+Dumasauthor=M.+Filaliauthor=C.+Lecoursauthor=S.+Lacroixauthor=S.+Rivestauthor=M.+E.+Tremblayauthor=L.+Vallieres&title=GPR84+deficiency+reduces+microgliosis%2C+but+accelerates+dendritic+degeneration+and+cognitive+decline+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bbi.2015.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Audoy-Remus, Julie; Bozoyan, Lusine; Dumas, Aline; Filali, Mohammed; Lecours, Cynthia; Lacroix, Steve; Rivest, Serge; Tremblay, Marie-Eve; Vallieres, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Brain, Behavior, and Immunity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112-120</span>CODEN:
                <span class="NLM_cas:coden">BBIMEW</span>;
        ISSN:<span class="NLM_cas:issn">0889-1591</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Microglia surrounds the amyloid plaques that form in the brains of patients with Alzheimer's disease (AD), but their role is controversial.  Under inflammatory conditions, these cells can express GPR84, an orphan receptor whose pathophysiol. role is unknown.  Here, we report that GPR84 is upregulated in microglia of APP/PS1 transgenic mice, a model of AD.  Without GPR84, these mice display both accelerated cognitive decline and a reduced no. of microglia, esp. in areas surrounding plaques.  The lack of GPR84 affects neither plaque formation nor hippocampal neurogenesis, but promotes dendritic degeneration.  Furthermore, GPR84 does not influence the clin. progression of other diseases in which its expression has been reported, i.e., exptl. autoimmune encephalomyelitis (EAE) and endotoxic shock.  We conclude that GPR84 plays a beneficial role in amyloid pathol. by acting as a sensor for a yet unknown ligand that promotes microglia recruitment, a response affecting dendritic degeneration and required to prevent further cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWBqsDH3-KvrVg90H21EOLACvtfcHk0lhnvwGVU3LzTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFCntbo%253D&md5=4b643287374786cdde611ffbb3002101</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2015.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2015.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DAudoy-Remus%26aufirst%3DJ.%26aulast%3DBozoyan%26aufirst%3DL.%26aulast%3DDumas%26aufirst%3DA.%26aulast%3DFilali%26aufirst%3DM.%26aulast%3DLecours%26aufirst%3DC.%26aulast%3DLacroix%26aufirst%3DS.%26aulast%3DRivest%26aufirst%3DS.%26aulast%3DTremblay%26aufirst%3DM.%2BE.%26aulast%3DVallieres%26aufirst%3DL.%26atitle%3DGPR84%2520deficiency%2520reduces%2520microgliosis%252C%2520but%2520accelerates%2520dendritic%2520degeneration%2520and%2520cognitive%2520decline%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2015%26volume%3D46%26spage%3D112%26epage%3D120%26doi%3D10.1016%2Fj.bbi.2015.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouchard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallieres, L.</span></span> <span> </span><span class="NLM_article-title">G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">790</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1002/glia.20506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1002%2Fglia.20506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=17390309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A280%3ADC%252BD2s3jtVemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=790-800&issue=8&author=C.+Bouchardauthor=J.+Pageauthor=A.+Bedardauthor=P.+Tremblayauthor=L.+Vallieres&title=G+protein-coupled+receptor+84%2C+a+microglia-associated+protein+expressed+in+neuroinflammatory+conditions&doi=10.1002%2Fglia.20506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions</span></div><div class="casAuthors">Bouchard Caroline; Page Julie; Bedard Andreanne; Tremblay Pierrot; Vallieres Luc</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">790-800</span>
        ISSN:<span class="NLM_cas:issn">0894-1491</span>.
    </div><div class="casAbstract">G protein-coupled receptor 84 (GPR84) is a recently discovered member of the seven transmembrane receptor superfamily whose function and regulation are unknown.  Here, we report that in mice suffering from endotoxemia, microglia express GPR84 in a strong and sustained manner.  This property is shared by subpopulations of peripheral macrophages and, to a much lesser extent, monocytes.  The induction of GPR84 expression by endotoxin is mediated, at least in part, by proinflammatory cytokines, notably tumor necrosis factor (TNF) and interleukin-1 (IL-1), because mice lacking either one or both of these molecules have fewer GPR84-expressing cells in their cerebral cortex than wild-type mice during the early phase of endotoxemia.  Moreover, when injected intracerebrally or added to microglial cultures, recombinant TNF stimulates GPR84 expression through a dexamethasone-insensitive mechanism.  Finally, we show that microglia produce GPR84 not only during endotoxemia, but also during experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis.  In conclusion, this study reports the identification of a new sensitive marker of microglial activation, which may play an important regulatory role in neuroimmunological processes, acting downstream to the effects of proinflammatory mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5WBo60SwdsPEeosoOnpOLfW6udTcc2eb29nSIgiSJsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3jtVemsw%253D%253D&md5=5bc25664243312ac66f94244ab598c9d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fglia.20506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20506%26sid%3Dliteratum%253Aachs%26aulast%3DBouchard%26aufirst%3DC.%26aulast%3DPage%26aufirst%3DJ.%26aulast%3DBedard%26aufirst%3DA.%26aulast%3DTremblay%26aufirst%3DP.%26aulast%3DVallieres%26aufirst%3DL.%26atitle%3DG%2520protein-coupled%2520receptor%252084%252C%2520a%2520microglia-associated%2520protein%2520expressed%2520in%2520neuroinflammatory%2520conditions%26jtitle%3DGlia%26date%3D2007%26volume%3D55%26issue%3D8%26spage%3D790%26epage%3D800%26doi%3D10.1002%2Fglia.20506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkataraman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, F.</span></span> <span> </span><span class="NLM_article-title">The G-protein coupled receptor, GPR84 regulates IL-4 production by T lymphocytes in response to CD3 crosslinking</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2005.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.imlet.2005.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=15993493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKjs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2005&pages=144-153&issue=2&author=C.+Venkataramanauthor=F.+Kuo&title=The+G-protein+coupled+receptor%2C+GPR84+regulates+IL-4+production+by+T+lymphocytes+in+response+to+CD3+crosslinking&doi=10.1016%2Fj.imlet.2005.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The G-protein coupled receptor, GPR84 regulates IL-4 production by T lymphocytes in response to CD3 crosslinking</span></div><div class="casAuthors">Venkataraman, Chandrasekar; Kuo, Frederick</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-153</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The orphan G-protein coupled receptor, GPR84 is highly expressed in the bone marrow, and in splenic T cells and B cells.  In this study, GPR84-deficient mice were generated to understand the biol. function of this orphan receptor.  The proliferation of T and B cells in response to various mitogens was normal in GPR84-deficient mice.  Interestingly, primary stimulation of T cells with anti-CD3 resulted in increased IL-4 but not IL-2 or IFN-γ prodn. in GPR84-/- mice compared to wild-type mice.  Augmented IL-4 prodn. in GPR84-deficient T cells was not related to increased frequency of IL-4-secreting cells in response to anti-CD3 stimulation.  In fact, stimulation with anti-CD3 and anti-CD28 resulted in increased levels of IL-4 but not IFN-γ steady-state mRNA in GPR84-/- T cells.  In addn., Th2 effector cells generated in vitro from GPR84-/- mice produced higher levels of IL-4, IL-5 and IL-13 compared to wild-type mice.  However, there was no detectable difference in the extent of IL-4 and IL-5 prodn. between the two groups of mice in response to antigen stimulation of spleen cells, isolated from mice previously immunized with OVA in alum.  These studies reveal a novel role for GPR84 in regulating early IL-4 gene expression in activated T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoxPqqzrLXAbVg90H21EOLACvtfcHk0lgKb5qDrirMFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKjs77L&md5=abef6f196008a5055ab99e9213c0d55d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2005.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2005.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DVenkataraman%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DF.%26atitle%3DThe%2520G-protein%2520coupled%2520receptor%252C%2520GPR84%2520regulates%2520IL-4%2520production%2520by%2520T%2520lymphocytes%2520in%2520response%2520to%2520CD3%2520crosslinking%26jtitle%3DImmunol.%2520Lett.%26date%3D2005%26volume%3D101%26issue%3D2%26spage%3D144%26epage%3D153%26doi%3D10.1016%2Fj.imlet.2005.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchigami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, Y.</span></span> <span> </span><span class="NLM_article-title">Inflammatory changes in adipose tissue enhance expression of GPR84, a medium-chain fatty acid receptor: TNFα enhances GPR84 expression in adipocytes</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>586</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">368</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2012.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.febslet.2012.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=22245676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1yqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=586&publication_year=2012&pages=368-372&issue=4&author=H.+Nagasakiauthor=T.+Kondoauthor=M.+Fuchigamiauthor=H.+Hashimotoauthor=Y.+Sugimuraauthor=N.+Ozakiauthor=H.+Arimaauthor=A.+Otaauthor=Y.+Oisoauthor=Y.+Hamada&title=Inflammatory+changes+in+adipose+tissue+enhance+expression+of+GPR84%2C+a+medium-chain+fatty+acid+receptor%3A+TNF%CE%B1+enhances+GPR84+expression+in+adipocytes&doi=10.1016%2Fj.febslet.2012.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory changes in adipose tissue enhance expression of GPR G-protein coupled receptor84, a medium-chain fatty acid receptor</span></div><div class="casAuthors">Nagasaki, Hiroshi; Kondo, Takaaki; Fuchigami, Masahiro; Hashimoto, Hiroyuki; Sugimura, Yoshihisa; Ozaki, Nobuaki; Arima, Hiroshi; Ota, Akira; Oiso, Yutaka; Hamada, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">586</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">368-372</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study we aimed to identify the physiol. roles of G protein-coupled receptor 84 (GPR84) in adipose tissue, together with medium-chain fatty acids (MCFAs), the specific ligands for GPR84.  In mice, high-fat diet up-regulated GPR84 expression in fat pads.  In 3T3-L1 adipocytes, coculture with a macrophage cell line, RAW264, or TNFα remarkably enhanced GPR84 expression.  In the presence of TNFα, MCFAs down-regulated adiponectin mRNA expression in 3T3-L1 adipocytes.  Taken together, our results suggest that GPR84 emerges in adipocytes in response to TNFα from infiltrating macrophages and exacerbates the vicious cycle between adiposity and diabesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiwUz5s6M9zLVg90H21EOLACvtfcHk0lghE4ozUyZJRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1yqu7w%253D&md5=8fecdea5b404e472d6f66a9ed22cd88b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2012.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2012.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DNagasaki%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DFuchigami%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DSugimura%26aufirst%3DY.%26aulast%3DOzaki%26aufirst%3DN.%26aulast%3DArima%26aufirst%3DH.%26aulast%3DOta%26aufirst%3DA.%26aulast%3DOiso%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DY.%26atitle%3DInflammatory%2520changes%2520in%2520adipose%2520tissue%2520enhance%2520expression%2520of%2520GPR84%252C%2520a%2520medium-chain%2520fatty%2520acid%2520receptor%253A%2520TNF%25CE%25B1%2520enhances%2520GPR84%2520expression%2520in%2520adipocytes%26jtitle%3DFEBS%2520Lett.%26date%3D2012%26volume%3D586%26issue%3D4%26spage%3D368%26epage%3D372%26doi%3D10.1016%2Fj.febslet.2012.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicol, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Russa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didangelos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcangio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, S. B.</span></span> <span> </span><span class="NLM_article-title">The role of G-protein receptor 84 in experimental neuropathic pain</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">8959</span>– <span class="NLM_lpage">8969</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3558-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1523%2FJNEUROSCI.3558-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=26063927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOqsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=8959-8969&issue=23&author=L.+S.+Nicolauthor=J.+M.+Dawesauthor=F.+La+Russaauthor=A.+Didangelosauthor=A.+K.+Clarkauthor=C.+Gentryauthor=J.+Gristauthor=J.+B.+Daviesauthor=M.+Malcangioauthor=S.+B.+McMahon&title=The+role+of+G-protein+receptor+84+in+experimental+neuropathic+pain&doi=10.1523%2FJNEUROSCI.3558-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The role of G-protein receptor 84 in experimental neuropathic pain</span></div><div class="casAuthors">Nicol, Louise S. C.; Dawes, John M.; La Russa, Federica; Didangelos, Athanasios; Clark, Anna K.; Gentry, Clive; Grist, John; Davies, John B.; Malcangio, Marzia; McMahon, Stephen B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8959-8969</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">G-protein receptor 84 (GPR84) is an orphan receptor that is induced markedly in monocytes/macrophages and microglia during inflammation, but its pathophysiol. function is unknown.  Here, we investigate the role of GPR84 in a murine model of traumatic nerve injury.  Naive GPR84 knock-out (KO) mice exhibited normal behavioral responses to acute noxious stimuli, but subsequent to partial sciatic nerve ligation (PNL), KOs did not develop mech. or thermal hypersensitivity, in contrast to wild-type (WT) littermates.  Nerve injury increased ionized calcium binding adapter mol. 1 (Iba1) and phosphorylated p38 MAPK immunoreactivity in the dorsal horn and Iba1 and cluster of differentiation 45 expression in the sciatic nerve, with no difference between genotypes.  PCR array anal. revealed that Gpr84 expression was upregulated in the spinal cord and sciatic nerve of WT mice.  In addn., the expression of arginase-1, a marker for anti-inflammatory macrophages, was upregulated in KO sciatic nerve.  Based on this evidence, we investigated whether peripheral macrophages behave differently in the absence of GPR84.  We found that lipopolysaccharide-stimulated KO macrophages exhibited attenuated expression of several proinflammatory mediators, including IL-1β, IL-6, and TNF-α.  Forskolin-stimulated KO macrophages also showed greater cAMP induction, a second messenger assocd. with immunosuppression.  In summary, our results demonstrate that GPR84 is a proinflammatory receptor that contributes to nociceptive signaling via the modulation of macrophages, whereas in its absence the response of these cells to an inflammatory insult is impaired.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEz_UEJb4WPbVg90H21EOLACvtfcHk0lghE4ozUyZJRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOqsLrJ&md5=4d7a16fa2471aaaa6ed9395ad1215544</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3558-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3558-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DNicol%26aufirst%3DL.%2BS.%26aulast%3DDawes%26aufirst%3DJ.%2BM.%26aulast%3DLa%2BRussa%26aufirst%3DF.%26aulast%3DDidangelos%26aufirst%3DA.%26aulast%3DClark%26aufirst%3DA.%2BK.%26aulast%3DGentry%26aufirst%3DC.%26aulast%3DGrist%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DJ.%2BB.%26aulast%3DMalcangio%26aufirst%3DM.%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26atitle%3DThe%2520role%2520of%2520G-protein%2520receptor%252084%2520in%2520experimental%2520neuropathic%2520pain%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26issue%3D23%26spage%3D8959%26epage%3D8969%26doi%3D10.1523%2FJNEUROSCI.3558-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundqvist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christenson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdfeldt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mårtensson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieckmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsman, H.</span></span> <span> </span><span class="NLM_article-title">Similarities and differences between the responses induced in human phagocytes through activation of the medium chain fatty acid receptor GPR84 and the short chain fatty acid receptor FFA2R</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1865</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">708</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2018.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.bbamcr.2018.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=29477577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFaju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1865&publication_year=2018&pages=695-708&issue=5&author=M.+Sundqvistauthor=K.+Christensonauthor=A.+Holdfeldtauthor=M.+Gablauthor=J.+M%C3%A5rtenssonauthor=L.+Bj%C3%B6rkmanauthor=R.+Dieckmannauthor=C.+Dahlgrenauthor=H.+Forsman&title=Similarities+and+differences+between+the+responses+induced+in+human+phagocytes+through+activation+of+the+medium+chain+fatty+acid+receptor+GPR84+and+the+short+chain+fatty+acid+receptor+FFA2R&doi=10.1016%2Fj.bbamcr.2018.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Similarities and differences between the responses induced in human phagocytes through activation of the medium chain fatty acid receptor GPR84 and the short chain fatty acid receptor FFA2R</span></div><div class="casAuthors">Sundqvist, Martina; Christenson, Karin; Holdfeldt, Andre; Gabl, Michael; Maartensson, Jonas; Bjoerkman, Lena; Dieckmann, Regis; Dahlgren, Claes; Forsman, Huamei</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1865</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-708</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, we have characterized the GPR84 activation profile and regulation mechanism in human phagocytes, using two recently developed small mols. that specifically target GPR84 agonistically (ZQ16) and antagonistically (GLPG1205), resp.  Compared to our earlier characterization of the short chain fatty acid receptor FFA2R which is functionally expressed in neutrophils but not in monocytes, GPR84 is expressed in both cell types and in monocyte-derived macrophages.  In neutrophils, the GPR84 agonist had an activation profile very similar to that of FFA2R.  The GPR84-mediated superoxide release was low in naive cells, but the response could be significantly primed by TNFα and by the actin cytoskeleton disrupting agent Latrunculin A.  Similar to that of FFA2R, a desensitization mechanism bypassing the actin cytoskeleton was utilized by GPR84.  All ZQ16-mediated cellular responses were sensitive to GLPG1205, confirming the GPR84-dependency.  Finally, our data of in vivo transmigrated tissue neutrophils indicate that both GPR84 and FFA2R are involved in neutrophil recruitment processes in vivo.  In summary, we show functional similarities but also some important differences between GPR84 and FFA2R in human phagocytes, thus providing some mechanistic insights into GPR84 regulation in blood neutrophils and cells recruited to an aseptic inflammatory site in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxFh26S2UftbVg90H21EOLACvtfcHk0lgCWS85eu9hLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFaju7w%253D&md5=5f80256de9cc62715bf953312937170e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2018.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2018.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DSundqvist%26aufirst%3DM.%26aulast%3DChristenson%26aufirst%3DK.%26aulast%3DHoldfeldt%26aufirst%3DA.%26aulast%3DGabl%26aufirst%3DM.%26aulast%3DM%25C3%25A5rtensson%26aufirst%3DJ.%26aulast%3DBj%25C3%25B6rkman%26aufirst%3DL.%26aulast%3DDieckmann%26aufirst%3DR.%26aulast%3DDahlgren%26aufirst%3DC.%26aulast%3DForsman%26aufirst%3DH.%26atitle%3DSimilarities%2520and%2520differences%2520between%2520the%2520responses%2520induced%2520in%2520human%2520phagocytes%2520through%2520activation%2520of%2520the%2520medium%2520chain%2520fatty%2520acid%2520receptor%2520GPR84%2520and%2520the%2520short%2520chain%2520fatty%2520acid%2520receptor%2520FFA2R%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2018%26volume%3D1865%26issue%3D5%26spage%3D695%26epage%3D708%26doi%3D10.1016%2Fj.bbamcr.2018.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arijs, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Hertogh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machiels, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Steen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemaire, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schraenen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Lommel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Assche, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuit, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutgeerts, P.</span></span> <span> </span><span class="NLM_article-title">Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment</span>. <i>Am. J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1038/ajg.2011.27</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1038%2Fajg.2011.27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=21326222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1ehsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2011&pages=748-761&issue=4&author=I.+Arijsauthor=G.+De+Hertoghauthor=K.+Machielsauthor=K.+Van+Steenauthor=K.+Lemaireauthor=A.+Schraenenauthor=L.+Van+Lommelauthor=R.+Quintensauthor=G.+Van+Asscheauthor=S.+Vermeireauthor=F.+Schuitauthor=P.+Rutgeerts&title=Mucosal+gene+expression+of+cell+adhesion+molecules%2C+chemokines%2C+and+chemokine+receptors+in+patients+with+inflammatory+bowel+disease+before+and+after+infliximab+treatment&doi=10.1038%2Fajg.2011.27"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines, and Chemokine Receptors in Patients With Inflammatory Bowel Disease Before and After Infliximab Treatment</span></div><div class="casAuthors">Arijs, Ingrid; De Hertogh, Gert; Machiels, Kathleen; Van Steen, Kristel; Lemaire, Katleen; Schraenen, Anica; Van Lommel, Leentje; Quintens, Roel; Van Assche, Gert; Vermeire, Severine; Schuit, Frans; Rutgeerts, Paul</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">748-761</span>CODEN:
                <span class="NLM_cas:coden">AJGAAR</span>;
        ISSN:<span class="NLM_cas:issn">0002-9270</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">OBJECTIVES: Inflammatory bowel disease (IBD) is characterized by a continuous influx of leukocytes into the gut wall.  This migration is regulated by cell adhesion mols. (CAMs), and selective antimigration therapies have been developed.  This study investigated the effect of infliximab therapy on the mucosal gene expression of CAMs in IBD.  METHODS: Mucosal gene expression of 69 leukocyte/endothelial CAMs and E-cadherin was investigated in 61 IBD patients before and after first infliximab infusion and in 12 normal controls, using Affymetrix gene expression microarrays.  Quant. reverse transcriptase-PCR (qRT-PCR), immunohistochem., and western blotting were used to confirm the microarray data.  RESULTS: When compared with control colons, the colonic mucosal gene expression of most leukocyte/endothelial adhesion mols. was upregulated and E-cadherin gene expression was downregulated in active colonic IBD (IBDc) before therapy, with no significant colonic gene expression differences between ulcerative colitis and colonic Crohn's disease.  Infliximab therapy restored the upregulations of leukocyte CAMs in IBDc responders to infliximab that paralleled the disappearance of the inflammatory cells from the colonic lamina propria.  Also, the colonic gene expression of endothelial CAMs and of most chemokines/chemokine receptors returned to normal after therapy in IBDc responders, and only CCL20 and CXCL1-2 expression remained increased after therapy in IBDc responders vs. control colons.  When compared with control ileums, the ileal gene expression of MADCAM1, THY1, PECAM1, CCL28, CXCL1, -2, -5, -6, and -11, and IL8 was increased and CD58 expression was decreased in active ileal Crohn's disease (CDi) before therapy, and none of the genes remained dysregulated after therapy in CDi responders vs. control ileums.  This microarray study identified a no. of interesting targets for antiadhesion therapy including PECAM1, IL8, and CCL20, besides the currently studied α4β7 integrin-MADCAM1 axis.  CONCLUSIONS: Our data demonstrate that many leukocyte/endothelial CAMs and chemokines/chemokine receptors are upregulated in inflamed IBD mucosa.  Controlling the inflammation with infliximab restores most of these dysregulations in IBD.  These results show that at least part of the mechanism of anti-tumor necrosis factor-α therapy goes through downregulation of certain adhesion mols.  Am J Gastroenterol 2011; 106:748-761; doi:10.1038/ajg.2011.27; published online 15 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1-CMItQPbZrVg90H21EOLACvtfcHk0lgKZhb-PMzVhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1ehsr8%253D&md5=f4483700084ba9b4a7dddae654ecd0e2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fajg.2011.27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajg.2011.27%26sid%3Dliteratum%253Aachs%26aulast%3DArijs%26aufirst%3DI.%26aulast%3DDe%2BHertogh%26aufirst%3DG.%26aulast%3DMachiels%26aufirst%3DK.%26aulast%3DVan%2BSteen%26aufirst%3DK.%26aulast%3DLemaire%26aufirst%3DK.%26aulast%3DSchraenen%26aufirst%3DA.%26aulast%3DVan%2BLommel%26aufirst%3DL.%26aulast%3DQuintens%26aufirst%3DR.%26aulast%3DVan%2BAssche%26aufirst%3DG.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DSchuit%26aufirst%3DF.%26aulast%3DRutgeerts%26aufirst%3DP.%26atitle%3DMucosal%2520gene%2520expression%2520of%2520cell%2520adhesion%2520molecules%252C%2520chemokines%252C%2520and%2520chemokine%2520receptors%2520in%2520patients%2520with%2520inflammatory%2520bowel%2520disease%2520before%2520and%2520after%2520infliximab%2520treatment%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2011%26volume%3D106%26issue%3D4%26spage%3D748%26epage%3D761%26doi%3D10.1038%2Fajg.2011.27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibodeau, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grouix, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarra-Bournet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hince, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geerts, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, C. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebert, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutsol, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holterman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gervais, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouboudinar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laverdure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letourneau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloutier, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duceppe, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacharie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupuis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurin, P.</span></span> <span> </span><span class="NLM_article-title">A newly discovered antifibrotic pathway regulated by two fatty acid receptors: GPR40 and GPR84</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>188</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1132</span>– <span class="NLM_lpage">1148</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2018.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.ajpath.2018.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=29454750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVGqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2018&pages=1132-1148&issue=5&author=L.+Gagnonauthor=M.+Leducauthor=J.+F.+Thibodeauauthor=M.+Z.+Zhangauthor=B.+Grouixauthor=F.+Sarra-Bournetauthor=W.+Gagnonauthor=K.+Hinceauthor=M.+Tremblayauthor=L.+Geertsauthor=C.+R.+J.+Kennedyauthor=R.+L.+Hebertauthor=A.+Gutsolauthor=C.+E.+Holtermanauthor=E.+Kamtoauthor=L.+Gervaisauthor=J.+Ouboudinarauthor=J.+Richardauthor=A.+Feltonauthor=A.+Laverdureauthor=J.+C.+Simardauthor=S.+Letourneauauthor=M.+P.+Cloutierauthor=F.+A.+Leblondauthor=S.+D.+Abbottauthor=C.+Penneyauthor=J.+S.+Duceppeauthor=B.+Zacharieauthor=J.+Dupuisauthor=A.+Calderoneauthor=Q.+T.+Nguyenauthor=R.+C.+Harrisauthor=P.+Laurin&title=A+newly+discovered+antifibrotic+pathway+regulated+by+two+fatty+acid+receptors%3A+GPR40+and+GPR84&doi=10.1016%2Fj.ajpath.2018.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors</span></div><div class="casAuthors">Gagnon, Lyne; Leduc, Martin; Thibodeau, Jean-Francois; Zhang, Ming-Zhi; Grouix, Brigitte; Sarra-Bournet, Francois; Gagnon, William; Hince, Kathy; Tremblay, Mikael; Geerts, Lilianne; Kennedy, Christopher R. J.; Hebert, Richard L.; Gutsol, Alex; Holterman, Chet E.; Kamto, Eldjonai; Gervais, Liette; Ouboudinar, Jugurtha; Richard, Jonathan; Felton, Alexandra; Laverdure, Alexandre; Simard, Jean-Christophe; Letourneau, Sylvie; Cloutier, Marie-Pier; Leblond, Francois A.; Abbott, Shaun D.; Penney, Christopher; Duceppe, Jean-Simon; Zacharie, Boulos; Dupuis, Jocelyn; Calderone, Angelino; Nguyen, Quang T.; Harris, Raymond C.; Laurin, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1132-1148</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Numerous clin. conditions can lead to organ fibrosis and functional failure.  There is a great need for therapies that could effectively target pathophysiol. pathways involved in fibrosis.  GPR40 and GPR84 are G protein-coupled receptors with free fatty acid ligands and are assocd. with metabolic and inflammatory disorders.  Although GPR40 and GPR84 are involved in diverse physiol. processes, no evidence has demonstrated the relevance of GPR40 and GPR84 in fibrosis pathways.  Using PBI-4050 (3-pentylbenzeneacetic acid sodium salt), a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, resp., we uncovered an antifibrotic pathway involving these receptors.  In expts. using Gpr40- and Gpr84-knockout mice in models of kidney fibrosis (unilateral ureteral obstruction, long-term post-acute ischemic injury, and adenine-induced chronic kidney disease), we found that GPR40 is protective and GPR84 is deleterious in these diseases.  Moreover, through binding to GPR40 and GPR84, PBI-4050 significantly attenuated fibrosis in many injury contexts, as evidenced by the antifibrotic activity obsd. in kidney, liver, heart, lung, pancreas, and skin fibrosis models.  Therefore, GPR40 and GPR84 may represent promising mol. targets in fibrosis pathways.  We conclude that PBI-4050 is a first-in-class compd. that may be effective for managing inflammatory and fibrosis-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogzjSwncX3zLVg90H21EOLACvtfcHk0lgZ7Z9Q6_LF4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVGqs7w%253D&md5=47fff3190f70beafa69897d9d89f206d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2018.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2018.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DGagnon%26aufirst%3DL.%26aulast%3DLeduc%26aufirst%3DM.%26aulast%3DThibodeau%26aufirst%3DJ.%2BF.%26aulast%3DZhang%26aufirst%3DM.%2BZ.%26aulast%3DGrouix%26aufirst%3DB.%26aulast%3DSarra-Bournet%26aufirst%3DF.%26aulast%3DGagnon%26aufirst%3DW.%26aulast%3DHince%26aufirst%3DK.%26aulast%3DTremblay%26aufirst%3DM.%26aulast%3DGeerts%26aufirst%3DL.%26aulast%3DKennedy%26aufirst%3DC.%2BR.%2BJ.%26aulast%3DHebert%26aufirst%3DR.%2BL.%26aulast%3DGutsol%26aufirst%3DA.%26aulast%3DHolterman%26aufirst%3DC.%2BE.%26aulast%3DKamto%26aufirst%3DE.%26aulast%3DGervais%26aufirst%3DL.%26aulast%3DOuboudinar%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DJ.%26aulast%3DFelton%26aufirst%3DA.%26aulast%3DLaverdure%26aufirst%3DA.%26aulast%3DSimard%26aufirst%3DJ.%2BC.%26aulast%3DLetourneau%26aufirst%3DS.%26aulast%3DCloutier%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DF.%2BA.%26aulast%3DAbbott%26aufirst%3DS.%2BD.%26aulast%3DPenney%26aufirst%3DC.%26aulast%3DDuceppe%26aufirst%3DJ.%2BS.%26aulast%3DZacharie%26aufirst%3DB.%26aulast%3DDupuis%26aufirst%3DJ.%26aulast%3DCalderone%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DQ.%2BT.%26aulast%3DHarris%26aufirst%3DR.%2BC.%26aulast%3DLaurin%26aufirst%3DP.%26atitle%3DA%2520newly%2520discovered%2520antifibrotic%2520pathway%2520regulated%2520by%2520two%2520fatty%2520acid%2520receptors%253A%2520GPR40%2520and%2520GPR84%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2018%26volume%3D188%26issue%3D5%26spage%3D1132%26epage%3D1148%26doi%3D10.1016%2Fj.ajpath.2018.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aziz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhuber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meguid Kassem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khailah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamal Eldeen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khairy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khayyal, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shcherbakova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich-Merzenich, G.</span></span> <span> </span><span class="NLM_article-title">GPR84 and TREM-1 signaling contribute to the pathogenesis of reflux esophagitis</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1024</span>, <span class="refDoi"> DOI: 10.2119/molmed.2015.00098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.2119%2Fmolmed.2015.00098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKlsLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=1011-1024&issue=1&author=H.+Abdel-Azizauthor=M.+Schneiderauthor=W.+Neuhuberauthor=A.+Meguid+Kassemauthor=S.+Khailahauthor=J.+Mullerauthor=H.+Gamal+Eldeenauthor=A.+Khairyauthor=M.+T.+Khayyalauthor=A.+Shcherbakovaauthor=T.+Efferthauthor=G.+Ulrich-Merzenich&title=GPR84+and+TREM-1+signaling+contribute+to+the+pathogenesis+of+reflux+esophagitis&doi=10.2119%2Fmolmed.2015.00098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">GPR84 and TREM-1 signaling contribute to the pathogenesis of reflux esophagitis</span></div><div class="casAuthors">Abdel-Aziz, Heba; Schneider, Mathias; Neuhuber, Winfried; Kassem, Abdel Meguid; Khailah, Saleem; Mueller, Juergen; Eldeen, Hadeel Gamal; Khairy, Ahmed; Khayyal, Mohamed T.; Shcherbakova, Anastasiia; Efferth, Thomas; Ulrich-Merzenich, Gudrun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1011-1024</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Gastro-esophageal reflux disease (GERD) is one of the most common disorders in gastroenterol.  Patients present with or without increased acid exposure indicating a nonuniform etiol.  Thus, the common treatment with proton pump inhibitors (PPIs) fails to control symptoms in up to 40% of patients.  To further elucidate the pathophysiol. of the condition and explore new treatment targets, transcriptomics, proteomics and histol. methods were applied to a surgically induced subchronic reflux esophagitis model in Wistar rats after treatment with either omeprazole (PPI) or STW5, a herbal prepn. shown to ameliorate esophagitis without affecting refluxate pH.  The normal human esophageal squamous cell line HET-1A and human endoscopic biopsies were used to confirm our findings to the G-protein-coupled receptor (GPR) 84 in human tissue.  Both treatments reduced reflux-induced macroscopic and microscopic lesions of the esophagi as well as known proinflammatory cytokines.  Proteomic and transcriptomic analyses identified CINC1-3, MIP-1/3α, MIG, RANTES and interleukin (IL)-1β as prominent mediators in GERD.  Most regulated cyto-/chemokines are linked to the TREM-1 signaling pathway.  The fatty acid receptor GPR84 was upregulated in esophagitis but significantly decreased in treated groups, a finding supported by Western blot and immunohistochem. in both rat tissue and HET-1A cells.  GPR84 was also found to be significantly upregulated in patients with grade B reflux esophagitis.  The expression of GPR84 in esophageal tissue and its potential involvement in GERD are reported for the first time.  IL-8 (CINC1-3) and the TREM-1 signaling pathway are proposed, besides GPR84, to play an important role in the pathogenesis of GERD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGv2akUPMqbbVg90H21EOLACvtfcHk0lgZ7Z9Q6_LF4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKlsLbI&md5=d626c0592ea9ac67a3700ec6b2138383</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2015.00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2015.00098%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Aziz%26aufirst%3DH.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DNeuhuber%26aufirst%3DW.%26aulast%3DMeguid%2BKassem%26aufirst%3DA.%26aulast%3DKhailah%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DGamal%2BEldeen%26aufirst%3DH.%26aulast%3DKhairy%26aufirst%3DA.%26aulast%3DKhayyal%26aufirst%3DM.%2BT.%26aulast%3DShcherbakova%26aufirst%3DA.%26aulast%3DEfferth%26aufirst%3DT.%26aulast%3DUlrich-Merzenich%26aufirst%3DG.%26atitle%3DGPR84%2520and%2520TREM-1%2520signaling%2520contribute%2520to%2520the%2520pathogenesis%2520of%2520reflux%2520esophagitis%26jtitle%3DMol.%2520Med.%26date%3D2015%26volume%3D21%26issue%3D1%26spage%3D1011%26epage%3D1024%26doi%3D10.2119%2Fmolmed.2015.00098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. Y.</span></span> <span> </span><span class="NLM_article-title">GPR84 sustains aberrant beta-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">3284</span>– <span class="NLM_lpage">3294</span>, <span class="refDoi"> DOI: 10.1182/blood-2013-10-532523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1182%2Fblood-2013-10-532523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=25293777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSgs73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3284-3294&issue=22&author=P.+A.+Dietrichauthor=C.+Yangauthor=H.+H.+Leungauthor=J.+R.+Lynchauthor=E.+Gonzalesauthor=B.+Liuauthor=M.+Haberauthor=M.+D.+Norrisauthor=J.+Wangauthor=J.+Y.+Wang&title=GPR84+sustains+aberrant+beta-catenin+signaling+in+leukemic+stem+cells+for+maintenance+of+MLL+leukemogenesis&doi=10.1182%2Fblood-2013-10-532523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">GPR84 sustains aberrant β-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis</span></div><div class="casAuthors">Dietrich, Philipp A.; Yang, Chen; Leung, Halina H. L.; Lynch, Jennifer R.; Gonzales, Estrella; Liu, Bing; Haber, Michelle; Norris, Murray D.; Wang, Jianlong; Wang, Jenny Yingzi</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3284-3294</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">β-Catenin is required for establishment of leukemic stem cells (LSCs) in acute myeloid leukemia (AML).  Targeted inhibition of β-catenin signaling has been hampered by the lack of pathway components amenable to pharmacol. manipulation.  Here we identified a novel β-catenin regulator, GPR84, a member of the G protein-coupled receptor family that represents a highly tractable class of drug targets.  High GPR84 expression levels were confirmed in human and mouse AML LSCs compared with hematopoietic stem cells (HSCs).  Suppression of GPR84 significantly inhibited cell growth by inducing G1-phase cell-cycle arrest in pre-LSCs, reduced LSC frequency, and impaired reconstitution of stem cell-derived mixed-lineage leukemia (MLL) AML, which represents an aggressive and drug-resistant subtype of AML.  The GPR84-deficient phenotype in established AML could be rescued by expression of constitutively active β-catenin.  Furthermore, GPR84 conferred a growth advantage to Hoxa9/Meis1a-transduced stem cells.  Microarray anal. demonstrated that GPR84 significantly upregulated a small set of MLL-fusion targets and β-catenin coeffectors, and downregulated a hematopoietic cell-cycle inhibitor.  Altogether, our data reveal a previously unrecognized role of GPR84 in maintaining fully developed AML by sustaining aberrant β-catenin signaling in LSCs, and suggest that targeting the oncogenic GPR84/β-catenin signaling axis may represent a novel therapeutic strategy for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqayOBoeIKDt7Vg90H21EOLACvtfcHk0lhuThABW7ikpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSgs73L&md5=3da07da89bd6da728d09aa26b273d659</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-10-532523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-10-532523%26sid%3Dliteratum%253Aachs%26aulast%3DDietrich%26aufirst%3DP.%2BA.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLeung%26aufirst%3DH.%2BH.%26aulast%3DLynch%26aufirst%3DJ.%2BR.%26aulast%3DGonzales%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHaber%26aufirst%3DM.%26aulast%3DNorris%26aufirst%3DM.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BY.%26atitle%3DGPR84%2520sustains%2520aberrant%2520beta-catenin%2520signaling%2520in%2520leukemic%2520stem%2520cells%2520for%2520maintenance%2520of%2520MLL%2520leukemogenesis%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26issue%3D22%26spage%3D3284%26epage%3D3294%26doi%3D10.1182%2Fblood-2013-10-532523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du
Toit, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irving-Rodgers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massa, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fozzard, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peak, I. R.</span></span> <span> </span><span class="NLM_article-title">Effect of GPR84 deletion on obesity and diabetes development in mice fed long chain or medium chain fatty acid rich diets</span>. <i>Eur. J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1737</span>– <span class="NLM_lpage">1746</span>, <span class="refDoi"> DOI: 10.1007/s00394-017-1456-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1007%2Fs00394-017-1456-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=28429080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFGjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1737-1746&issue=5&author=E.+Du%0AToitauthor=L.+Browneauthor=H.+Irving-Rodgersauthor=H.+M.+Massaauthor=N.+Fozzardauthor=M.+P.+Jenningsauthor=I.+R.+Peak&title=Effect+of+GPR84+deletion+on+obesity+and+diabetes+development+in+mice+fed+long+chain+or+medium+chain+fatty+acid+rich+diets&doi=10.1007%2Fs00394-017-1456-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of GPR84 deletion on obesity and diabetes development in mice fed long chain or medium chain fatty acid rich diets</span></div><div class="casAuthors">Du Toit, Eugene; Browne, Liam; Irving-Rodgers, Helen; Massa, Helen M.; Fozzard, Nicolette; Jennings, Michael P.; Peak, Ian R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nutrition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1737-1746</span>CODEN:
                <span class="NLM_cas:coden">EJNUFZ</span>;
        ISSN:<span class="NLM_cas:issn">1436-6207</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Although there is good evidence showing that diets rich in medium chain fatty acids (MCFAs) have less marked obesogenic and diabetogenic effects than diets rich in long chain fatty acids (LCFAs), the role of the pro-inflammatory, medium chain fatty acid receptor (GPR84) in the etiol. of obesity and glucose intolerance is not well characterised.  We set out to det. whether GPR84 expression influences obesity and glucose intolerance susceptibility in MCFA and LCFA rich diet fed mice.  Methods: Wild type (WT) and GPR84 knockout (KO) mice were fed a control, MCFA or LCFA diet, and body mass, heart, liver and epididymal fat mass was assessed, as well as glucose tolerance and adipocyte size.  Results: LCFA diets increased body mass and decreased glucose tolerance in both WT and GPR84 KO animals while MCFA diets had no effect on these parameters.  There were no differences in body wt. when comparing WT and GPR84 KO mice on the resp. diets.  Glucose tolerance was also similar in WT and GPR84 KO mice irresp. of diet.  Liver mass was increased following LCFA feeding in WT but not GPR84 KO mice.  Hepatic triglyceride content was increased in GPR84 KO animals fed MCFA, and myocardial triglyceride content was increased in GPR84 KO animals fed LCFA.  Conclusions: GPR84 deletion had no effects on body wt. or glucose tolerance in mice fed either a high MCFA or LCFA diet.  GPR84 may influence lipid metab., as GPR84 KO mice had smaller livers and increased myocardial triglyceride accumulation when fed LCFA diets, and increased liver triglyceride accumulation in responses to increased dietary MCFAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSLrrTgd2sTrVg90H21EOLACvtfcHk0liopByLEWqVTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFGjsbs%253D&md5=5c76ae9693f9d1e78aed516c0f5e3567</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs00394-017-1456-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00394-017-1456-5%26sid%3Dliteratum%253Aachs%26aulast%3DDu%2BToit%26aufirst%3DE.%26aulast%3DBrowne%26aufirst%3DL.%26aulast%3DIrving-Rodgers%26aufirst%3DH.%26aulast%3DMassa%26aufirst%3DH.%2BM.%26aulast%3DFozzard%26aufirst%3DN.%26aulast%3DJennings%26aufirst%3DM.%2BP.%26aulast%3DPeak%26aufirst%3DI.%2BR.%26atitle%3DEffect%2520of%2520GPR84%2520deletion%2520on%2520obesity%2520and%2520diabetes%2520development%2520in%2520mice%2520fed%2520long%2520chain%2520or%2520medium%2520chain%2520fatty%2520acid%2520rich%2520diets%26jtitle%3DEur.%2520J.%2520Nutr.%26date%3D2018%26volume%3D57%26issue%3D5%26spage%3D1737%26epage%3D1746%26doi%3D10.1007%2Fs00394-017-1456-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mignani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majoral, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, R. A.</span></span> <span> </span><span class="NLM_article-title">Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">615</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2018.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.drudis.2018.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=29330127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A280%3ADC%252BC1MvgtlCksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=605-615&issue=3&author=S.+Mignaniauthor=J.+Rodriguesauthor=H.+Tomasauthor=R.+Jalalauthor=P.+P.+Singhauthor=J.+P.+Majoralauthor=R.+A.+Vishwakarma&title=Present+drug-likeness+filters+in+medicinal+chemistry+during+the+hit+and+lead+optimization+process%3A+how+far+can+they+be+simplified%3F&doi=10.1016%2Fj.drudis.2018.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?</span></div><div class="casAuthors">Mignani Serge; Rodrigues Joao; Tomas Helena; Jalal Rachid; Singh Parvinder Pal; Vishwakarma Ram A; Majoral Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">605-615</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the past decade, decreasing the attrition rate of drug development candidates reaching the market has become one of the major challenges in pharmaceutical research and drug development (R&D).  To facilitate the decision-making process, and to increase the probability of rapidly finding and developing high-quality compounds, a variety of multiparametric guidelines, also known as rules and ligand efficiency (LE) metrics, have been developed.  However, what are the 'best' descriptors and how far can we simplify these drug-likeness prediction tools in terms of the numerous, complex properties that they relate to?</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2XT6-2EQJ3n6oPH0mYWL1fW6udTcc2eZhplEOPOa1mbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvgtlCksw%253D%253D&md5=a61e00552a35b455199f0a8d351d0522</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2018.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2018.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DMignani%26aufirst%3DS.%26aulast%3DRodrigues%26aufirst%3DJ.%26aulast%3DTomas%26aufirst%3DH.%26aulast%3DJalal%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DP.%2BP.%26aulast%3DMajoral%26aufirst%3DJ.%2BP.%26aulast%3DVishwakarma%26aufirst%3DR.%2BA.%26atitle%3DPresent%2520drug-likeness%2520filters%2520in%2520medicinal%2520chemistry%2520during%2520the%2520hit%2520and%2520lead%2520optimization%2520process%253A%2520how%2520far%2520can%2520they%2520be%2520simplified%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D605%26epage%3D615%26doi%3D10.1016%2Fj.drudis.2018.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kodimuthali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabaris, S. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, M.</span></span> <span> </span><span class="NLM_article-title">Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5471</span>– <span class="NLM_lpage">5489</span>, <span class="refDoi"> DOI: 10.1021/jm800582j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800582j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1alsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5471-5489&issue=18&author=A.+Kodimuthaliauthor=S.+S.+L.+Jabarisauthor=M.+Pal&title=Recent+advances+on+phosphodiesterase+4+inhibitors+for+the+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease&doi=10.1021%2Fjm800582j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances on Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease</span></div><div class="casAuthors">Kodimuthali, Arumugam; Jabaris, S. Sugin Lal; Pal, Manojit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5471-5489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDQPTfmPINKbVg90H21EOLACvtfcHk0lh5dXuQtuR16w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1alsbg%253D&md5=d4502dc5ce4b8b17d5b1d4d853403768</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800582j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800582j%26sid%3Dliteratum%253Aachs%26aulast%3DKodimuthali%26aufirst%3DA.%26aulast%3DJabaris%26aufirst%3DS.%2BS.%2BL.%26aulast%3DPal%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520on%2520phosphodiesterase%25204%2520inhibitors%2520for%2520the%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D18%26spage%3D5471%26epage%3D5489%26doi%3D10.1021%2Fjm800582j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fida, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span> <span> </span><span class="NLM_article-title">Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">e82360</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0082360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1371%2Fjournal.pone.0082360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=24340020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVCju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e82360&issue=12&author=M.+Niuauthor=F.+Dongauthor=S.+Tangauthor=G.+Fidaauthor=J.+Qinauthor=J.+Qiuauthor=K.+Liuauthor=W.+Gaoauthor=Y.+Gu&title=Pharmacophore+modeling+and+virtual+screening+for+the+discovery+of+new+type+4+cAMP+phosphodiesterase+%28PDE4%29+inhibitors&doi=10.1371%2Fjournal.pone.0082360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors</span></div><div class="casAuthors">Niu, Miaomiao; Dong, Fenggong; Tang, Shi; Fida, Guissi; Qin, Jingyi; Qiu, Jiadan; Liu, Kangbo; Gao, Weidong; Gu, Yueqing</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e82360/1-e82360/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Type 4 cAMP phosphodiesterase (PDE4) inhibitors show a broad spectrum of anti-inflammatory effects in almost all kinds of inflamed cells, by an increase in cAMP levels which is a pivotal second messenger responsible for various biol. processes.  These inhibitors are now considered as the potential drugs for treatment of chronic inflammatory diseases.  However, some recently marketed inhibitors e.g., roflumilast, have shown adverse effects such as nausea and emesis, thus restricting its use.  In order to identify novel PDE4 inhibitors with improved therapeutic indexes, a highly correlating (r = 0.963930) pharmacophore model (Hypo1) was established on the basis of known PDE4 inhibitors.  Validated Hypo1 was used in database screening to identify chem. with required pharmacophoric features.  These compds. are further screened by using the rule of five, ADMET and mol. docking.  Finally, twelve hits which showed good results with respect to following properties such as estd. activity, calcd. drug-like properties and scores were proposed as potential leads to inhibit the PDE4 activity.  Therefore, this study will not only assist in the development of new potent hits for PDE4 inhibitors, but also give a better understanding of their interaction with PDE4.  On a wider scope, this will be helpful for the rational design of novel potent enzyme inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpah67dLxz_KLVg90H21EOLACvtfcHk0lh5dXuQtuR16w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVCju74%253D&md5=d1b6be4406df69aea27e763c04522d42</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0082360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0082360%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DFida%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DY.%26atitle%3DPharmacophore%2520modeling%2520and%2520virtual%2520screening%2520for%2520the%2520discovery%2520of%2520new%2520type%25204%2520cAMP%2520phosphodiesterase%2520%2528PDE4%2529%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D12%26spage%3De82360%26doi%3D10.1371%2Fjournal.pone.0082360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oxford, A. W.</span>; <span class="NLM_string-name">Jack, D.</span></span> <span> </span><span class="NLM_article-title">Derivatives of Pyrimido[6,1-A]Isoquinolin-4-One</span>. <span class="NLM_patent">WO/2000/058309</span>, Mar 29, <span class="NLM_year">2000</span>; <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2000058309" class="extLink">https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2000058309</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=A.+W.+Oxford&author=D.+Jack&title=Derivatives+of+Pyrimido%5B6%2C1-A%5DIsoquinolin-4-One"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOxford%26aufirst%3DA.%2BW.%26atitle%3DDerivatives%2520of%2520Pyrimido%255B6%252C1-A%255DIsoquinolin-4-One%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Till, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildebrand, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raabe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalaris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häsler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolaus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fölsch, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose-John, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenstiel, P.</span></span> <span> </span><span class="NLM_article-title">G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>183</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">7514</span>– <span class="NLM_lpage">7522</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0900063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.4049%2Fjimmunol.0900063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=19917676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVehtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=7514-7522&issue=11&author=C.+Sinaauthor=O.+Gavrilovaauthor=M.+F%C3%B6rsterauthor=A.+Tillauthor=S.+Dererauthor=F.+Hildebrandauthor=B.+Raabeauthor=A.+Chalarisauthor=J.+Schellerauthor=A.+Rehmannauthor=A.+Frankeauthor=S.+Ottauthor=R.+H%C3%A4slerauthor=S.+Nikolausauthor=U.+R.+F%C3%B6lschauthor=S.+Rose-Johnauthor=H.+P.+Jiangauthor=J.+Liauthor=S.+Schreiberauthor=P.+Rosenstiel&title=G+protein-coupled+receptor+43+is+essential+for+neutrophil+recruitment+during+intestinal+inflammation&doi=10.4049%2Fjimmunol.0900063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation</span></div><div class="casAuthors">Sina, Christian; Gavrilova, Olga; Foerster, Matti; Till, Andreas; Derer, Stefanie; Hildebrand, Friederike; Raabe, Bjoern; Chalaris, Athena; Scheller, Juergen; Rehmann, Ateequr; Franke, Andre; Ott, Stephan; Haesler, Robert; Nikolaus, Susanna; Foelsch, Ulrich R.; Rose-John, Stefan; Jiang, Hui-Ping; Li, Jun; Schreiber, Stefan; Rosenstiel, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7514-7522</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Mol. danger signals attract neutrophilic granulocytes (polymorphonuclear leukocytes (PMNs)) to sites of infection.  The G protein-coupled receptor (GPR) 43 recognizes propionate and butyrate and is abundantly expressed on PMNs.  The functional role of GPR43 activation for in vivo orchestration of immune response is unclear.  The authors examd. dextrane sodium sulfate (DSS)-induced acute and chronic intestinal inflammatory response in wild-type and Gpr43-deficient mice.  The severity of colonic inflammation was assessed by clin. signs, histol. scoring, and cytokine prodn.  Chemotaxis of wild-type and Gpr43-deficient PMNs was assessed through transwell cell chemotactic assay.  A reduced invasion of PMNs and increased mortality due to septic complications were obsd. in acute DSS colitis.  In chronic DSS colitis, Gpr43-/- animals showed diminished PMN intestinal migration, but protection against inflammatory tissue destruction.  No significant difference in PMN migration and cytokine secretion was detected in a sterile inflammatory model.  Ex vivo expts. show that GPR43-induced migration is dependent on activation of the protein kinase p38α, and that this signal acts in cooperation with the chemotactic cytokine keratinocyte chemoattractant.  Interestingly, shedding of L-selectin in response to propionate and butyrate was compromised in Gpr43-/- mice.  These results indicate a crit. role for GPR43-mediated recruitment of PMNs in contg. intestinal bacterial translocation, yet also emphasize the bipotential role of PMNs in mediating tissue destruction in chronic intestinal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9D9mLPKWZD7Vg90H21EOLACvtfcHk0lgc_b6poYRYJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVehtrrN&md5=98fd06777b79a924befb00cdc5ee1b6b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0900063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0900063%26sid%3Dliteratum%253Aachs%26aulast%3DSina%26aufirst%3DC.%26aulast%3DGavrilova%26aufirst%3DO.%26aulast%3DF%25C3%25B6rster%26aufirst%3DM.%26aulast%3DTill%26aufirst%3DA.%26aulast%3DDerer%26aufirst%3DS.%26aulast%3DHildebrand%26aufirst%3DF.%26aulast%3DRaabe%26aufirst%3DB.%26aulast%3DChalaris%26aufirst%3DA.%26aulast%3DScheller%26aufirst%3DJ.%26aulast%3DRehmann%26aufirst%3DA.%26aulast%3DFranke%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DS.%26aulast%3DH%25C3%25A4sler%26aufirst%3DR.%26aulast%3DNikolaus%26aufirst%3DS.%26aulast%3DF%25C3%25B6lsch%26aufirst%3DU.%2BR.%26aulast%3DRose-John%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%2BP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DRosenstiel%26aufirst%3DP.%26atitle%3DG%2520protein-coupled%2520receptor%252043%2520is%2520essential%2520for%2520neutrophil%2520recruitment%2520during%2520intestinal%2520inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26issue%3D11%26spage%3D7514%26epage%3D7522%26doi%3D10.4049%2Fjimmunol.0900063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirtz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span> <span> </span><span class="NLM_article-title">Chemically induced mouse models of intestinal inflammation</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1038%2Fnprot.2007.41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=17406617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=541-546&issue=3&author=S.+Wirtzauthor=C.+Neufertauthor=B.+Weigmannauthor=M.+F.+Neurath&title=Chemically+induced+mouse+models+of+intestinal+inflammation&doi=10.1038%2Fnprot.2007.41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically induced mouse models of intestinal inflammation</span></div><div class="casAuthors">Wirtz, Stefan; Neufert, Clemens; Weigmann, Benno; Neurath, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">541-546</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Animal models of intestinal inflammation are indispensable for our understanding of the pathogenesis of Crohn disease and ulcerative colitis, the two major forms of inflammatory bowel disease in humans.  Here, we provide protocols for establishing murine 2,4,6-trinitro benzene sulfonic acid (TNBS)-, oxazolone- and both acute and chronic dextran sodium sulfate (DSS) colitis, the most widely used chem. induced models of intestinal inflammation.  In the former two models, colitis is induced by intrarectal administration of the covalently reactive reagents TNBS/oxazolone, which are believed to induce a T-cell-mediated response against hapten-modified autologous proteins/luminal antigens.  In the DSS model, mice are subjected several days to drinking water supplemented with DSS, which seems to be directly toxic to colonic epithelial cells of the basal crypts.  The procedures for the hapten models of colitis and acute DSS colitis can be accomplished in about 2 wk but the protocol for chronic DSS colitis takes about 2 mo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-D9fB-7WMbVg90H21EOLACvtfcHk0lgc_b6poYRYJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbnL&md5=7a3c29eaca8be756e3d866e23e151fdf</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.41%26sid%3Dliteratum%253Aachs%26aulast%3DWirtz%26aufirst%3DS.%26aulast%3DNeufert%26aufirst%3DC.%26aulast%3DWeigmann%26aufirst%3DB.%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26atitle%3DChemically%2520induced%2520mouse%2520models%2520of%2520intestinal%2520inflammation%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26issue%3D3%26spage%3D541%26epage%3D546%26doi%3D10.1038%2Fnprot.2007.41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahmud, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labéguère, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosmini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikhonova, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">17953</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-18159-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1038%2Fs41598-017-18159-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=29263400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A280%3ADC%252BC1MzjslSqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=17953&issue=1&author=Z.+A.+Mahmudauthor=L.+Jenkinsauthor=T.+Ulvenauthor=F.+Lab%C3%A9gu%C3%A8reauthor=R.+Gosminiauthor=S.+De+Vosauthor=B.+D.+Hudsonauthor=I.+G.+Tikhonovaauthor=G.+Milligan&title=Three+classes+of+ligands+each+bind+to+distinct+sites+on+the+orphan+G+protein-coupled+receptor+GPR84&doi=10.1038%2Fs41598-017-18159-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84</span></div><div class="casAuthors">Mahmud Zobaer Al; Jenkins Laura; Hudson Brian D; Milligan Graeme; Ulven Trond; Labeguere Frederic; Gosmini Romain; Labeguere Frederic; De Vos Steve; Tikhonova Irina G</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17953</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Medium chain fatty acids can activate the pro-inflammatory receptor GPR84 but so also can molecules related to 3,3'-diindolylmethane. 3,3'-Diindolylmethane and decanoic acid acted as strong positive allosteric modulators of the function of each other and analysis showed the affinity of 3,3'-diindolylmethane to be at least 100 fold higher.  Methyl decanoate was not an agonist at GPR84.  This implies a key role in binding for the carboxylic acid of the fatty acid.  Via homology modelling we predicted and confirmed an integral role of arginine(172), located in the 2nd extracellular loop, in the action of decanoic acid but not of 3,3'-diindolylmethane.  Exemplars from a patented series of GPR84 antagonists were able to block agonist actions of both decanoic acid and 3,3'-diindolylmethane at GPR84.  However, although a radiolabelled form of a related antagonist, [(3)H]G9543, was able to bind with high affinity to GPR84, this was not competed for by increasing concentrations of either decanoic acid or 3,3'-diindolylmethane and was not affected adversely by mutation of arginine(172).  These studies identify three separable ligand binding sites within GPR84 and suggest that if medium chain fatty acids are true endogenous regulators then co-binding with a positive allosteric modulator would greatly enhance their function in physiological settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREMjSSm_naSC-bLEOO4dYpfW6udTcc2eaPqWaXtCUaMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzjslSqug%253D%253D&md5=fe3d58f70952bef231505deb9bbb9de0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-18159-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-18159-3%26sid%3Dliteratum%253Aachs%26aulast%3DMahmud%26aufirst%3DZ.%2BA.%26aulast%3DJenkins%26aufirst%3DL.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DLab%25C3%25A9gu%25C3%25A8re%26aufirst%3DF.%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DThree%2520classes%2520of%2520ligands%2520each%2520bind%2520to%2520distinct%2520sites%2520on%2520the%2520orphan%2520G%2520protein-coupled%2520receptor%2520GPR84%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D17953%26doi%3D10.1038%2Fs41598-017-18159-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patkar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of dioxane-based antiviral agents and evaluation of their biological activities as inhibitors of Sindbis virus replication</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2667</span>– <span class="NLM_lpage">2679</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.01.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.bmc.2007.01.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=17287124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVagtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=2667-2679&issue=7&author=H.+Y.+Kimauthor=R.+J.+Kuhnauthor=C.+Patkarauthor=R.+Warrierauthor=M.+Cushman&title=Synthesis+of+dioxane-based+antiviral+agents+and+evaluation+of+their+biological+activities+as+inhibitors+of+Sindbis+virus+replication&doi=10.1016%2Fj.bmc.2007.01.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of dioxane-based antiviral agents and evaluation of their biological activities as inhibitors of Sindbis virus replication</span></div><div class="casAuthors">Kim, Ha Young; Kuhn, Richard J.; Patkar, Chinmay; Warrier, Ranjit; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2667-2679</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The crystal structure of the Sindbis virus capsid protein contains one or two solvent-derived dioxane mols. in the hydrophobic binding pocket.  A bis-dioxane antiviral agent was designed by linking the two dioxane mols. with a three-carbon chain having R,R connecting stereochem., and a stereospecific synthesis was performed.  This resulted in an effective antiviral agent that inhibited Sindbis virus replication with an EC50 of 14 μM.  The synthesis proceeded through an intermediate (R)-2-hydroxymethyl-[1,4]-dioxane, which unexpectedly proved to be a more effecting antiviral agent than the target compd., as evidenced by its EC50 of 3.4 μM as an inhibitor of Sindbis virus replication.  Both compds. were not cytotoxic in uninfected BHK cells at concns. of 1 mM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZryWPZMnZvbVg90H21EOLACvtfcHk0ljfuT0BqCZn8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVagtro%253D&md5=67f56b313ec33524f54720fc702d6bd1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DKuhn%26aufirst%3DR.%2BJ.%26aulast%3DPatkar%26aufirst%3DC.%26aulast%3DWarrier%26aufirst%3DR.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520dioxane-based%2520antiviral%2520agents%2520and%2520evaluation%2520of%2520their%2520biological%2520activities%2520as%2520inhibitors%2520of%2520Sindbis%2520virus%2520replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26issue%3D7%26spage%3D2667%26epage%3D2679%26doi%3D10.1016%2Fj.bmc.2007.01.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kaem, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouy, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gheyle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandeghinste, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haazen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van’t Klooster, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beetens, J.</span></span> <span> </span><span class="NLM_article-title">Human safety, pharmacokinetics and pharmacodynamics of the GPR84 antagonist GLPG1205, a potential new approach to treat IBD</span>. <i>United Eur. Gastroenterol. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">1S</span>),  <span class="NLM_fpage">A224</span>, (Abstract P0341)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=A224&issue=1S&author=F.+Vanhoutteauthor=S.+Dupontauthor=T.+Van+Kaemauthor=M.-H.+Gouyauthor=L.+Gheyleauthor=R.+Blanqueauthor=R.+Brysauthor=N.+Vandeghinsteauthor=W.+Haazenauthor=G.+van%E2%80%99t+Kloosterauthor=J.+Beetens&title=Human+safety%2C+pharmacokinetics+and+pharmacodynamics+of+the+GPR84+antagonist+GLPG1205%2C+a+potential+new+approach+to+treat+IBD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVanhoutte%26aufirst%3DF.%26aulast%3DDupont%26aufirst%3DS.%26aulast%3DVan%2BKaem%26aufirst%3DT.%26aulast%3DGouy%26aufirst%3DM.-H.%26aulast%3DGheyle%26aufirst%3DL.%26aulast%3DBlanque%26aufirst%3DR.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DVandeghinste%26aufirst%3DN.%26aulast%3DHaazen%26aufirst%3DW.%26aulast%3Dvan%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26aulast%3DBeetens%26aufirst%3DJ.%26atitle%3DHuman%2520safety%252C%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520the%2520GPR84%2520antagonist%2520GLPG1205%252C%2520a%2520potential%2520new%2520approach%2520to%2520treat%2520IBD%26jtitle%3DUnited%2520Eur.%2520Gastroenterol.%2520J.%26date%3D2014%26volume%3D2%26issue%3D1S%26spage%3DA224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span>Galapagos
Reports Results with GLPG1205 in Ulcerative Colitis. Galapagos Press
Release January 26, <span class="NLM_year">2016</span>. <a href="https://cws.huginonline.com/G/133350/PR/201601/1981193_5.html" class="extLink">https://cws.huginonline.com/G/133350/PR/201601/1981193_5.html</a> (accessed Apr 3, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Galapagos%0AReports+Results+with+GLPG1205+in+Ulcerative+Colitis.+Galapagos+Press%0ARelease+January+26%2C+2016.+https%3A%2F%2Fcws.huginonline.com%2FG%2F133350%2FPR%2F201601%2F1981193_5.html+%28accessed+Apr+3%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puengel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundertmark, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhepp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guldiken, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujuguet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auberval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saniere, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trautwein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strnad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement-Lacroix, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tacke, F.</span></span> <span> </span><span class="NLM_article-title">The medium-chain fatty acid receptor GPR84 mediates myeloid cell infiltration promoting steatohepatitis and fibrosis</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">E1140</span>, <span class="refDoi"> DOI: 10.3390/jcm9041140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.3390%2Fjcm9041140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=32316235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovF2hur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=E1140&issue=4&author=T.+Puengelauthor=S.+De+Vosauthor=J.+Hundertmarkauthor=M.+Kohlheppauthor=N.+Guldikenauthor=P.+Pujuguetauthor=M.+Aubervalauthor=F.+Marsaisauthor=K.+F.+Shojiauthor=L.+Saniereauthor=C.+Trautweinauthor=T.+Lueddeauthor=P.+Strnadauthor=R.+Brysauthor=P.+Clement-Lacroixauthor=F.+Tacke&title=The+medium-chain+fatty+acid+receptor+GPR84+mediates+myeloid+cell+infiltration+promoting+steatohepatitis+and+fibrosis&doi=10.3390%2Fjcm9041140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The medium-chain fatty acid receptor GPR84 mediates myeloid cell infiltration promoting steatohepatitis and fibrosis</span></div><div class="casAuthors">Puengel, Tobias; De Vos, Steve; Hundertmark, Jana; Kohlhepp, Marlene; Guldiken, Nurdan; Pujuguet, Philippe; Auberval, Marielle; Marsais, Florence; Shoji, Kenji F.; Saniere, Laurent; Trautwein, Christian; Luedde, Tom; Strnad, Pavel; Brys, Reginald; Clement-Lacroix, Philippe; Tacke, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1140</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Medium-chain fatty acids (MCFAs) have been assocd. with anti-steatotic effects in hepatocytes.  Expression of the MCFA receptor GPR84 (G protein-coupled receptor 84) is induced in immune cells under inflammatory conditions and can promote fibrogenesis.  We aimed at deciphering the role of GPR84 in the pathogenesis of non-alc. steatohepatitis (NASH), exploring its potential as a therapeutic target.  GPR84 expression is upregulated in liver from patients with non-alc. fatty liver disease (NAFLD), correlating with the histol. degree of inflammation and fibrosis.  In mouse and human, activated monocytes and neutrophils upregulate GPR84 expression.  Chemotaxis of these myeloid cells by GPR84 stimulation is inhibited by two novel, small mol. GPR84 antagonists.  Upon acute liver injury in mice, treatment with GPR84 antagonists significantly reduced the hepatic recruitment of neutrophils, monocytes, and monocyte-derived macrophages (MoMF).  We, therefore, evaluated the therapeutic inhibition of GPR84 by these two novel antagonists in comparison to selonsertib, an apoptosis signal-regulating kinase 1 (ASK1) inhibitor, in three NASH mouse models.  Pharmacol. inhibition of GPR84 significantly reduced macrophage accumulation and ameliorated inflammation and fibrosis, to an extent similar to selonsertib.  In conclusion, our findings support that GPR84 mediates myeloid cell infiltration in liver injury and is a promising therapeutic target in steatohepatitis and fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPNuXkRo5CrLVg90H21EOLACvtfcHk0lizg4tYlnotwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovF2hur0%253D&md5=e9977d9275af8aad56c1715aa362eaf0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fjcm9041140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm9041140%26sid%3Dliteratum%253Aachs%26aulast%3DPuengel%26aufirst%3DT.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DHundertmark%26aufirst%3DJ.%26aulast%3DKohlhepp%26aufirst%3DM.%26aulast%3DGuldiken%26aufirst%3DN.%26aulast%3DPujuguet%26aufirst%3DP.%26aulast%3DAuberval%26aufirst%3DM.%26aulast%3DMarsais%26aufirst%3DF.%26aulast%3DShoji%26aufirst%3DK.%2BF.%26aulast%3DSaniere%26aufirst%3DL.%26aulast%3DTrautwein%26aufirst%3DC.%26aulast%3DLuedde%26aufirst%3DT.%26aulast%3DStrnad%26aufirst%3DP.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DClement-Lacroix%26aufirst%3DP.%26aulast%3DTacke%26aufirst%3DF.%26atitle%3DThe%2520medium-chain%2520fatty%2520acid%2520receptor%2520GPR84%2520mediates%2520myeloid%2520cell%2520infiltration%2520promoting%2520steatohepatitis%2520and%2520fibrosis%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2020%26volume%3D9%26issue%3D4%26spage%3DE1140%26doi%3D10.3390%2Fjcm9041140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saniere, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagerschmidt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurisse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement-Lacroix, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Osselaer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vos, S.</span></span> <span> </span><span class="NLM_article-title">Characterization of GLPG1205 in mouse fibrosis models: a potent and selective antagonist of GPR84 for treatment of idiopathic pulmonary fibrosis</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>199</i></span>,  <span class="NLM_fpage">A1046</span>, <span class="refDoi"> DOI: 10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A1046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1164%2Fajrccm-conference.2019.199.1_MeetingAbstracts.A1046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2019&pages=A1046&author=L.+Saniereauthor=F.+Marsaisauthor=C.+Jagerschmidtauthor=S.+Meurisseauthor=S.+Cuzicauthor=K.+Shojiauthor=P.+Clement-Lacroixauthor=N.+Van+Osselaerauthor=S.+De+Vos&title=Characterization+of+GLPG1205+in+mouse+fibrosis+models%3A+a+potent+and+selective+antagonist+of+GPR84+for+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.1164%2Fajrccm-conference.2019.199.1_MeetingAbstracts.A1046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1164%2Fajrccm-conference.2019.199.1_MeetingAbstracts.A1046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm-conference.2019.199.1_MeetingAbstracts.A1046%26sid%3Dliteratum%253Aachs%26aulast%3DSaniere%26aufirst%3DL.%26aulast%3DMarsais%26aufirst%3DF.%26aulast%3DJagerschmidt%26aufirst%3DC.%26aulast%3DMeurisse%26aufirst%3DS.%26aulast%3DCuzic%26aufirst%3DS.%26aulast%3DShoji%26aufirst%3DK.%26aulast%3DClement-Lacroix%26aufirst%3DP.%26aulast%3DVan%2BOsselaer%26aufirst%3DN.%26aulast%3DDe%2BVos%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520GLPG1205%2520in%2520mouse%2520fibrosis%2520models%253A%2520a%2520potent%2520and%2520selective%2520antagonist%2520of%2520GPR84%2520for%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2019%26volume%3D199%26spage%3DA1046%26doi%3D10.1164%2Fajrccm-conference.2019.199.1_MeetingAbstracts.A1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, S.J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Mahmud, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edye, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">On-target and off-target effects of novel orthosteric and allosteric activators of GPR84</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1861</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-38539-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1038%2Fs41598-019-38539-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=30755705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A280%3ADC%252BB3cfis1amsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1861&issue=1&author=S.J.+Manciniauthor=Z.+Al+Mahmudauthor=L.+Jenkinsauthor=D.+Bologniniauthor=R.+Newmanauthor=M.+Barnesauthor=M.+E.+Edyeauthor=S.+B.+McMahonauthor=A.+Tobinauthor=G.+Milligan&title=On-target+and+off-target+effects+of+novel+orthosteric+and+allosteric+activators+of+GPR84&doi=10.1038%2Fs41598-019-38539-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">On-target and off-target effects of novel orthosteric and allosteric activators of GPR84</span></div><div class="casAuthors">Mancini Sarah J; Mahmud Zobaer Al; Jenkins Laura; Bolognini Daniele; Tobin Andrew B; Milligan Graeme; Newman Robert; Barnes Matt; Edye Michelle E; McMahon Stephen B</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1861</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Many members of the G protein-coupled receptor family, including examples with clear therapeutic potential, remain poorly characterised.  This often reflects limited availability of suitable tool ligands with which to interrogate receptor function.  In the case of GPR84, currently a target for the treatment of idiopathic pulmonary fibrosis, recent times have seen the description of novel orthosteric and allosteric agonists.  Using 2-(hexylthiol)pyrimidine-4,6 diol (2-HTP) and di(5,7-difluoro-1H-indole-3-yl)methane (PSB-16671) as exemplars of each class, in cell lines transfected to express either human or mouse GPR84, both ligands acted as effective on-target activators and with high co-operativity in their interactions.  This was also the case in lipopolysaccharide-activated model human and mouse immune cell lines.  However in mouse bone-marrow-derived neutrophils, where expression of GPR84 is particularly high, the capacity of PSB-16671 but not of 2-HTP to promote G protein activation was predominantly off-target because it was not blocked by an antagonist of GPR84 and was preserved in neutrophils isolated from GPR84 deficient mice.  These results illustrate the challenges of attempting to study and define functions of poorly characterised receptors using ligands that have been developed via medicinal chemistry programmes, but where assessed activity has been limited largely to the initially identified target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQc62oWEy_4Oqrn-c4Of3KfW6udTcc2ebsde0bPVth-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfis1amsA%253D%253D&md5=1bd20c2443890cb3691d558cb8511c5f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-38539-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-38539-1%26sid%3Dliteratum%253Aachs%26aulast%3DMancini%26aufirst%3DS.J.%26aulast%3DAl%2BMahmud%26aufirst%3DZ.%26aulast%3DJenkins%26aufirst%3DL.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DNewman%26aufirst%3DR.%26aulast%3DBarnes%26aufirst%3DM.%26aulast%3DEdye%26aufirst%3DM.%2BE.%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26aulast%3DTobin%26aufirst%3DA.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DOn-target%2520and%2520off-target%2520effects%2520of%2520novel%2520orthosteric%2520and%2520allosteric%2520activators%2520of%2520GPR84%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D1861%26doi%3D10.1038%2Fs41598-019-38539-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 4 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lin-Hai Chen, Qing Zhang, Xin Xie, <span class="NLM_string-name hlFld-ContribAuthor">Fa-Jun Nan</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of the G-Protein-Coupled Receptor 84 (GPR84) by Agonists and Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (24)
                                     , 15399-15409. <a href="https://doi.org/10.1021/acs.jmedchem.0c01378" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01378%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DModulation%252Bof%252Bthe%252BG-Protein-Coupled%252BReceptor%252B84%252B%252528GPR84%252529%252Bby%252BAgonists%252Band%252BAntagonists%26aulast%3DChen%26aufirst%3DLin-Hai%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06082020%26date%3D03122020%26volume%3D63%26issue%3D24%26spage%3D15399%26epage%3D15409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helen  Timmis</span>, <span class="hlFld-ContribAuthor ">Tim  Van Kaem</span>, <span class="hlFld-ContribAuthor ">Julie  Desrivot</span>, <span class="hlFld-ContribAuthor ">Sonia  Dupont</span>, <span class="hlFld-ContribAuthor ">Luc  Meuleners</span>, <span class="hlFld-ContribAuthor ">Johan  Beetens</span>, <span class="hlFld-ContribAuthor ">Eric  Helmer</span>, <span class="hlFld-ContribAuthor ">Eva  Santermans</span>, <span class="hlFld-ContribAuthor ">Silke  Huettner</span>. </span><span class="cited-content_cbyCitation_article-title">GLPG1205, a GPR84 Modulator: Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Subjects. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology in Drug Development</span><span> <strong>2021,</strong> <em>188 </em><a href="https://doi.org/10.1002/cpdd.955" title="DOI URL">https://doi.org/10.1002/cpdd.955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpdd.955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpdd.955%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520in%2520Drug%2520Development%26atitle%3DGLPG1205%25252C%252Ba%252BGPR84%252BModulator%25253A%252BSafety%25252C%252BPharmacokinetics%25252C%252Band%252BPharmacodynamics%252Bin%252BHealthy%252BSubjects%26aulast%3DTimmis%26aufirst%3DHelen%26date%3D2021%26date%3D2021%26volume%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  Grundmann</span>, <span class="hlFld-ContribAuthor ">Eckhard  Bender</span>, <span class="hlFld-ContribAuthor ">Jens  Schamberger</span>, <span class="hlFld-ContribAuthor ">Frank  Eitner</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacology of Free Fatty Acid Receptors and Their Allosteric Modulators. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2021,</strong> <em>22 </em>
                                    (4)
                                     , 1763. <a href="https://doi.org/10.3390/ijms22041763" title="DOI URL">https://doi.org/10.3390/ijms22041763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms22041763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms22041763%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPharmacology%252Bof%252BFree%252BFatty%252BAcid%252BReceptors%252Band%252BTheir%252BAllosteric%252BModulators%26aulast%3DGrundmann%26aufirst%3DManuel%26date%3D2021%26date%3D2021%26volume%3D22%26issue%3D4%26spage%3D1763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Marsango</span>, <span class="hlFld-ContribAuthor ">Natasja  Barki</span>, <span class="hlFld-ContribAuthor ">Laura  Jenkins</span>, <span class="hlFld-ContribAuthor ">Andrew B.  Tobin</span>, <span class="hlFld-ContribAuthor ">Graeme  Milligan</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic validation of an orphan G protein‐coupled receptor: The case of GPR84. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2020,</strong> <em>21 </em><a href="https://doi.org/10.1111/bph.15248" title="DOI URL">https://doi.org/10.1111/bph.15248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15248%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DTherapeutic%252Bvalidation%252Bof%252Ban%252Borphan%252BG%252Bprotein%2525E2%252580%252590coupled%252Breceptor%25253A%252BThe%252Bcase%252Bof%252BGPR84%26aulast%3DMarsango%26aufirst%3DSara%26date%3D2020%26date%3D2020%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of known GPR84 agonists MCFA C10, embelin, 2-HTP, and DIM derivatives and the GPR84 antagonists PBI-4050 and 6-OAU. Abbreviations: 2-HTP, 2-(hexylthiol)pyrimidine-4,6 diol; 6-OAU, 6-<i>n</i>-octylaminouracil; DIM, 3,3′-diindolylmethane; MCFA, medium-chain free fatty acids.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Disease activity index score in a mouse DSS-induced chronic colitis model. Diseased mice were administered with 4% DSS in drinking water for 4 days, followed by 3 days of regular drinking water and a new cycle of DSS. In addition they were orally administered <b>26</b> at 10 mg/kg once daily (qd), cyclosporine at 25 mg/kg qd (positive control), or vehicle for 11 consecutive days. Control mice were administered water alone as a negative control. Data are the mean ± SEM. No scores were measured on days 5 and 6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Disease activity index score in a mouse DSS-induced chronic colitis model. Diseased mice were administered with 4% DSS in drinking water for 4 days, followed by 3 days of regular drinking water and a new cycle of DSS. In addition they were orally administered <b>35</b> at 1*, 3<sup>†</sup> or 10<sup>‡</sup> mg/kg qd, cyclosporine at 25 mg/kg qd (positive control), or vehicle, for 11 consecutive days. Control mice were administered water alone as a negative control. Data are the mean ± SEM. No scores were measured on days 5 and 6.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Effect of increasing concentrations of <b>36</b> on effects of orthosteric and allosteric GPR84 agonists (GTPyS assay with agonists used at EC<sub>80</sub>). (B) Structure of tritiated ligand <b>38</b>. (C) Ability of various concentrations of C10, PSB-16671, and <b>36</b> to compete for binding with [<sup>3</sup>H]<b>38</b> to GPR84 (competition binding + 0.2 nM [<sup>3</sup>H]<b>38</b>). (D) Schild analysis showing inhibition of PSB-16671 activity with <b>36</b> at concentrations of 10 nM, 30 nM, 100 nM, and 300 nM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Diseased mice (DSS-induced chronic colitis model) were administered with 4% DSS in drinking water for 4 days, followed by 3 days of regular drinking water and a new cycle of DSS. In addition they were orally administered <b>36</b> at 3* and 10<sup>†</sup> mg/kg qd, sulfasalazine 20 mg/kg qd (positive control) or vehicle, for 11 consecutive days. Control mice were administered water alone as a negative control. (A) Disease activity index score. Data are the mean ± SEM. No scores were measured on days 5 and 6. (B) Neutrophil density (number of cells per square millimeter of colon area, as determined by immunohistochemistry assay with anti-Ly6G/Ly6C antibodies).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/medium/jm0c00272_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (<i>S</i>)-GLPG1205 (<b>36</b>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-22/acs.jmedchem.0c00272/20201209/images/large/jm0c00272_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00272&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) urea, AcOH, conc HCl, water, reflux; (b) conc HBr, reflux; (c) AllylBr, K<sub>2</sub>CO<sub>3</sub>, DMF; (d) Na, EtOH, diethyl malonate, reflux; (e) POCl<sub>3</sub>, 50 °C; (f) [(2<i>R</i>)-1,4-dioxan-2-yl]methanol, <i>t</i>BuOK, DCM; (g) Pd(PPh<sub>3</sub>)<sub>4</sub>, K<sub>2</sub>CO<sub>3</sub>, MeOH/THF; (h) PhN(SO<sub>3</sub>CF<sub>3</sub>)<sub>2</sub>, Et<sub>3</sub>N, DCM; (i) ethynylcyclopropane, Pd(PPh<sub>3</sub>)<sub>4</sub>, CuI, Et<sub>3</sub>N, DMF.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i59">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonavicius, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, L.</span></span> <span> </span><span class="NLM_article-title">Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span> (<span class="NLM_issue">45</span>),  <span class="NLM_fpage">34457</span>– <span class="NLM_lpage">34464</span>, <span class="refDoi"> DOI: 10.1074/jbc.M608019200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1074%2Fjbc.M608019200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=16966319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKgur%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=34457-34464&issue=45&author=J.+Wangauthor=X.+Wuauthor=N.+Simonaviciusauthor=H.+Tianauthor=L.+Ling&title=Medium-chain+fatty+acids+as+ligands+for+orphan+G+protein-coupled+receptor+GPR84&doi=10.1074%2Fjbc.M608019200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Medium-chain Fatty Acids as Ligands for Orphan G Protein-coupled Receptor GPR84</span></div><div class="casAuthors">Wang, Jinghong; Wu, Xiaosu; Simonavicius, Nicole; Tian, Hui; Ling, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">45</span>),
    <span class="NLM_cas:pages">34457-34464</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Free fatty acids (FFAs) play important physiol. roles in many tissues as an energy source and as signaling mols. in various cellular processes.  Elevated levels of circulating FFAs are assocd. with obesity, dyslipidemia, and diabetes.  Here we show that GPR84, a previously orphan G protein-coupled receptor, functions as a receptor for medium-chain FFAs with carbon chain lengths of 9-14.  Medium-chain FFAs elicit calcium mobilization, inhibit 3',5'-cAMP prodn., and stimulate [35S]guanosine 5'-O-(3-thiotriphosphate) binding in a GPR84-dependent manner.  The activation of GPR84 by medium-chain FFAs couples primarily to a pertussis toxin-sensitive Gi/o pathway.  In addn., we show that GPR84 is selectively expressed in leukocytes and markedly induced in monocytes/macrophages upon activation by lipopolysaccharide.  Furthermore, we demonstrate that medium-chain FFAs amplify lipopolysaccharide-stimulated prodn. of the proinflammatory cytokine interleukin-12 p40 through GPR84.  Our results indicate a role for GPR84 in directly linking fatty acid metab. to immunol. regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-BrABfXO2grVg90H21EOLACvtfcHk0li3zc6Pg8xB2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKgur%252FI&md5=2bbe13a202723f62e59eab0b08a25878</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608019200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608019200%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DSimonavicius%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DLing%26aufirst%3DL.%26atitle%3DMedium-chain%2520fatty%2520acids%2520as%2520ligands%2520for%2520orphan%2520G%2520protein-coupled%2520receptor%2520GPR84%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26issue%3D45%26spage%3D34457%26epage%3D34464%26doi%3D10.1074%2Fjbc.M608019200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawson, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liew, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mpamhanga, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonner, T. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubig, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spedding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmar, A. J.</span></span> <span> </span><span class="NLM_article-title">International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>65</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">986</span>, <span class="refDoi"> DOI: 10.1124/pr.112.007179</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1124%2Fpr.112.007179" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=23686350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtVyrtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2013&pages=967-986&issue=3&author=A.+P.+Davenportauthor=S.+P.+Alexanderauthor=J.+L.+Sharmanauthor=A.+J.+Pawsonauthor=H.+E.+Bensonauthor=A.+E.+Monaghanauthor=W.+C.+Liewauthor=C.+P.+Mpamhangaauthor=T.+I.+Bonnerauthor=R.+R.+Neubigauthor=J.+P.+Pinauthor=M.+Speddingauthor=A.+J.+Harmar&title=International+Union+of+Basic+and+Clinical+Pharmacology.+LXXXVIII.+G+protein-coupled+receptor+list%3A+recommendations+for+new+pairings+with+cognate+ligands&doi=10.1124%2Fpr.112.007179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands</span></div><div class="casAuthors">Davenport, Anthony P.; Alexander, Stephen P. H.; Sharman, Joanna L.; Pawson, Adam J.; Benson, Helen E.; Monaghan, Amy E.; Liew, Wen Chiy; Mpamhanga, Chidochangu P.; Bonner, Tom I.; Neubig, Richard R.; Pin, Jean Philippe; Spedding, Michael; Harmar, Anthony J.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">967-986</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  In 2005, the International Union of Basic and Clin. Pharmacol. Committee on Receptor Nomenclature and Drug Classification (NC-IUPHAR) published a catalog of all of the human gene sequences known or predicted to encode G protein-coupled receptors (GPCRs), excluding sensory receptors.  This review updates the list of orphan GPCRs and describes the criteria used by NC-IUPHAR to recommend the pairing of an orphan receptor with its cognate ligand(s).  The following recommendations are made for new receptor names based on 11 pairings for class A GPCRs: hydroxycarboxylic acid receptors [HCA1 (GPR81) with lactate, HCA2 (GPR109A) with 3-hydroxybutyric acid, HCA3 (GPR109B) with 3-hydroxyoctanoic acid]; lysophosphatidic acid receptors [LPA4 (GPR23), LPA5 (GPR92), LPA6 (P2Y5)]; free fatty acid receptors [FFA4 (GPR120) with omega-3 fatty acids]; chemerin receptor (CMKLR1; ChemR23) with chemerin; CXCR7 (CMKOR1) with chemokines CXCL12 (SDF-1) and CXCL11 (ITAC); succinate receptor (SUCNR1) with succinate; and oxoglutarate receptor [OXGR1 with 2-oxoglutarate].  Pairings are highlighted for an addnl. 30 receptors in class A where further input is needed from the scientific community to validate these findings.  Fifty-seven human class A receptors (excluding pseudogenes) are still considered orphans; information has been provided where there is a significant phenotype in genetically modified animals.  In class B, six pairings have been reported by a single publication, with 28 (excluding pseudogenes) still classified as orphans.  Seven orphan receptors remain in class C, with one pairing described by a single paper.  The objective is to stimulate research into confirming pairings of orphan receptors where there is currently limited information and to identify cognate ligands for the remaining GPCRs.  Further information can be found on the IUPHAR Database website.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm8TAKeZwHO7Vg90H21EOLACvtfcHk0li3zc6Pg8xB2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtVyrtLvN&md5=561149f6eb486cf3aea0bb255a9cbf39</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fpr.112.007179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.112.007179%26sid%3Dliteratum%253Aachs%26aulast%3DDavenport%26aufirst%3DA.%2BP.%26aulast%3DAlexander%26aufirst%3DS.%2BP.%26aulast%3DSharman%26aufirst%3DJ.%2BL.%26aulast%3DPawson%26aufirst%3DA.%2BJ.%26aulast%3DBenson%26aufirst%3DH.%2BE.%26aulast%3DMonaghan%26aufirst%3DA.%2BE.%26aulast%3DLiew%26aufirst%3DW.%2BC.%26aulast%3DMpamhanga%26aufirst%3DC.%2BP.%26aulast%3DBonner%26aufirst%3DT.%2BI.%26aulast%3DNeubig%26aufirst%3DR.%2BR.%26aulast%3DPin%26aufirst%3DJ.%2BP.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DHarmar%26aufirst%3DA.%2BJ.%26atitle%3DInternational%2520Union%2520of%2520Basic%2520and%2520Clinical%2520Pharmacology.%2520LXXXVIII.%2520G%2520protein-coupled%2520receptor%2520list%253A%2520recommendations%2520for%2520new%2520pairings%2520with%2520cognate%2520ligands%26jtitle%3DPharmacol.%2520Rev.%26date%3D2013%26volume%3D65%26issue%3D3%26spage%3D967%26epage%3D986%26doi%3D10.1124%2Fpr.112.007179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaishi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onozawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iino, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oda, T.</span></span> <span> </span><span class="NLM_article-title">Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>288</i></span> (<span class="NLM_issue">15</span>),  <span class="NLM_fpage">10684</span>– <span class="NLM_lpage">10691</span>, <span class="refDoi"> DOI: 10.1074/jbc.M112.420042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1074%2Fjbc.M112.420042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=23449982" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlvFSisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=10684-10691&issue=15&author=M.+Suzukiauthor=S.+Takaishiauthor=M.+Nagasakiauthor=Y.+Onozawaauthor=I.+Iinoauthor=H.+Maedaauthor=T.+Komaiauthor=T.+Oda&title=Medium-chain+fatty+acid-sensing+receptor%2C+GPR84%2C+is+a+proinflammatory+receptor&doi=10.1074%2Fjbc.M112.420042"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Medium-chain Fatty Acid-sensing Receptor, GPR84, Is a Proinflammatory Receptor</span></div><div class="casAuthors">Suzuki, Masakatsu; Takaishi, Sachiko; Nagasaki, Miyuki; Onozawa, Yoshiko; Iino, Ikue; Maeda, Hiroaki; Komai, Tomoaki; Oda, Tomiichiro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">288</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">10684-10691</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">G protein-coupled receptor 84 (GPR84) is a putative receptor for medium-chain fatty acids (MCFAs), whose pathophysiol. roles have not yet been clarified.  Here, the authors show that GPR84 was activated by MCFAs with the hydroxyl group at the 2- or 3-position more effectively than nonhydroxylated MCFAs.  The authors also identified a surrogate agonist, 6-n-octylaminouracil (6-OAU), for GPR84.  These potential ligands and the surrogate agonist, 6-OAU, stimulated [35S]GTP binding and accumulated phosphoinositides in a GPR84-dependent manner.  The surrogate agonist, 6-OAU, internalized GPR84-EGFP from the cell surface.  Both the potential ligands and 6-OAU elicited chemotaxis of human polymorphonuclear leukocytes (PMNs) and macrophages and amplified LPS-stimulated prodn. of the proinflammatory cytokine IL-8 from PMNs and TNFα from macrophages.  Furthermore, the i.v. injection of 6-OAU raised the blood CXCL1 level in rats, and the inoculation of 6-OAU into the rat air pouch accumulated PMNs and macrophages in the site.  The results indicate a proinflammatory role of GPR84, suggesting that the receptor may be a novel target to treat chronic low grade inflammation assocd.-disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTeAePnQZYFrVg90H21EOLACvtfcHk0lgPJR7r74jJlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlvFSisr8%253D&md5=63a395e01eb2083bfb7d4a1195c88b1a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.420042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.420042%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DTakaishi%26aufirst%3DS.%26aulast%3DNagasaki%26aufirst%3DM.%26aulast%3DOnozawa%26aufirst%3DY.%26aulast%3DIino%26aufirst%3DI.%26aulast%3DMaeda%26aufirst%3DH.%26aulast%3DKomai%26aufirst%3DT.%26aulast%3DOda%26aufirst%3DT.%26atitle%3DMedium-chain%2520fatty%2520acid-sensing%2520receptor%252C%2520GPR84%252C%2520is%2520a%2520proinflammatory%2520receptor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26issue%3D15%26spage%3D10684%26epage%3D10691%26doi%3D10.1074%2Fjbc.M112.420042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nan, F. J.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of 2-alkylpyrimidine-4,6-diol and 6-alkylpyridine-2,4-diol as potent GPR84 agonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">583</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFGht7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=579-583&issue=6&author=Y.+Liuauthor=Q.+Zhangauthor=L.+H.+Chenauthor=H.+Yangauthor=W.+Luauthor=X.+Xieauthor=F.+J.+Nan&title=Design+and+synthesis+of+2-alkylpyrimidine-4%2C6-diol+and+6-alkylpyridine-2%2C4-diol+as+potent+GPR84+agonists&doi=10.1021%2Facsmedchemlett.6b00025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 2-Alkylpyrimidine-4,6-diol and 6-Alkylpyridine-2,4-diol as Potent GPR84 Agonists</span></div><div class="casAuthors">Liu, Yang; Zhang, Qing; Chen, Lin-Hai; Yang, Hui; Lu, Wei; Xie, Xin; Nan, Fa-Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">579-583</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of alkylpyrimidine-4,6-diol derivs. were designed and synthesized as novel GPR84 agonists based on a high-throughput screening (HTS) hit I. 6-Nonylpyridine-2,4-diol was identified as the most potent agonist of GPR84 reported so far, with an EC50 of 0.189 nM.  These novel GPR84 agonists will provide valuable tools for the study of the physiol. functions of GPR84.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyEcxh2lX2Q7Vg90H21EOLACvtfcHk0lgPJR7r74jJlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFGht7c%253D&md5=52f50ffae4ab4bbfd79f9eeda0bb063b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00025%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DL.%2BH.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DNan%26aufirst%3DF.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25202-alkylpyrimidine-4%252C6-diol%2520and%25206-alkylpyridine-2%252C4-diol%2520as%2520potent%2520GPR84%2520agonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D6%26spage%3D579%26epage%3D583%26doi%3D10.1021%2Facsmedchemlett.6b00025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of a novel small-molecule agonist for medium-chain free fatty acid receptor G protein-coupled receptor 84</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>357</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">344</span>, <span class="refDoi"> DOI: 10.1124/jpet.116.232033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1124%2Fjpet.116.232033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=26962172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWhu7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2016&pages=337-344&issue=2&author=Q.+Zhangauthor=H.+Yangauthor=J.+Liauthor=X.+Xie&title=Discovery+and+characterization+of+a+novel+small-molecule+agonist+for+medium-chain+free+fatty+acid+receptor+G+protein-coupled+receptor+84&doi=10.1124%2Fjpet.116.232033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and characterization of a novel small-molecule agonist for medium-chain free fatty acid receptor G protein-coupled receptor 84</span></div><div class="casAuthors">Zhang, Qing; Yang, Hui; Li, Jing; Xie, Xin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">337-344</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">G protein-coupled receptor 84 (GPR84) is a free fatty acid receptor activated by medium-chain free fatty acids with 9-14 carbons.  It is expressed mainly in the immune-related tissues, such as spleen, bone marrow, and peripheral blood leukocytes.  GPR84 plays significant roles in inflammatory processes and may represent a novel drug target for the treatment of immune-mediated diseases.  However, the lack of potent and specific ligands for GPR84 hindered the study of its functions and the development of potential clin. applications.  Here, we report the screen of 160,000 small- mol. compds. with a calcium mobilization assay using a human embryonic kidney 293 cell line stably expressing GPR84 and Ga16, and the identification of 2-(hexylthio)pyrimidine-4,6-diol (ZQ-16) as a potent and selective agonist of GPR84 with a novel structure.  ZQ-16 activates several GPR84-mediated signaling pathways, including calcium mobilization, inhibition of cAMP accumulation, phosphorylation of extracellular signal-regulated protein kinase 1/2, receptor desensitization and internalization, and receptor-β-arrestin interaction.  This compd. may be a useful tool to study the functions of GPR84 and a potential candidate for further structural optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjdl6EN67bhbVg90H21EOLACvtfcHk0liKJN9lzSSNGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWhu7fE&md5=8a2f4113fddcb35cdd39f99b9470e0c7</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fjpet.116.232033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.116.232033%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520novel%2520small-molecule%2520agonist%2520for%2520medium-chain%2520free%2520fatty%2520acid%2520receptor%2520G%2520protein-coupled%2520receptor%252084%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26volume%3D357%26issue%3D2%26spage%3D337%26epage%3D344%26doi%3D10.1124%2Fjpet.116.232033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pillaiyar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kose, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sylvester, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borges, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thimm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kugelgen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, C. E.</span></span> <span> </span><span class="NLM_article-title">6-(Ar)alkylamino-substituted uracil derivatives: lipid mimetics with potent activity at the orphan G protein-coupled receptor 84 (GPR84)</span>. <i>ACS omega</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">3365</span>– <span class="NLM_lpage">3383</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b02092</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b02092" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVyqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2018&pages=3365-3383&issue=3&author=T.+Pillaiyarauthor=M.+Koseauthor=V.+Namasivayamauthor=K.+Sylvesterauthor=G.+Borgesauthor=D.+Thimmauthor=I.+von+Kugelgenauthor=C.+E.+Muller&title=6-%28Ar%29alkylamino-substituted+uracil+derivatives%3A+lipid+mimetics+with+potent+activity+at+the+orphan+G+protein-coupled+receptor+84+%28GPR84%29&doi=10.1021%2Facsomega.7b02092"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">6-(Ar)Alkylamino-Substituted Uracil Derivatives: Lipid Mimetics with Potent Activity at the Orphan G Protein-Coupled Receptor 84 (GPR84)</span></div><div class="casAuthors">Pillaiyar, Thanigaimalai; Koese, Meryem; Namasivayam, Vigneshwaran; Sylvester, Katharina; Borges, Gleice; Thimm, Dominik; von Kuegelgen, Ivar; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">3365-3383</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR84, a Gi protein-coupled receptor that is activated by medium-chain (hydroxy)fatty acids, appears to play an important role in inflammation, immunity, and cancer.  Recently, 6-octylaminouracil has been reported to act as an agonist at GPR84.  Here, we describe the synthesis of 69 derivs. and analogs which represent new compds.  They were evaluated in (a) cyclic adenosine monophosphate accumulation and (b) β-arrestin assays in human GPR84-expressing cells.  Potent nonbiased as well as G protein-biased agonists were developed, e.g., 6-hexylamino-2,4(1H,3H)-pyrimidinedione (PSB-1584, EC50 5.0 nM (a), 3.2 nM (b), bias factor: 0) and 6-((p-chloro- and p-bromo-phenylethyl)amino)-2,4(1H,3H)-pyrimidinedione (PSB-16434, EC50 7.1 nM (a), 520 nM (b), bias factor: 1.9 = 79-fold Gi pathway-selective; I, PSB-17365, EC50 2.5 nM (a), 100 nM (b), bias factor 1.3 = 20-fold selective), which were selective vs. other free fatty acid-activated receptors.  Compds. II and I were found to be metabolically stable upon incubation with human liver microsomes.  A pharmacophore model was created on the basis of structurally diverse lipidlike GPR84 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc4TDL4U0tF7Vg90H21EOLACvtfcHk0liKJN9lzSSNGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVyqu7g%253D&md5=184964bac823f7cd34d4de98da0cef53</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b02092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b02092%26sid%3Dliteratum%253Aachs%26aulast%3DPillaiyar%26aufirst%3DT.%26aulast%3DKose%26aufirst%3DM.%26aulast%3DNamasivayam%26aufirst%3DV.%26aulast%3DSylvester%26aufirst%3DK.%26aulast%3DBorges%26aufirst%3DG.%26aulast%3DThimm%26aufirst%3DD.%26aulast%3Dvon%2BKugelgen%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DC.%2BE.%26atitle%3D6-%2528Ar%2529alkylamino-substituted%2520uracil%2520derivatives%253A%2520lipid%2520mimetics%2520with%2520potent%2520activity%2520at%2520the%2520orphan%2520G%2520protein-coupled%2520receptor%252084%2520%2528GPR84%2529%26jtitle%3DACS%2520omega%26date%3D2018%26volume%3D3%26issue%3D3%26spage%3D3365%26epage%3D3383%26doi%3D10.1021%2Facsomega.7b02092" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yousefi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarai, G.</span></span> <span> </span><span class="NLM_article-title">Cloning and expression analysis of a novel G-protein-coupled receptor selectively expressed on granulocytes</span>. <i>Journal Leukocyte Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>69</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1045</span>– <span class="NLM_lpage">1052</span>, <span class="refDoi"> DOI: 10.1189/jlb.69.6.1045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1189%2Fjlb.69.6.1045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=11404393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkslWrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2001&pages=1045-1052&issue=6&author=S.+Yousefiauthor=P.+R.+Cooperauthor=S.+L.+Potterauthor=B.+Mueckauthor=G.+Jarai&title=Cloning+and+expression+analysis+of+a+novel+G-protein-coupled+receptor+selectively+expressed+on+granulocytes&doi=10.1189%2Fjlb.69.6.1045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and expression analysis of a novel G-protein-coupled receptor selectively expressed on granulocytes</span></div><div class="casAuthors">Yousefi, Shida; Cooper, Paul R.; Potter, Suzanne L.; Mueck, Beatrice; Jarai, Gabor</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Leukocyte Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1045-1052</span>CODEN:
                <span class="NLM_cas:coden">JLBIE7</span>;
        ISSN:<span class="NLM_cas:issn">0741-5400</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">The migration of neutrophils into sites of acute and chronic inflammation is mediated by chemokines.  The authors used degenerate-primer reverse transcriptase-polymerase chain reaction (RT-PCR) to analyze chemokine receptor expression in neutrophils and identify novel receptors.  RNA was isolated from human peripheral blood neutrophils and from neutrophils that had been stimulated for 5 h with granulocyte-macrophage colony-stimulating factor or by coculturing with primary human bronchial epithelial cells.  Amplification products were cloned, and clone redundancy was detd.  Seven known G-protein-coupled receptors were identified among 38 clones-CCR1, CCR4, CXCR1, CXCR2, CXCR4, HM63, and FPR1-as well as a novel gene, EX33.  The full-length EX33 clone was obtained, and an in silico approach was used to identify the putative murine homolog.  The EX33 gene encodes a 396-amino-acid protein with limited sequence identity to known receptors.  Expression studies of several known chemokine receptors and EX33 revealed that resting neutrophils expressed higher levels of CXCRs and EX33 compared with activated neutrophils.  Northern blot expts. revealed that EX33 is expressed mainly in bone marrow, lung, and peripheral blood leukocytes.  Using RT-PCR anal., the authors showed more abundant expression of EX33 in neutrophils and eosinophils, in comparison with that in T- or B-lymphocytes, indicating cell-specific expression among leukocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAMqeieaewbrVg90H21EOLACvtfcHk0liKJN9lzSSNGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkslWrurs%253D&md5=03d1eb21f619cdd4790ace3c2b571d23</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1189%2Fjlb.69.6.1045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1189%252Fjlb.69.6.1045%26sid%3Dliteratum%253Aachs%26aulast%3DYousefi%26aufirst%3DS.%26aulast%3DCooper%26aufirst%3DP.%2BR.%26aulast%3DPotter%26aufirst%3DS.%2BL.%26aulast%3DMueck%26aufirst%3DB.%26aulast%3DJarai%26aufirst%3DG.%26atitle%3DCloning%2520and%2520expression%2520analysis%2520of%2520a%2520novel%2520G-protein-coupled%2520receptor%2520selectively%2520expressed%2520on%2520granulocytes%26jtitle%3DJournal%2520Leukocyte%2520Biol.%26date%3D2001%26volume%3D69%26issue%3D6%26spage%3D1045%26epage%3D1052%26doi%3D10.1189%2Fjlb.69.6.1045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lattin, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiltshire, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saijo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glass, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hume, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweet, M. J.</span></span> <span> </span><span class="NLM_article-title">Expression analysis of G protein-coupled receptors in mouse macrophages</span>. <i>Immunome Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">5</span>, <span class="refDoi"> DOI: 10.1186/1745-7580-4-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1186%2F1745-7580-4-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=18442421" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A280%3ADC%252BC3czktlyjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=5&author=J.+E.+Lattinauthor=K.+Schroderauthor=A.+I.+Suauthor=J.+R.+Walkerauthor=J.+Zhangauthor=T.+Wiltshireauthor=K.+Saijoauthor=C.+K.+Glassauthor=D.+A.+Humeauthor=S.+Kellieauthor=M.+J.+Sweet&title=Expression+analysis+of+G+protein-coupled+receptors+in+mouse+macrophages&doi=10.1186%2F1745-7580-4-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Expression analysis of G Protein-Coupled Receptors in mouse macrophages</span></div><div class="casAuthors">Lattin Jane E; Schroder Kate; Su Andrew I; Walker John R; Zhang Jie; Wiltshire Tim; Saijo Kaoru; Glass Christopher K; Hume David A; Kellie Stuart; Sweet Matthew J</div><div class="citationInfo"><span class="NLM_cas:title">Immunome research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Monocytes and macrophages express an extensive repertoire of G Protein-Coupled Receptors (GPCRs) that regulate inflammation and immunity.  In this study we performed a systematic micro-array analysis of GPCR expression in primary mouse macrophages to identify family members that are either enriched in macrophages compared to a panel of other cell types, or are regulated by an inflammatory stimulus, the bacterial product lipopolysaccharide (LPS).  RESULTS:  Several members of the P2RY family had striking expression patterns in macrophages; P2ry6 mRNA was essentially expressed in a macrophage-specific fashion, whilst P2ry1 and P2ry5 mRNA levels were strongly down-regulated by LPS.  Expression of several other GPCRs was either restricted to macrophages (e.g.  Gpr84) or to both macrophages and neural tissues (e.g.  P2ry12, Gpr85).  The GPCR repertoire expressed by bone marrow-derived macrophages and thioglycollate-elicited peritoneal macrophages had some commonality, but there were also several GPCRs preferentially expressed by either cell population.  CONCLUSION:  The constitutive or regulated expression in macrophages of several GPCRs identified in this study has not previously been described.  Future studies on such GPCRs and their agonists are likely to provide important insights into macrophage biology, as well as novel inflammatory pathways that could be future targets for drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrwQCcalOvk2gRQsDqrjW_fW6udTcc2eYjBHnDEG_Lg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czktlyjtw%253D%253D&md5=d0f33a92e85b59309930de7b0bfb36ec</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1186%2F1745-7580-4-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1745-7580-4-5%26sid%3Dliteratum%253Aachs%26aulast%3DLattin%26aufirst%3DJ.%2BE.%26aulast%3DSchroder%26aufirst%3DK.%26aulast%3DSu%26aufirst%3DA.%2BI.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWiltshire%26aufirst%3DT.%26aulast%3DSaijo%26aufirst%3DK.%26aulast%3DGlass%26aufirst%3DC.%2BK.%26aulast%3DHume%26aufirst%3DD.%2BA.%26aulast%3DKellie%26aufirst%3DS.%26aulast%3DSweet%26aufirst%3DM.%2BJ.%26atitle%3DExpression%2520analysis%2520of%2520G%2520protein-coupled%2520receptors%2520in%2520mouse%2520macrophages%26jtitle%3DImmunome%2520Res.%26date%3D2008%26volume%3D4%26spage%3D5%26doi%3D10.1186%2F1745-7580-4-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Audoy-Remus, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozoyan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecours, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lacroix, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivest, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallieres, L.</span></span> <span> </span><span class="NLM_article-title">GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer’s disease</span>. <i>Brain, Behav., Immun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">120</span>, <span class="refDoi"> DOI: 10.1016/j.bbi.2015.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.bbi.2015.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=25637481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitFCntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2015&pages=112-120&author=J.+Audoy-Remusauthor=L.+Bozoyanauthor=A.+Dumasauthor=M.+Filaliauthor=C.+Lecoursauthor=S.+Lacroixauthor=S.+Rivestauthor=M.+E.+Tremblayauthor=L.+Vallieres&title=GPR84+deficiency+reduces+microgliosis%2C+but+accelerates+dendritic+degeneration+and+cognitive+decline+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bbi.2015.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">GPR84 deficiency reduces microgliosis, but accelerates dendritic degeneration and cognitive decline in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Audoy-Remus, Julie; Bozoyan, Lusine; Dumas, Aline; Filali, Mohammed; Lecours, Cynthia; Lacroix, Steve; Rivest, Serge; Tremblay, Marie-Eve; Vallieres, Luc</div><div class="citationInfo"><span class="NLM_cas:title">Brain, Behavior, and Immunity</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112-120</span>CODEN:
                <span class="NLM_cas:coden">BBIMEW</span>;
        ISSN:<span class="NLM_cas:issn">0889-1591</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Microglia surrounds the amyloid plaques that form in the brains of patients with Alzheimer's disease (AD), but their role is controversial.  Under inflammatory conditions, these cells can express GPR84, an orphan receptor whose pathophysiol. role is unknown.  Here, we report that GPR84 is upregulated in microglia of APP/PS1 transgenic mice, a model of AD.  Without GPR84, these mice display both accelerated cognitive decline and a reduced no. of microglia, esp. in areas surrounding plaques.  The lack of GPR84 affects neither plaque formation nor hippocampal neurogenesis, but promotes dendritic degeneration.  Furthermore, GPR84 does not influence the clin. progression of other diseases in which its expression has been reported, i.e., exptl. autoimmune encephalomyelitis (EAE) and endotoxic shock.  We conclude that GPR84 plays a beneficial role in amyloid pathol. by acting as a sensor for a yet unknown ligand that promotes microglia recruitment, a response affecting dendritic degeneration and required to prevent further cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWBqsDH3-KvrVg90H21EOLACvtfcHk0lhG-iajBjr2og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitFCntbo%253D&md5=4b643287374786cdde611ffbb3002101</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2015.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2015.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DAudoy-Remus%26aufirst%3DJ.%26aulast%3DBozoyan%26aufirst%3DL.%26aulast%3DDumas%26aufirst%3DA.%26aulast%3DFilali%26aufirst%3DM.%26aulast%3DLecours%26aufirst%3DC.%26aulast%3DLacroix%26aufirst%3DS.%26aulast%3DRivest%26aufirst%3DS.%26aulast%3DTremblay%26aufirst%3DM.%2BE.%26aulast%3DVallieres%26aufirst%3DL.%26atitle%3DGPR84%2520deficiency%2520reduces%2520microgliosis%252C%2520but%2520accelerates%2520dendritic%2520degeneration%2520and%2520cognitive%2520decline%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2015%26volume%3D46%26spage%3D112%26epage%3D120%26doi%3D10.1016%2Fj.bbi.2015.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouchard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallieres, L.</span></span> <span> </span><span class="NLM_article-title">G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions</span>. <i>Glia</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>55</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">790</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1002/glia.20506</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1002%2Fglia.20506" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=17390309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A280%3ADC%252BD2s3jtVemsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2007&pages=790-800&issue=8&author=C.+Bouchardauthor=J.+Pageauthor=A.+Bedardauthor=P.+Tremblayauthor=L.+Vallieres&title=G+protein-coupled+receptor+84%2C+a+microglia-associated+protein+expressed+in+neuroinflammatory+conditions&doi=10.1002%2Fglia.20506"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions</span></div><div class="casAuthors">Bouchard Caroline; Page Julie; Bedard Andreanne; Tremblay Pierrot; Vallieres Luc</div><div class="citationInfo"><span class="NLM_cas:title">Glia</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">790-800</span>
        ISSN:<span class="NLM_cas:issn">0894-1491</span>.
    </div><div class="casAbstract">G protein-coupled receptor 84 (GPR84) is a recently discovered member of the seven transmembrane receptor superfamily whose function and regulation are unknown.  Here, we report that in mice suffering from endotoxemia, microglia express GPR84 in a strong and sustained manner.  This property is shared by subpopulations of peripheral macrophages and, to a much lesser extent, monocytes.  The induction of GPR84 expression by endotoxin is mediated, at least in part, by proinflammatory cytokines, notably tumor necrosis factor (TNF) and interleukin-1 (IL-1), because mice lacking either one or both of these molecules have fewer GPR84-expressing cells in their cerebral cortex than wild-type mice during the early phase of endotoxemia.  Moreover, when injected intracerebrally or added to microglial cultures, recombinant TNF stimulates GPR84 expression through a dexamethasone-insensitive mechanism.  Finally, we show that microglia produce GPR84 not only during endotoxemia, but also during experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis.  In conclusion, this study reports the identification of a new sensitive marker of microglial activation, which may play an important regulatory role in neuroimmunological processes, acting downstream to the effects of proinflammatory mediators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR5WBo60SwdsPEeosoOnpOLfW6udTcc2eYjBHnDEG_Lg7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s3jtVemsw%253D%253D&md5=5bc25664243312ac66f94244ab598c9d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fglia.20506&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.20506%26sid%3Dliteratum%253Aachs%26aulast%3DBouchard%26aufirst%3DC.%26aulast%3DPage%26aufirst%3DJ.%26aulast%3DBedard%26aufirst%3DA.%26aulast%3DTremblay%26aufirst%3DP.%26aulast%3DVallieres%26aufirst%3DL.%26atitle%3DG%2520protein-coupled%2520receptor%252084%252C%2520a%2520microglia-associated%2520protein%2520expressed%2520in%2520neuroinflammatory%2520conditions%26jtitle%3DGlia%26date%3D2007%26volume%3D55%26issue%3D8%26spage%3D790%26epage%3D800%26doi%3D10.1002%2Fglia.20506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkataraman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, F.</span></span> <span> </span><span class="NLM_article-title">The G-protein coupled receptor, GPR84 regulates IL-4 production by T lymphocytes in response to CD3 crosslinking</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">144</span>– <span class="NLM_lpage">153</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2005.05.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.imlet.2005.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=15993493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKjs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2005&pages=144-153&issue=2&author=C.+Venkataramanauthor=F.+Kuo&title=The+G-protein+coupled+receptor%2C+GPR84+regulates+IL-4+production+by+T+lymphocytes+in+response+to+CD3+crosslinking&doi=10.1016%2Fj.imlet.2005.05.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The G-protein coupled receptor, GPR84 regulates IL-4 production by T lymphocytes in response to CD3 crosslinking</span></div><div class="casAuthors">Venkataraman, Chandrasekar; Kuo, Frederick</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">144-153</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The orphan G-protein coupled receptor, GPR84 is highly expressed in the bone marrow, and in splenic T cells and B cells.  In this study, GPR84-deficient mice were generated to understand the biol. function of this orphan receptor.  The proliferation of T and B cells in response to various mitogens was normal in GPR84-deficient mice.  Interestingly, primary stimulation of T cells with anti-CD3 resulted in increased IL-4 but not IL-2 or IFN-γ prodn. in GPR84-/- mice compared to wild-type mice.  Augmented IL-4 prodn. in GPR84-deficient T cells was not related to increased frequency of IL-4-secreting cells in response to anti-CD3 stimulation.  In fact, stimulation with anti-CD3 and anti-CD28 resulted in increased levels of IL-4 but not IFN-γ steady-state mRNA in GPR84-/- T cells.  In addn., Th2 effector cells generated in vitro from GPR84-/- mice produced higher levels of IL-4, IL-5 and IL-13 compared to wild-type mice.  However, there was no detectable difference in the extent of IL-4 and IL-5 prodn. between the two groups of mice in response to antigen stimulation of spleen cells, isolated from mice previously immunized with OVA in alum.  These studies reveal a novel role for GPR84 in regulating early IL-4 gene expression in activated T cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoxPqqzrLXAbVg90H21EOLACvtfcHk0lgJTVQO0a8GNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKjs77L&md5=abef6f196008a5055ab99e9213c0d55d</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2005.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2005.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DVenkataraman%26aufirst%3DC.%26aulast%3DKuo%26aufirst%3DF.%26atitle%3DThe%2520G-protein%2520coupled%2520receptor%252C%2520GPR84%2520regulates%2520IL-4%2520production%2520by%2520T%2520lymphocytes%2520in%2520response%2520to%2520CD3%2520crosslinking%26jtitle%3DImmunol.%2520Lett.%26date%3D2005%26volume%3D101%26issue%3D2%26spage%3D144%26epage%3D153%26doi%3D10.1016%2Fj.imlet.2005.05.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagasaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchigami, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ozaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arima, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ota, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oiso, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamada, Y.</span></span> <span> </span><span class="NLM_article-title">Inflammatory changes in adipose tissue enhance expression of GPR84, a medium-chain fatty acid receptor: TNFα enhances GPR84 expression in adipocytes</span>. <i>FEBS Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>586</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">368</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1016/j.febslet.2012.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.febslet.2012.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=22245676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1yqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=586&publication_year=2012&pages=368-372&issue=4&author=H.+Nagasakiauthor=T.+Kondoauthor=M.+Fuchigamiauthor=H.+Hashimotoauthor=Y.+Sugimuraauthor=N.+Ozakiauthor=H.+Arimaauthor=A.+Otaauthor=Y.+Oisoauthor=Y.+Hamada&title=Inflammatory+changes+in+adipose+tissue+enhance+expression+of+GPR84%2C+a+medium-chain+fatty+acid+receptor%3A+TNF%CE%B1+enhances+GPR84+expression+in+adipocytes&doi=10.1016%2Fj.febslet.2012.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammatory changes in adipose tissue enhance expression of GPR G-protein coupled receptor84, a medium-chain fatty acid receptor</span></div><div class="casAuthors">Nagasaki, Hiroshi; Kondo, Takaaki; Fuchigami, Masahiro; Hashimoto, Hiroyuki; Sugimura, Yoshihisa; Ozaki, Nobuaki; Arima, Hiroshi; Ota, Akira; Oiso, Yutaka; Hamada, Yoji</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">586</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">368-372</span>CODEN:
                <span class="NLM_cas:coden">FEBLAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-5793</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study we aimed to identify the physiol. roles of G protein-coupled receptor 84 (GPR84) in adipose tissue, together with medium-chain fatty acids (MCFAs), the specific ligands for GPR84.  In mice, high-fat diet up-regulated GPR84 expression in fat pads.  In 3T3-L1 adipocytes, coculture with a macrophage cell line, RAW264, or TNFα remarkably enhanced GPR84 expression.  In the presence of TNFα, MCFAs down-regulated adiponectin mRNA expression in 3T3-L1 adipocytes.  Taken together, our results suggest that GPR84 emerges in adipocytes in response to TNFα from infiltrating macrophages and exacerbates the vicious cycle between adiposity and diabesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiwUz5s6M9zLVg90H21EOLACvtfcHk0lgJTVQO0a8GNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1yqu7w%253D&md5=8fecdea5b404e472d6f66a9ed22cd88b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.febslet.2012.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.febslet.2012.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DNagasaki%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DFuchigami%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DSugimura%26aufirst%3DY.%26aulast%3DOzaki%26aufirst%3DN.%26aulast%3DArima%26aufirst%3DH.%26aulast%3DOta%26aufirst%3DA.%26aulast%3DOiso%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DY.%26atitle%3DInflammatory%2520changes%2520in%2520adipose%2520tissue%2520enhance%2520expression%2520of%2520GPR84%252C%2520a%2520medium-chain%2520fatty%2520acid%2520receptor%253A%2520TNF%25CE%25B1%2520enhances%2520GPR84%2520expression%2520in%2520adipocytes%26jtitle%3DFEBS%2520Lett.%26date%3D2012%26volume%3D586%26issue%3D4%26spage%3D368%26epage%3D372%26doi%3D10.1016%2Fj.febslet.2012.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicol, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Russa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Didangelos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentry, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grist, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malcangio, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, S. B.</span></span> <span> </span><span class="NLM_article-title">The role of G-protein receptor 84 in experimental neuropathic pain</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">23</span>),  <span class="NLM_fpage">8959</span>– <span class="NLM_lpage">8969</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.3558-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1523%2FJNEUROSCI.3558-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=26063927" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOqsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=8959-8969&issue=23&author=L.+S.+Nicolauthor=J.+M.+Dawesauthor=F.+La+Russaauthor=A.+Didangelosauthor=A.+K.+Clarkauthor=C.+Gentryauthor=J.+Gristauthor=J.+B.+Daviesauthor=M.+Malcangioauthor=S.+B.+McMahon&title=The+role+of+G-protein+receptor+84+in+experimental+neuropathic+pain&doi=10.1523%2FJNEUROSCI.3558-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The role of G-protein receptor 84 in experimental neuropathic pain</span></div><div class="casAuthors">Nicol, Louise S. C.; Dawes, John M.; La Russa, Federica; Didangelos, Athanasios; Clark, Anna K.; Gentry, Clive; Grist, John; Davies, John B.; Malcangio, Marzia; McMahon, Stephen B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8959-8969</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">G-protein receptor 84 (GPR84) is an orphan receptor that is induced markedly in monocytes/macrophages and microglia during inflammation, but its pathophysiol. function is unknown.  Here, we investigate the role of GPR84 in a murine model of traumatic nerve injury.  Naive GPR84 knock-out (KO) mice exhibited normal behavioral responses to acute noxious stimuli, but subsequent to partial sciatic nerve ligation (PNL), KOs did not develop mech. or thermal hypersensitivity, in contrast to wild-type (WT) littermates.  Nerve injury increased ionized calcium binding adapter mol. 1 (Iba1) and phosphorylated p38 MAPK immunoreactivity in the dorsal horn and Iba1 and cluster of differentiation 45 expression in the sciatic nerve, with no difference between genotypes.  PCR array anal. revealed that Gpr84 expression was upregulated in the spinal cord and sciatic nerve of WT mice.  In addn., the expression of arginase-1, a marker for anti-inflammatory macrophages, was upregulated in KO sciatic nerve.  Based on this evidence, we investigated whether peripheral macrophages behave differently in the absence of GPR84.  We found that lipopolysaccharide-stimulated KO macrophages exhibited attenuated expression of several proinflammatory mediators, including IL-1β, IL-6, and TNF-α.  Forskolin-stimulated KO macrophages also showed greater cAMP induction, a second messenger assocd. with immunosuppression.  In summary, our results demonstrate that GPR84 is a proinflammatory receptor that contributes to nociceptive signaling via the modulation of macrophages, whereas in its absence the response of these cells to an inflammatory insult is impaired.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEz_UEJb4WPbVg90H21EOLACvtfcHk0lgJTVQO0a8GNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOqsLrJ&md5=4d7a16fa2471aaaa6ed9395ad1215544</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3558-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3558-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DNicol%26aufirst%3DL.%2BS.%26aulast%3DDawes%26aufirst%3DJ.%2BM.%26aulast%3DLa%2BRussa%26aufirst%3DF.%26aulast%3DDidangelos%26aufirst%3DA.%26aulast%3DClark%26aufirst%3DA.%2BK.%26aulast%3DGentry%26aufirst%3DC.%26aulast%3DGrist%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DJ.%2BB.%26aulast%3DMalcangio%26aufirst%3DM.%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26atitle%3DThe%2520role%2520of%2520G-protein%2520receptor%252084%2520in%2520experimental%2520neuropathic%2520pain%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26issue%3D23%26spage%3D8959%26epage%3D8969%26doi%3D10.1523%2FJNEUROSCI.3558-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sundqvist, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christenson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdfeldt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mårtensson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Björkman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dieckmann, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlgren, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsman, H.</span></span> <span> </span><span class="NLM_article-title">Similarities and differences between the responses induced in human phagocytes through activation of the medium chain fatty acid receptor GPR84 and the short chain fatty acid receptor FFA2R</span>. <i>Biochim. Biophys. Acta, Mol. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>1865</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">695</span>– <span class="NLM_lpage">708</span>, <span class="refDoi"> DOI: 10.1016/j.bbamcr.2018.02.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.bbamcr.2018.02.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=29477577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFaju7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1865&publication_year=2018&pages=695-708&issue=5&author=M.+Sundqvistauthor=K.+Christensonauthor=A.+Holdfeldtauthor=M.+Gablauthor=J.+M%C3%A5rtenssonauthor=L.+Bj%C3%B6rkmanauthor=R.+Dieckmannauthor=C.+Dahlgrenauthor=H.+Forsman&title=Similarities+and+differences+between+the+responses+induced+in+human+phagocytes+through+activation+of+the+medium+chain+fatty+acid+receptor+GPR84+and+the+short+chain+fatty+acid+receptor+FFA2R&doi=10.1016%2Fj.bbamcr.2018.02.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Similarities and differences between the responses induced in human phagocytes through activation of the medium chain fatty acid receptor GPR84 and the short chain fatty acid receptor FFA2R</span></div><div class="casAuthors">Sundqvist, Martina; Christenson, Karin; Holdfeldt, Andre; Gabl, Michael; Maartensson, Jonas; Bjoerkman, Lena; Dieckmann, Regis; Dahlgren, Claes; Forsman, Huamei</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">1865</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">695-708</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this study, we have characterized the GPR84 activation profile and regulation mechanism in human phagocytes, using two recently developed small mols. that specifically target GPR84 agonistically (ZQ16) and antagonistically (GLPG1205), resp.  Compared to our earlier characterization of the short chain fatty acid receptor FFA2R which is functionally expressed in neutrophils but not in monocytes, GPR84 is expressed in both cell types and in monocyte-derived macrophages.  In neutrophils, the GPR84 agonist had an activation profile very similar to that of FFA2R.  The GPR84-mediated superoxide release was low in naive cells, but the response could be significantly primed by TNFα and by the actin cytoskeleton disrupting agent Latrunculin A.  Similar to that of FFA2R, a desensitization mechanism bypassing the actin cytoskeleton was utilized by GPR84.  All ZQ16-mediated cellular responses were sensitive to GLPG1205, confirming the GPR84-dependency.  Finally, our data of in vivo transmigrated tissue neutrophils indicate that both GPR84 and FFA2R are involved in neutrophil recruitment processes in vivo.  In summary, we show functional similarities but also some important differences between GPR84 and FFA2R in human phagocytes, thus providing some mechanistic insights into GPR84 regulation in blood neutrophils and cells recruited to an aseptic inflammatory site in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxFh26S2UftbVg90H21EOLACvtfcHk0ljbpxAbDZqTkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFaju7w%253D&md5=5f80256de9cc62715bf953312937170e</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2018.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2018.02.008%26sid%3Dliteratum%253Aachs%26aulast%3DSundqvist%26aufirst%3DM.%26aulast%3DChristenson%26aufirst%3DK.%26aulast%3DHoldfeldt%26aufirst%3DA.%26aulast%3DGabl%26aufirst%3DM.%26aulast%3DM%25C3%25A5rtensson%26aufirst%3DJ.%26aulast%3DBj%25C3%25B6rkman%26aufirst%3DL.%26aulast%3DDieckmann%26aufirst%3DR.%26aulast%3DDahlgren%26aufirst%3DC.%26aulast%3DForsman%26aufirst%3DH.%26atitle%3DSimilarities%2520and%2520differences%2520between%2520the%2520responses%2520induced%2520in%2520human%2520phagocytes%2520through%2520activation%2520of%2520the%2520medium%2520chain%2520fatty%2520acid%2520receptor%2520GPR84%2520and%2520the%2520short%2520chain%2520fatty%2520acid%2520receptor%2520FFA2R%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2018%26volume%3D1865%26issue%3D5%26spage%3D695%26epage%3D708%26doi%3D10.1016%2Fj.bbamcr.2018.02.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arijs, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Hertogh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Machiels, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Steen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemaire, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schraenen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Lommel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quintens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Assche, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeire, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuit, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rutgeerts, P.</span></span> <span> </span><span class="NLM_article-title">Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment</span>. <i>Am. J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>106</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">761</span>, <span class="refDoi"> DOI: 10.1038/ajg.2011.27</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1038%2Fajg.2011.27" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=21326222" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1ehsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2011&pages=748-761&issue=4&author=I.+Arijsauthor=G.+De+Hertoghauthor=K.+Machielsauthor=K.+Van+Steenauthor=K.+Lemaireauthor=A.+Schraenenauthor=L.+Van+Lommelauthor=R.+Quintensauthor=G.+Van+Asscheauthor=S.+Vermeireauthor=F.+Schuitauthor=P.+Rutgeerts&title=Mucosal+gene+expression+of+cell+adhesion+molecules%2C+chemokines%2C+and+chemokine+receptors+in+patients+with+inflammatory+bowel+disease+before+and+after+infliximab+treatment&doi=10.1038%2Fajg.2011.27"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mucosal Gene Expression of Cell Adhesion Molecules, Chemokines, and Chemokine Receptors in Patients With Inflammatory Bowel Disease Before and After Infliximab Treatment</span></div><div class="casAuthors">Arijs, Ingrid; De Hertogh, Gert; Machiels, Kathleen; Van Steen, Kristel; Lemaire, Katleen; Schraenen, Anica; Van Lommel, Leentje; Quintens, Roel; Van Assche, Gert; Vermeire, Severine; Schuit, Frans; Rutgeerts, Paul</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">748-761</span>CODEN:
                <span class="NLM_cas:coden">AJGAAR</span>;
        ISSN:<span class="NLM_cas:issn">0002-9270</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">OBJECTIVES: Inflammatory bowel disease (IBD) is characterized by a continuous influx of leukocytes into the gut wall.  This migration is regulated by cell adhesion mols. (CAMs), and selective antimigration therapies have been developed.  This study investigated the effect of infliximab therapy on the mucosal gene expression of CAMs in IBD.  METHODS: Mucosal gene expression of 69 leukocyte/endothelial CAMs and E-cadherin was investigated in 61 IBD patients before and after first infliximab infusion and in 12 normal controls, using Affymetrix gene expression microarrays.  Quant. reverse transcriptase-PCR (qRT-PCR), immunohistochem., and western blotting were used to confirm the microarray data.  RESULTS: When compared with control colons, the colonic mucosal gene expression of most leukocyte/endothelial adhesion mols. was upregulated and E-cadherin gene expression was downregulated in active colonic IBD (IBDc) before therapy, with no significant colonic gene expression differences between ulcerative colitis and colonic Crohn's disease.  Infliximab therapy restored the upregulations of leukocyte CAMs in IBDc responders to infliximab that paralleled the disappearance of the inflammatory cells from the colonic lamina propria.  Also, the colonic gene expression of endothelial CAMs and of most chemokines/chemokine receptors returned to normal after therapy in IBDc responders, and only CCL20 and CXCL1-2 expression remained increased after therapy in IBDc responders vs. control colons.  When compared with control ileums, the ileal gene expression of MADCAM1, THY1, PECAM1, CCL28, CXCL1, -2, -5, -6, and -11, and IL8 was increased and CD58 expression was decreased in active ileal Crohn's disease (CDi) before therapy, and none of the genes remained dysregulated after therapy in CDi responders vs. control ileums.  This microarray study identified a no. of interesting targets for antiadhesion therapy including PECAM1, IL8, and CCL20, besides the currently studied α4β7 integrin-MADCAM1 axis.  CONCLUSIONS: Our data demonstrate that many leukocyte/endothelial CAMs and chemokines/chemokine receptors are upregulated in inflamed IBD mucosa.  Controlling the inflammation with infliximab restores most of these dysregulations in IBD.  These results show that at least part of the mechanism of anti-tumor necrosis factor-α therapy goes through downregulation of certain adhesion mols.  Am J Gastroenterol 2011; 106:748-761; doi:10.1038/ajg.2011.27; published online 15 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1-CMItQPbZrVg90H21EOLACvtfcHk0ljbpxAbDZqTkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1ehsr8%253D&md5=f4483700084ba9b4a7dddae654ecd0e2</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fajg.2011.27&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fajg.2011.27%26sid%3Dliteratum%253Aachs%26aulast%3DArijs%26aufirst%3DI.%26aulast%3DDe%2BHertogh%26aufirst%3DG.%26aulast%3DMachiels%26aufirst%3DK.%26aulast%3DVan%2BSteen%26aufirst%3DK.%26aulast%3DLemaire%26aufirst%3DK.%26aulast%3DSchraenen%26aufirst%3DA.%26aulast%3DVan%2BLommel%26aufirst%3DL.%26aulast%3DQuintens%26aufirst%3DR.%26aulast%3DVan%2BAssche%26aufirst%3DG.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DSchuit%26aufirst%3DF.%26aulast%3DRutgeerts%26aufirst%3DP.%26atitle%3DMucosal%2520gene%2520expression%2520of%2520cell%2520adhesion%2520molecules%252C%2520chemokines%252C%2520and%2520chemokine%2520receptors%2520in%2520patients%2520with%2520inflammatory%2520bowel%2520disease%2520before%2520and%2520after%2520infliximab%2520treatment%26jtitle%3DAm.%2520J.%2520Gastroenterol.%26date%3D2011%26volume%3D106%26issue%3D4%26spage%3D748%26epage%3D761%26doi%3D10.1038%2Fajg.2011.27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leduc, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibodeau, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grouix, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarra-Bournet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hince, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremblay, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geerts, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, C. R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebert, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutsol, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holterman, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gervais, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouboudinar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felton, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laverdure, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letourneau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cloutier, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblond, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbott, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penney, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duceppe, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacharie, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupuis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calderone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, Q. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laurin, P.</span></span> <span> </span><span class="NLM_article-title">A newly discovered antifibrotic pathway regulated by two fatty acid receptors: GPR40 and GPR84</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>188</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1132</span>– <span class="NLM_lpage">1148</span>, <span class="refDoi"> DOI: 10.1016/j.ajpath.2018.01.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.ajpath.2018.01.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=29454750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltVGqs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=188&publication_year=2018&pages=1132-1148&issue=5&author=L.+Gagnonauthor=M.+Leducauthor=J.+F.+Thibodeauauthor=M.+Z.+Zhangauthor=B.+Grouixauthor=F.+Sarra-Bournetauthor=W.+Gagnonauthor=K.+Hinceauthor=M.+Tremblayauthor=L.+Geertsauthor=C.+R.+J.+Kennedyauthor=R.+L.+Hebertauthor=A.+Gutsolauthor=C.+E.+Holtermanauthor=E.+Kamtoauthor=L.+Gervaisauthor=J.+Ouboudinarauthor=J.+Richardauthor=A.+Feltonauthor=A.+Laverdureauthor=J.+C.+Simardauthor=S.+Letourneauauthor=M.+P.+Cloutierauthor=F.+A.+Leblondauthor=S.+D.+Abbottauthor=C.+Penneyauthor=J.+S.+Duceppeauthor=B.+Zacharieauthor=J.+Dupuisauthor=A.+Calderoneauthor=Q.+T.+Nguyenauthor=R.+C.+Harrisauthor=P.+Laurin&title=A+newly+discovered+antifibrotic+pathway+regulated+by+two+fatty+acid+receptors%3A+GPR40+and+GPR84&doi=10.1016%2Fj.ajpath.2018.01.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors</span></div><div class="casAuthors">Gagnon, Lyne; Leduc, Martin; Thibodeau, Jean-Francois; Zhang, Ming-Zhi; Grouix, Brigitte; Sarra-Bournet, Francois; Gagnon, William; Hince, Kathy; Tremblay, Mikael; Geerts, Lilianne; Kennedy, Christopher R. J.; Hebert, Richard L.; Gutsol, Alex; Holterman, Chet E.; Kamto, Eldjonai; Gervais, Liette; Ouboudinar, Jugurtha; Richard, Jonathan; Felton, Alexandra; Laverdure, Alexandre; Simard, Jean-Christophe; Letourneau, Sylvie; Cloutier, Marie-Pier; Leblond, Francois A.; Abbott, Shaun D.; Penney, Christopher; Duceppe, Jean-Simon; Zacharie, Boulos; Dupuis, Jocelyn; Calderone, Angelino; Nguyen, Quang T.; Harris, Raymond C.; Laurin, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">188</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1132-1148</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Numerous clin. conditions can lead to organ fibrosis and functional failure.  There is a great need for therapies that could effectively target pathophysiol. pathways involved in fibrosis.  GPR40 and GPR84 are G protein-coupled receptors with free fatty acid ligands and are assocd. with metabolic and inflammatory disorders.  Although GPR40 and GPR84 are involved in diverse physiol. processes, no evidence has demonstrated the relevance of GPR40 and GPR84 in fibrosis pathways.  Using PBI-4050 (3-pentylbenzeneacetic acid sodium salt), a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, resp., we uncovered an antifibrotic pathway involving these receptors.  In expts. using Gpr40- and Gpr84-knockout mice in models of kidney fibrosis (unilateral ureteral obstruction, long-term post-acute ischemic injury, and adenine-induced chronic kidney disease), we found that GPR40 is protective and GPR84 is deleterious in these diseases.  Moreover, through binding to GPR40 and GPR84, PBI-4050 significantly attenuated fibrosis in many injury contexts, as evidenced by the antifibrotic activity obsd. in kidney, liver, heart, lung, pancreas, and skin fibrosis models.  Therefore, GPR40 and GPR84 may represent promising mol. targets in fibrosis pathways.  We conclude that PBI-4050 is a first-in-class compd. that may be effective for managing inflammatory and fibrosis-related diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogzjSwncX3zLVg90H21EOLACvtfcHk0lgyqiFxEMvyQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltVGqs7w%253D&md5=47fff3190f70beafa69897d9d89f206d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ajpath.2018.01.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajpath.2018.01.009%26sid%3Dliteratum%253Aachs%26aulast%3DGagnon%26aufirst%3DL.%26aulast%3DLeduc%26aufirst%3DM.%26aulast%3DThibodeau%26aufirst%3DJ.%2BF.%26aulast%3DZhang%26aufirst%3DM.%2BZ.%26aulast%3DGrouix%26aufirst%3DB.%26aulast%3DSarra-Bournet%26aufirst%3DF.%26aulast%3DGagnon%26aufirst%3DW.%26aulast%3DHince%26aufirst%3DK.%26aulast%3DTremblay%26aufirst%3DM.%26aulast%3DGeerts%26aufirst%3DL.%26aulast%3DKennedy%26aufirst%3DC.%2BR.%2BJ.%26aulast%3DHebert%26aufirst%3DR.%2BL.%26aulast%3DGutsol%26aufirst%3DA.%26aulast%3DHolterman%26aufirst%3DC.%2BE.%26aulast%3DKamto%26aufirst%3DE.%26aulast%3DGervais%26aufirst%3DL.%26aulast%3DOuboudinar%26aufirst%3DJ.%26aulast%3DRichard%26aufirst%3DJ.%26aulast%3DFelton%26aufirst%3DA.%26aulast%3DLaverdure%26aufirst%3DA.%26aulast%3DSimard%26aufirst%3DJ.%2BC.%26aulast%3DLetourneau%26aufirst%3DS.%26aulast%3DCloutier%26aufirst%3DM.%2BP.%26aulast%3DLeblond%26aufirst%3DF.%2BA.%26aulast%3DAbbott%26aufirst%3DS.%2BD.%26aulast%3DPenney%26aufirst%3DC.%26aulast%3DDuceppe%26aufirst%3DJ.%2BS.%26aulast%3DZacharie%26aufirst%3DB.%26aulast%3DDupuis%26aufirst%3DJ.%26aulast%3DCalderone%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DQ.%2BT.%26aulast%3DHarris%26aufirst%3DR.%2BC.%26aulast%3DLaurin%26aufirst%3DP.%26atitle%3DA%2520newly%2520discovered%2520antifibrotic%2520pathway%2520regulated%2520by%2520two%2520fatty%2520acid%2520receptors%253A%2520GPR40%2520and%2520GPR84%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2018%26volume%3D188%26issue%3D5%26spage%3D1132%26epage%3D1148%26doi%3D10.1016%2Fj.ajpath.2018.01.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Aziz, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neuhuber, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meguid Kassem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khailah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamal Eldeen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khairy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khayyal, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shcherbakova, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efferth, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulrich-Merzenich, G.</span></span> <span> </span><span class="NLM_article-title">GPR84 and TREM-1 signaling contribute to the pathogenesis of reflux esophagitis</span>. <i>Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1011</span>– <span class="NLM_lpage">1024</span>, <span class="refDoi"> DOI: 10.2119/molmed.2015.00098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.2119%2Fmolmed.2015.00098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKlsLbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=1011-1024&issue=1&author=H.+Abdel-Azizauthor=M.+Schneiderauthor=W.+Neuhuberauthor=A.+Meguid+Kassemauthor=S.+Khailahauthor=J.+Mullerauthor=H.+Gamal+Eldeenauthor=A.+Khairyauthor=M.+T.+Khayyalauthor=A.+Shcherbakovaauthor=T.+Efferthauthor=G.+Ulrich-Merzenich&title=GPR84+and+TREM-1+signaling+contribute+to+the+pathogenesis+of+reflux+esophagitis&doi=10.2119%2Fmolmed.2015.00098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">GPR84 and TREM-1 signaling contribute to the pathogenesis of reflux esophagitis</span></div><div class="casAuthors">Abdel-Aziz, Heba; Schneider, Mathias; Neuhuber, Winfried; Kassem, Abdel Meguid; Khailah, Saleem; Mueller, Juergen; Eldeen, Hadeel Gamal; Khairy, Ahmed; Khayyal, Mohamed T.; Shcherbakova, Anastasiia; Efferth, Thomas; Ulrich-Merzenich, Gudrun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine (Manhasset, NY, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1011-1024</span>CODEN:
                <span class="NLM_cas:coden">MOMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1528-3658</span>.
    
            (<span class="NLM_cas:orgname">Feinstein Institute for Medical Research</span>)
        </div><div class="casAbstract">Gastro-esophageal reflux disease (GERD) is one of the most common disorders in gastroenterol.  Patients present with or without increased acid exposure indicating a nonuniform etiol.  Thus, the common treatment with proton pump inhibitors (PPIs) fails to control symptoms in up to 40% of patients.  To further elucidate the pathophysiol. of the condition and explore new treatment targets, transcriptomics, proteomics and histol. methods were applied to a surgically induced subchronic reflux esophagitis model in Wistar rats after treatment with either omeprazole (PPI) or STW5, a herbal prepn. shown to ameliorate esophagitis without affecting refluxate pH.  The normal human esophageal squamous cell line HET-1A and human endoscopic biopsies were used to confirm our findings to the G-protein-coupled receptor (GPR) 84 in human tissue.  Both treatments reduced reflux-induced macroscopic and microscopic lesions of the esophagi as well as known proinflammatory cytokines.  Proteomic and transcriptomic analyses identified CINC1-3, MIP-1/3α, MIG, RANTES and interleukin (IL)-1β as prominent mediators in GERD.  Most regulated cyto-/chemokines are linked to the TREM-1 signaling pathway.  The fatty acid receptor GPR84 was upregulated in esophagitis but significantly decreased in treated groups, a finding supported by Western blot and immunohistochem. in both rat tissue and HET-1A cells.  GPR84 was also found to be significantly upregulated in patients with grade B reflux esophagitis.  The expression of GPR84 in esophageal tissue and its potential involvement in GERD are reported for the first time.  IL-8 (CINC1-3) and the TREM-1 signaling pathway are proposed, besides GPR84, to play an important role in the pathogenesis of GERD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGv2akUPMqbbVg90H21EOLACvtfcHk0lgyqiFxEMvyQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKlsLbI&md5=d626c0592ea9ac67a3700ec6b2138383</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2119%2Fmolmed.2015.00098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2119%252Fmolmed.2015.00098%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Aziz%26aufirst%3DH.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DNeuhuber%26aufirst%3DW.%26aulast%3DMeguid%2BKassem%26aufirst%3DA.%26aulast%3DKhailah%26aufirst%3DS.%26aulast%3DMuller%26aufirst%3DJ.%26aulast%3DGamal%2BEldeen%26aufirst%3DH.%26aulast%3DKhairy%26aufirst%3DA.%26aulast%3DKhayyal%26aufirst%3DM.%2BT.%26aulast%3DShcherbakova%26aufirst%3DA.%26aulast%3DEfferth%26aufirst%3DT.%26aulast%3DUlrich-Merzenich%26aufirst%3DG.%26atitle%3DGPR84%2520and%2520TREM-1%2520signaling%2520contribute%2520to%2520the%2520pathogenesis%2520of%2520reflux%2520esophagitis%26jtitle%3DMol.%2520Med.%26date%3D2015%26volume%3D21%26issue%3D1%26spage%3D1011%26epage%3D1024%26doi%3D10.2119%2Fmolmed.2015.00098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norris, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. Y.</span></span> <span> </span><span class="NLM_article-title">GPR84 sustains aberrant beta-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>124</i></span> (<span class="NLM_issue">22</span>),  <span class="NLM_fpage">3284</span>– <span class="NLM_lpage">3294</span>, <span class="refDoi"> DOI: 10.1182/blood-2013-10-532523</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1182%2Fblood-2013-10-532523" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=25293777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSgs73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2014&pages=3284-3294&issue=22&author=P.+A.+Dietrichauthor=C.+Yangauthor=H.+H.+Leungauthor=J.+R.+Lynchauthor=E.+Gonzalesauthor=B.+Liuauthor=M.+Haberauthor=M.+D.+Norrisauthor=J.+Wangauthor=J.+Y.+Wang&title=GPR84+sustains+aberrant+beta-catenin+signaling+in+leukemic+stem+cells+for+maintenance+of+MLL+leukemogenesis&doi=10.1182%2Fblood-2013-10-532523"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">GPR84 sustains aberrant β-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis</span></div><div class="casAuthors">Dietrich, Philipp A.; Yang, Chen; Leung, Halina H. L.; Lynch, Jennifer R.; Gonzales, Estrella; Liu, Bing; Haber, Michelle; Norris, Murray D.; Wang, Jianlong; Wang, Jenny Yingzi</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">3284-3294</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">β-Catenin is required for establishment of leukemic stem cells (LSCs) in acute myeloid leukemia (AML).  Targeted inhibition of β-catenin signaling has been hampered by the lack of pathway components amenable to pharmacol. manipulation.  Here we identified a novel β-catenin regulator, GPR84, a member of the G protein-coupled receptor family that represents a highly tractable class of drug targets.  High GPR84 expression levels were confirmed in human and mouse AML LSCs compared with hematopoietic stem cells (HSCs).  Suppression of GPR84 significantly inhibited cell growth by inducing G1-phase cell-cycle arrest in pre-LSCs, reduced LSC frequency, and impaired reconstitution of stem cell-derived mixed-lineage leukemia (MLL) AML, which represents an aggressive and drug-resistant subtype of AML.  The GPR84-deficient phenotype in established AML could be rescued by expression of constitutively active β-catenin.  Furthermore, GPR84 conferred a growth advantage to Hoxa9/Meis1a-transduced stem cells.  Microarray anal. demonstrated that GPR84 significantly upregulated a small set of MLL-fusion targets and β-catenin coeffectors, and downregulated a hematopoietic cell-cycle inhibitor.  Altogether, our data reveal a previously unrecognized role of GPR84 in maintaining fully developed AML by sustaining aberrant β-catenin signaling in LSCs, and suggest that targeting the oncogenic GPR84/β-catenin signaling axis may represent a novel therapeutic strategy for AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqayOBoeIKDt7Vg90H21EOLACvtfcHk0lhNN_F_RnnrUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSgs73L&md5=3da07da89bd6da728d09aa26b273d659</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1182%2Fblood-2013-10-532523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2013-10-532523%26sid%3Dliteratum%253Aachs%26aulast%3DDietrich%26aufirst%3DP.%2BA.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DLeung%26aufirst%3DH.%2BH.%26aulast%3DLynch%26aufirst%3DJ.%2BR.%26aulast%3DGonzales%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHaber%26aufirst%3DM.%26aulast%3DNorris%26aufirst%3DM.%2BD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BY.%26atitle%3DGPR84%2520sustains%2520aberrant%2520beta-catenin%2520signaling%2520in%2520leukemic%2520stem%2520cells%2520for%2520maintenance%2520of%2520MLL%2520leukemogenesis%26jtitle%3DBlood%26date%3D2014%26volume%3D124%26issue%3D22%26spage%3D3284%26epage%3D3294%26doi%3D10.1182%2Fblood-2013-10-532523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Du
Toit, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Browne, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irving-Rodgers, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massa, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fozzard, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peak, I. R.</span></span> <span> </span><span class="NLM_article-title">Effect of GPR84 deletion on obesity and diabetes development in mice fed long chain or medium chain fatty acid rich diets</span>. <i>Eur. J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">1737</span>– <span class="NLM_lpage">1746</span>, <span class="refDoi"> DOI: 10.1007/s00394-017-1456-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1007%2Fs00394-017-1456-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=28429080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFGjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=1737-1746&issue=5&author=E.+Du%0AToitauthor=L.+Browneauthor=H.+Irving-Rodgersauthor=H.+M.+Massaauthor=N.+Fozzardauthor=M.+P.+Jenningsauthor=I.+R.+Peak&title=Effect+of+GPR84+deletion+on+obesity+and+diabetes+development+in+mice+fed+long+chain+or+medium+chain+fatty+acid+rich+diets&doi=10.1007%2Fs00394-017-1456-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of GPR84 deletion on obesity and diabetes development in mice fed long chain or medium chain fatty acid rich diets</span></div><div class="casAuthors">Du Toit, Eugene; Browne, Liam; Irving-Rodgers, Helen; Massa, Helen M.; Fozzard, Nicolette; Jennings, Michael P.; Peak, Ian R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nutrition</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1737-1746</span>CODEN:
                <span class="NLM_cas:coden">EJNUFZ</span>;
        ISSN:<span class="NLM_cas:issn">1436-6207</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Although there is good evidence showing that diets rich in medium chain fatty acids (MCFAs) have less marked obesogenic and diabetogenic effects than diets rich in long chain fatty acids (LCFAs), the role of the pro-inflammatory, medium chain fatty acid receptor (GPR84) in the etiol. of obesity and glucose intolerance is not well characterised.  We set out to det. whether GPR84 expression influences obesity and glucose intolerance susceptibility in MCFA and LCFA rich diet fed mice.  Methods: Wild type (WT) and GPR84 knockout (KO) mice were fed a control, MCFA or LCFA diet, and body mass, heart, liver and epididymal fat mass was assessed, as well as glucose tolerance and adipocyte size.  Results: LCFA diets increased body mass and decreased glucose tolerance in both WT and GPR84 KO animals while MCFA diets had no effect on these parameters.  There were no differences in body wt. when comparing WT and GPR84 KO mice on the resp. diets.  Glucose tolerance was also similar in WT and GPR84 KO mice irresp. of diet.  Liver mass was increased following LCFA feeding in WT but not GPR84 KO mice.  Hepatic triglyceride content was increased in GPR84 KO animals fed MCFA, and myocardial triglyceride content was increased in GPR84 KO animals fed LCFA.  Conclusions: GPR84 deletion had no effects on body wt. or glucose tolerance in mice fed either a high MCFA or LCFA diet.  GPR84 may influence lipid metab., as GPR84 KO mice had smaller livers and increased myocardial triglyceride accumulation when fed LCFA diets, and increased liver triglyceride accumulation in responses to increased dietary MCFAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSLrrTgd2sTrVg90H21EOLACvtfcHk0lhNN_F_RnnrUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFGjsbs%253D&md5=5c76ae9693f9d1e78aed516c0f5e3567</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2Fs00394-017-1456-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00394-017-1456-5%26sid%3Dliteratum%253Aachs%26aulast%3DDu%2BToit%26aufirst%3DE.%26aulast%3DBrowne%26aufirst%3DL.%26aulast%3DIrving-Rodgers%26aufirst%3DH.%26aulast%3DMassa%26aufirst%3DH.%2BM.%26aulast%3DFozzard%26aufirst%3DN.%26aulast%3DJennings%26aufirst%3DM.%2BP.%26aulast%3DPeak%26aufirst%3DI.%2BR.%26atitle%3DEffect%2520of%2520GPR84%2520deletion%2520on%2520obesity%2520and%2520diabetes%2520development%2520in%2520mice%2520fed%2520long%2520chain%2520or%2520medium%2520chain%2520fatty%2520acid%2520rich%2520diets%26jtitle%3DEur.%2520J.%2520Nutr.%26date%3D2018%26volume%3D57%26issue%3D5%26spage%3D1737%26epage%3D1746%26doi%3D10.1007%2Fs00394-017-1456-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mignani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomas, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jalal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majoral, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, R. A.</span></span> <span> </span><span class="NLM_article-title">Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">615</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2018.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.drudis.2018.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=29330127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A280%3ADC%252BC1MvgtlCksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=605-615&issue=3&author=S.+Mignaniauthor=J.+Rodriguesauthor=H.+Tomasauthor=R.+Jalalauthor=P.+P.+Singhauthor=J.+P.+Majoralauthor=R.+A.+Vishwakarma&title=Present+drug-likeness+filters+in+medicinal+chemistry+during+the+hit+and+lead+optimization+process%3A+how+far+can+they+be+simplified%3F&doi=10.1016%2Fj.drudis.2018.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?</span></div><div class="casAuthors">Mignani Serge; Rodrigues Joao; Tomas Helena; Jalal Rachid; Singh Parvinder Pal; Vishwakarma Ram A; Majoral Jean-Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">605-615</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">During the past decade, decreasing the attrition rate of drug development candidates reaching the market has become one of the major challenges in pharmaceutical research and drug development (R&D).  To facilitate the decision-making process, and to increase the probability of rapidly finding and developing high-quality compounds, a variety of multiparametric guidelines, also known as rules and ligand efficiency (LE) metrics, have been developed.  However, what are the 'best' descriptors and how far can we simplify these drug-likeness prediction tools in terms of the numerous, complex properties that they relate to?</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2XT6-2EQJ3n6oPH0mYWL1fW6udTcc2eZpHUKchaSn6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvgtlCksw%253D%253D&md5=a61e00552a35b455199f0a8d351d0522</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2018.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2018.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DMignani%26aufirst%3DS.%26aulast%3DRodrigues%26aufirst%3DJ.%26aulast%3DTomas%26aufirst%3DH.%26aulast%3DJalal%26aufirst%3DR.%26aulast%3DSingh%26aufirst%3DP.%2BP.%26aulast%3DMajoral%26aufirst%3DJ.%2BP.%26aulast%3DVishwakarma%26aufirst%3DR.%2BA.%26atitle%3DPresent%2520drug-likeness%2520filters%2520in%2520medicinal%2520chemistry%2520during%2520the%2520hit%2520and%2520lead%2520optimization%2520process%253A%2520how%2520far%2520can%2520they%2520be%2520simplified%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D605%26epage%3D615%26doi%3D10.1016%2Fj.drudis.2018.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kodimuthali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jabaris, S. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, M.</span></span> <span> </span><span class="NLM_article-title">Recent advances on phosphodiesterase 4 inhibitors for the treatment of asthma and chronic obstructive pulmonary disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">18</span>),  <span class="NLM_fpage">5471</span>– <span class="NLM_lpage">5489</span>, <span class="refDoi"> DOI: 10.1021/jm800582j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800582j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1alsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5471-5489&issue=18&author=A.+Kodimuthaliauthor=S.+S.+L.+Jabarisauthor=M.+Pal&title=Recent+advances+on+phosphodiesterase+4+inhibitors+for+the+treatment+of+asthma+and+chronic+obstructive+pulmonary+disease&doi=10.1021%2Fjm800582j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Recent Advances on Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease</span></div><div class="casAuthors">Kodimuthali, Arumugam; Jabaris, S. Sugin Lal; Pal, Manojit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5471-5489</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDQPTfmPINKbVg90H21EOLACvtfcHk0lim6DRxY77x_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1alsbg%253D&md5=d4502dc5ce4b8b17d5b1d4d853403768</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800582j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800582j%26sid%3Dliteratum%253Aachs%26aulast%3DKodimuthali%26aufirst%3DA.%26aulast%3DJabaris%26aufirst%3DS.%2BS.%2BL.%26aulast%3DPal%26aufirst%3DM.%26atitle%3DRecent%2520advances%2520on%2520phosphodiesterase%25204%2520inhibitors%2520for%2520the%2520treatment%2520of%2520asthma%2520and%2520chronic%2520obstructive%2520pulmonary%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D18%26spage%3D5471%26epage%3D5489%26doi%3D10.1021%2Fjm800582j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fida, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, Y.</span></span> <span> </span><span class="NLM_article-title">Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">e82360</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0082360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1371%2Fjournal.pone.0082360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=24340020" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVCju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e82360&issue=12&author=M.+Niuauthor=F.+Dongauthor=S.+Tangauthor=G.+Fidaauthor=J.+Qinauthor=J.+Qiuauthor=K.+Liuauthor=W.+Gaoauthor=Y.+Gu&title=Pharmacophore+modeling+and+virtual+screening+for+the+discovery+of+new+type+4+cAMP+phosphodiesterase+%28PDE4%29+inhibitors&doi=10.1371%2Fjournal.pone.0082360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore modeling and virtual screening for the discovery of new type 4 cAMP phosphodiesterase (PDE4) inhibitors</span></div><div class="casAuthors">Niu, Miaomiao; Dong, Fenggong; Tang, Shi; Fida, Guissi; Qin, Jingyi; Qiu, Jiadan; Liu, Kangbo; Gao, Weidong; Gu, Yueqing</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">e82360/1-e82360/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Type 4 cAMP phosphodiesterase (PDE4) inhibitors show a broad spectrum of anti-inflammatory effects in almost all kinds of inflamed cells, by an increase in cAMP levels which is a pivotal second messenger responsible for various biol. processes.  These inhibitors are now considered as the potential drugs for treatment of chronic inflammatory diseases.  However, some recently marketed inhibitors e.g., roflumilast, have shown adverse effects such as nausea and emesis, thus restricting its use.  In order to identify novel PDE4 inhibitors with improved therapeutic indexes, a highly correlating (r = 0.963930) pharmacophore model (Hypo1) was established on the basis of known PDE4 inhibitors.  Validated Hypo1 was used in database screening to identify chem. with required pharmacophoric features.  These compds. are further screened by using the rule of five, ADMET and mol. docking.  Finally, twelve hits which showed good results with respect to following properties such as estd. activity, calcd. drug-like properties and scores were proposed as potential leads to inhibit the PDE4 activity.  Therefore, this study will not only assist in the development of new potent hits for PDE4 inhibitors, but also give a better understanding of their interaction with PDE4.  On a wider scope, this will be helpful for the rational design of novel potent enzyme inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpah67dLxz_KLVg90H21EOLACvtfcHk0ljGIcugRvtfRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVCju74%253D&md5=d1b6be4406df69aea27e763c04522d42</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0082360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0082360%26sid%3Dliteratum%253Aachs%26aulast%3DNiu%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DF.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DFida%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DY.%26atitle%3DPharmacophore%2520modeling%2520and%2520virtual%2520screening%2520for%2520the%2520discovery%2520of%2520new%2520type%25204%2520cAMP%2520phosphodiesterase%2520%2528PDE4%2529%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D12%26spage%3De82360%26doi%3D10.1371%2Fjournal.pone.0082360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oxford, A. W.</span>; <span class="NLM_string-name">Jack, D.</span></span> <span> </span><span class="NLM_article-title">Derivatives of Pyrimido[6,1-A]Isoquinolin-4-One</span>. <span class="NLM_patent">WO/2000/058309</span>, Mar 29, <span class="NLM_year">2000</span>; <a href="https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2000058309" class="extLink">https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2000058309</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2000&author=A.+W.+Oxford&author=D.+Jack&title=Derivatives+of+Pyrimido%5B6%2C1-A%5DIsoquinolin-4-One"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DOxford%26aufirst%3DA.%2BW.%26atitle%3DDerivatives%2520of%2520Pyrimido%255B6%252C1-A%255DIsoquinolin-4-One%26date%3D2000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sina, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilova, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Till, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildebrand, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raabe, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalaris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ott, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Häsler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolaus, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fölsch, U. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose-John, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenstiel, P.</span></span> <span> </span><span class="NLM_article-title">G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>183</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">7514</span>– <span class="NLM_lpage">7522</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.0900063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.4049%2Fjimmunol.0900063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=19917676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVehtrrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=183&publication_year=2009&pages=7514-7522&issue=11&author=C.+Sinaauthor=O.+Gavrilovaauthor=M.+F%C3%B6rsterauthor=A.+Tillauthor=S.+Dererauthor=F.+Hildebrandauthor=B.+Raabeauthor=A.+Chalarisauthor=J.+Schellerauthor=A.+Rehmannauthor=A.+Frankeauthor=S.+Ottauthor=R.+H%C3%A4slerauthor=S.+Nikolausauthor=U.+R.+F%C3%B6lschauthor=S.+Rose-Johnauthor=H.+P.+Jiangauthor=J.+Liauthor=S.+Schreiberauthor=P.+Rosenstiel&title=G+protein-coupled+receptor+43+is+essential+for+neutrophil+recruitment+during+intestinal+inflammation&doi=10.4049%2Fjimmunol.0900063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation</span></div><div class="casAuthors">Sina, Christian; Gavrilova, Olga; Foerster, Matti; Till, Andreas; Derer, Stefanie; Hildebrand, Friederike; Raabe, Bjoern; Chalaris, Athena; Scheller, Juergen; Rehmann, Ateequr; Franke, Andre; Ott, Stephan; Haesler, Robert; Nikolaus, Susanna; Foelsch, Ulrich R.; Rose-John, Stefan; Jiang, Hui-Ping; Li, Jun; Schreiber, Stefan; Rosenstiel, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">183</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">7514-7522</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Mol. danger signals attract neutrophilic granulocytes (polymorphonuclear leukocytes (PMNs)) to sites of infection.  The G protein-coupled receptor (GPR) 43 recognizes propionate and butyrate and is abundantly expressed on PMNs.  The functional role of GPR43 activation for in vivo orchestration of immune response is unclear.  The authors examd. dextrane sodium sulfate (DSS)-induced acute and chronic intestinal inflammatory response in wild-type and Gpr43-deficient mice.  The severity of colonic inflammation was assessed by clin. signs, histol. scoring, and cytokine prodn.  Chemotaxis of wild-type and Gpr43-deficient PMNs was assessed through transwell cell chemotactic assay.  A reduced invasion of PMNs and increased mortality due to septic complications were obsd. in acute DSS colitis.  In chronic DSS colitis, Gpr43-/- animals showed diminished PMN intestinal migration, but protection against inflammatory tissue destruction.  No significant difference in PMN migration and cytokine secretion was detected in a sterile inflammatory model.  Ex vivo expts. show that GPR43-induced migration is dependent on activation of the protein kinase p38α, and that this signal acts in cooperation with the chemotactic cytokine keratinocyte chemoattractant.  Interestingly, shedding of L-selectin in response to propionate and butyrate was compromised in Gpr43-/- mice.  These results indicate a crit. role for GPR43-mediated recruitment of PMNs in contg. intestinal bacterial translocation, yet also emphasize the bipotential role of PMNs in mediating tissue destruction in chronic intestinal inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9D9mLPKWZD7Vg90H21EOLACvtfcHk0ljGIcugRvtfRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVehtrrN&md5=98fd06777b79a924befb00cdc5ee1b6b</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0900063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0900063%26sid%3Dliteratum%253Aachs%26aulast%3DSina%26aufirst%3DC.%26aulast%3DGavrilova%26aufirst%3DO.%26aulast%3DF%25C3%25B6rster%26aufirst%3DM.%26aulast%3DTill%26aufirst%3DA.%26aulast%3DDerer%26aufirst%3DS.%26aulast%3DHildebrand%26aufirst%3DF.%26aulast%3DRaabe%26aufirst%3DB.%26aulast%3DChalaris%26aufirst%3DA.%26aulast%3DScheller%26aufirst%3DJ.%26aulast%3DRehmann%26aufirst%3DA.%26aulast%3DFranke%26aufirst%3DA.%26aulast%3DOtt%26aufirst%3DS.%26aulast%3DH%25C3%25A4sler%26aufirst%3DR.%26aulast%3DNikolaus%26aufirst%3DS.%26aulast%3DF%25C3%25B6lsch%26aufirst%3DU.%2BR.%26aulast%3DRose-John%26aufirst%3DS.%26aulast%3DJiang%26aufirst%3DH.%2BP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSchreiber%26aufirst%3DS.%26aulast%3DRosenstiel%26aufirst%3DP.%26atitle%3DG%2520protein-coupled%2520receptor%252043%2520is%2520essential%2520for%2520neutrophil%2520recruitment%2520during%2520intestinal%2520inflammation%26jtitle%3DJ.%2520Immunol.%26date%3D2009%26volume%3D183%26issue%3D11%26spage%3D7514%26epage%3D7522%26doi%3D10.4049%2Fjimmunol.0900063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wirtz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neufert, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weigmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neurath, M. F.</span></span> <span> </span><span class="NLM_article-title">Chemically induced mouse models of intestinal inflammation</span>. <i>Nat. Protoc.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">541</span>– <span class="NLM_lpage">546</span>, <span class="refDoi"> DOI: 10.1038/nprot.2007.41</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1038%2Fnprot.2007.41" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=17406617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=541-546&issue=3&author=S.+Wirtzauthor=C.+Neufertauthor=B.+Weigmannauthor=M.+F.+Neurath&title=Chemically+induced+mouse+models+of+intestinal+inflammation&doi=10.1038%2Fnprot.2007.41"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Chemically induced mouse models of intestinal inflammation</span></div><div class="casAuthors">Wirtz, Stefan; Neufert, Clemens; Weigmann, Benno; Neurath, Markus F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Protocols</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">541-546</span>CODEN:
                <span class="NLM_cas:coden">NPARDW</span>;
        ISSN:<span class="NLM_cas:issn">1750-2799</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Animal models of intestinal inflammation are indispensable for our understanding of the pathogenesis of Crohn disease and ulcerative colitis, the two major forms of inflammatory bowel disease in humans.  Here, we provide protocols for establishing murine 2,4,6-trinitro benzene sulfonic acid (TNBS)-, oxazolone- and both acute and chronic dextran sodium sulfate (DSS) colitis, the most widely used chem. induced models of intestinal inflammation.  In the former two models, colitis is induced by intrarectal administration of the covalently reactive reagents TNBS/oxazolone, which are believed to induce a T-cell-mediated response against hapten-modified autologous proteins/luminal antigens.  In the DSS model, mice are subjected several days to drinking water supplemented with DSS, which seems to be directly toxic to colonic epithelial cells of the basal crypts.  The procedures for the hapten models of colitis and acute DSS colitis can be accomplished in about 2 wk but the protocol for chronic DSS colitis takes about 2 mo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq-D9fB-7WMbVg90H21EOLACvtfcHk0lj3KYlotTAddQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGntbnL&md5=7a3c29eaca8be756e3d866e23e151fdf</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnprot.2007.41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnprot.2007.41%26sid%3Dliteratum%253Aachs%26aulast%3DWirtz%26aufirst%3DS.%26aulast%3DNeufert%26aufirst%3DC.%26aulast%3DWeigmann%26aufirst%3DB.%26aulast%3DNeurath%26aufirst%3DM.%2BF.%26atitle%3DChemically%2520induced%2520mouse%2520models%2520of%2520intestinal%2520inflammation%26jtitle%3DNat.%2520Protoc.%26date%3D2007%26volume%3D2%26issue%3D3%26spage%3D541%26epage%3D546%26doi%3D10.1038%2Fnprot.2007.41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mahmud, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulven, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labéguère, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosmini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tikhonova, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">17953</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-18159-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1038%2Fs41598-017-18159-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=29263400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A280%3ADC%252BC1MzjslSqug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=17953&issue=1&author=Z.+A.+Mahmudauthor=L.+Jenkinsauthor=T.+Ulvenauthor=F.+Lab%C3%A9gu%C3%A8reauthor=R.+Gosminiauthor=S.+De+Vosauthor=B.+D.+Hudsonauthor=I.+G.+Tikhonovaauthor=G.+Milligan&title=Three+classes+of+ligands+each+bind+to+distinct+sites+on+the+orphan+G+protein-coupled+receptor+GPR84&doi=10.1038%2Fs41598-017-18159-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84</span></div><div class="casAuthors">Mahmud Zobaer Al; Jenkins Laura; Hudson Brian D; Milligan Graeme; Ulven Trond; Labeguere Frederic; Gosmini Romain; Labeguere Frederic; De Vos Steve; Tikhonova Irina G</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17953</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Medium chain fatty acids can activate the pro-inflammatory receptor GPR84 but so also can molecules related to 3,3'-diindolylmethane. 3,3'-Diindolylmethane and decanoic acid acted as strong positive allosteric modulators of the function of each other and analysis showed the affinity of 3,3'-diindolylmethane to be at least 100 fold higher.  Methyl decanoate was not an agonist at GPR84.  This implies a key role in binding for the carboxylic acid of the fatty acid.  Via homology modelling we predicted and confirmed an integral role of arginine(172), located in the 2nd extracellular loop, in the action of decanoic acid but not of 3,3'-diindolylmethane.  Exemplars from a patented series of GPR84 antagonists were able to block agonist actions of both decanoic acid and 3,3'-diindolylmethane at GPR84.  However, although a radiolabelled form of a related antagonist, [(3)H]G9543, was able to bind with high affinity to GPR84, this was not competed for by increasing concentrations of either decanoic acid or 3,3'-diindolylmethane and was not affected adversely by mutation of arginine(172).  These studies identify three separable ligand binding sites within GPR84 and suggest that if medium chain fatty acids are true endogenous regulators then co-binding with a positive allosteric modulator would greatly enhance their function in physiological settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcREMjSSm_naSC-bLEOO4dYpfW6udTcc2ebXhAEhm4u7nLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MzjslSqug%253D%253D&md5=fe3d58f70952bef231505deb9bbb9de0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-18159-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-18159-3%26sid%3Dliteratum%253Aachs%26aulast%3DMahmud%26aufirst%3DZ.%2BA.%26aulast%3DJenkins%26aufirst%3DL.%26aulast%3DUlven%26aufirst%3DT.%26aulast%3DLab%25C3%25A9gu%25C3%25A8re%26aufirst%3DF.%26aulast%3DGosmini%26aufirst%3DR.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DHudson%26aufirst%3DB.%2BD.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DThree%2520classes%2520of%2520ligands%2520each%2520bind%2520to%2520distinct%2520sites%2520on%2520the%2520orphan%2520G%2520protein-coupled%2520receptor%2520GPR84%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26issue%3D1%26spage%3D17953%26doi%3D10.1038%2Fs41598-017-18159-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhn, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patkar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrier, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cushman, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of dioxane-based antiviral agents and evaluation of their biological activities as inhibitors of Sindbis virus replication</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2667</span>– <span class="NLM_lpage">2679</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2007.01.040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1016%2Fj.bmc.2007.01.040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=17287124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVagtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=2667-2679&issue=7&author=H.+Y.+Kimauthor=R.+J.+Kuhnauthor=C.+Patkarauthor=R.+Warrierauthor=M.+Cushman&title=Synthesis+of+dioxane-based+antiviral+agents+and+evaluation+of+their+biological+activities+as+inhibitors+of+Sindbis+virus+replication&doi=10.1016%2Fj.bmc.2007.01.040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of dioxane-based antiviral agents and evaluation of their biological activities as inhibitors of Sindbis virus replication</span></div><div class="casAuthors">Kim, Ha Young; Kuhn, Richard J.; Patkar, Chinmay; Warrier, Ranjit; Cushman, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2667-2679</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The crystal structure of the Sindbis virus capsid protein contains one or two solvent-derived dioxane mols. in the hydrophobic binding pocket.  A bis-dioxane antiviral agent was designed by linking the two dioxane mols. with a three-carbon chain having R,R connecting stereochem., and a stereospecific synthesis was performed.  This resulted in an effective antiviral agent that inhibited Sindbis virus replication with an EC50 of 14 μM.  The synthesis proceeded through an intermediate (R)-2-hydroxymethyl-[1,4]-dioxane, which unexpectedly proved to be a more effecting antiviral agent than the target compd., as evidenced by its EC50 of 3.4 μM as an inhibitor of Sindbis virus replication.  Both compds. were not cytotoxic in uninfected BHK cells at concns. of 1 mM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZryWPZMnZvbVg90H21EOLACvtfcHk0lgwRmUmi_fV4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVagtro%253D&md5=67f56b313ec33524f54720fc702d6bd1</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2007.01.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2007.01.040%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%2BY.%26aulast%3DKuhn%26aufirst%3DR.%2BJ.%26aulast%3DPatkar%26aufirst%3DC.%26aulast%3DWarrier%26aufirst%3DR.%26aulast%3DCushman%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520dioxane-based%2520antiviral%2520agents%2520and%2520evaluation%2520of%2520their%2520biological%2520activities%2520as%2520inhibitors%2520of%2520Sindbis%2520virus%2520replication%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26issue%3D7%26spage%3D2667%26epage%3D2679%26doi%3D10.1016%2Fj.bmc.2007.01.040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dupont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kaem, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gouy, M.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gheyle, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandeghinste, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haazen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van’t Klooster, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beetens, J.</span></span> <span> </span><span class="NLM_article-title">Human safety, pharmacokinetics and pharmacodynamics of the GPR84 antagonist GLPG1205, a potential new approach to treat IBD</span>. <i>United Eur. Gastroenterol. J.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">1S</span>),  <span class="NLM_fpage">A224</span>, (Abstract P0341)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=A224&issue=1S&author=F.+Vanhoutteauthor=S.+Dupontauthor=T.+Van+Kaemauthor=M.-H.+Gouyauthor=L.+Gheyleauthor=R.+Blanqueauthor=R.+Brysauthor=N.+Vandeghinsteauthor=W.+Haazenauthor=G.+van%E2%80%99t+Kloosterauthor=J.+Beetens&title=Human+safety%2C+pharmacokinetics+and+pharmacodynamics+of+the+GPR84+antagonist+GLPG1205%2C+a+potential+new+approach+to+treat+IBD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVanhoutte%26aufirst%3DF.%26aulast%3DDupont%26aufirst%3DS.%26aulast%3DVan%2BKaem%26aufirst%3DT.%26aulast%3DGouy%26aufirst%3DM.-H.%26aulast%3DGheyle%26aufirst%3DL.%26aulast%3DBlanque%26aufirst%3DR.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DVandeghinste%26aufirst%3DN.%26aulast%3DHaazen%26aufirst%3DW.%26aulast%3Dvan%25E2%2580%2599t%2BKlooster%26aufirst%3DG.%26aulast%3DBeetens%26aufirst%3DJ.%26atitle%3DHuman%2520safety%252C%2520pharmacokinetics%2520and%2520pharmacodynamics%2520of%2520the%2520GPR84%2520antagonist%2520GLPG1205%252C%2520a%2520potential%2520new%2520approach%2520to%2520treat%2520IBD%26jtitle%3DUnited%2520Eur.%2520Gastroenterol.%2520J.%26date%3D2014%26volume%3D2%26issue%3D1S%26spage%3DA224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span>Galapagos
Reports Results with GLPG1205 in Ulcerative Colitis. Galapagos Press
Release January 26, <span class="NLM_year">2016</span>. <a href="https://cws.huginonline.com/G/133350/PR/201601/1981193_5.html" class="extLink">https://cws.huginonline.com/G/133350/PR/201601/1981193_5.html</a> (accessed Apr 3, 2019).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Galapagos%0AReports+Results+with+GLPG1205+in+Ulcerative+Colitis.+Galapagos+Press%0ARelease+January+26%2C+2016.+https%3A%2F%2Fcws.huginonline.com%2FG%2F133350%2FPR%2F201601%2F1981193_5.html+%28accessed+Apr+3%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puengel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hundertmark, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlhepp, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guldiken, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujuguet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auberval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saniere, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trautwein, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luedde, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strnad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement-Lacroix, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tacke, F.</span></span> <span> </span><span class="NLM_article-title">The medium-chain fatty acid receptor GPR84 mediates myeloid cell infiltration promoting steatohepatitis and fibrosis</span>. <i>J. Clin. Med.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">E1140</span>, <span class="refDoi"> DOI: 10.3390/jcm9041140</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.3390%2Fjcm9041140" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=32316235" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A528%3ADC%252BB3cXovF2hur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2020&pages=E1140&issue=4&author=T.+Puengelauthor=S.+De+Vosauthor=J.+Hundertmarkauthor=M.+Kohlheppauthor=N.+Guldikenauthor=P.+Pujuguetauthor=M.+Aubervalauthor=F.+Marsaisauthor=K.+F.+Shojiauthor=L.+Saniereauthor=C.+Trautweinauthor=T.+Lueddeauthor=P.+Strnadauthor=R.+Brysauthor=P.+Clement-Lacroixauthor=F.+Tacke&title=The+medium-chain+fatty+acid+receptor+GPR84+mediates+myeloid+cell+infiltration+promoting+steatohepatitis+and+fibrosis&doi=10.3390%2Fjcm9041140"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The medium-chain fatty acid receptor GPR84 mediates myeloid cell infiltration promoting steatohepatitis and fibrosis</span></div><div class="casAuthors">Puengel, Tobias; De Vos, Steve; Hundertmark, Jana; Kohlhepp, Marlene; Guldiken, Nurdan; Pujuguet, Philippe; Auberval, Marielle; Marsais, Florence; Shoji, Kenji F.; Saniere, Laurent; Trautwein, Christian; Luedde, Tom; Strnad, Pavel; Brys, Reginald; Clement-Lacroix, Philippe; Tacke, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Medicine</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1140</span>CODEN:
                <span class="NLM_cas:coden">JCMOHK</span>;
        ISSN:<span class="NLM_cas:issn">2077-0383</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Medium-chain fatty acids (MCFAs) have been assocd. with anti-steatotic effects in hepatocytes.  Expression of the MCFA receptor GPR84 (G protein-coupled receptor 84) is induced in immune cells under inflammatory conditions and can promote fibrogenesis.  We aimed at deciphering the role of GPR84 in the pathogenesis of non-alc. steatohepatitis (NASH), exploring its potential as a therapeutic target.  GPR84 expression is upregulated in liver from patients with non-alc. fatty liver disease (NAFLD), correlating with the histol. degree of inflammation and fibrosis.  In mouse and human, activated monocytes and neutrophils upregulate GPR84 expression.  Chemotaxis of these myeloid cells by GPR84 stimulation is inhibited by two novel, small mol. GPR84 antagonists.  Upon acute liver injury in mice, treatment with GPR84 antagonists significantly reduced the hepatic recruitment of neutrophils, monocytes, and monocyte-derived macrophages (MoMF).  We, therefore, evaluated the therapeutic inhibition of GPR84 by these two novel antagonists in comparison to selonsertib, an apoptosis signal-regulating kinase 1 (ASK1) inhibitor, in three NASH mouse models.  Pharmacol. inhibition of GPR84 significantly reduced macrophage accumulation and ameliorated inflammation and fibrosis, to an extent similar to selonsertib.  In conclusion, our findings support that GPR84 mediates myeloid cell infiltration in liver injury and is a promising therapeutic target in steatohepatitis and fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPNuXkRo5CrLVg90H21EOLACvtfcHk0liSx9cQauwoEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXovF2hur0%253D&md5=e9977d9275af8aad56c1715aa362eaf0</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.3390%2Fjcm9041140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcm9041140%26sid%3Dliteratum%253Aachs%26aulast%3DPuengel%26aufirst%3DT.%26aulast%3DDe%2BVos%26aufirst%3DS.%26aulast%3DHundertmark%26aufirst%3DJ.%26aulast%3DKohlhepp%26aufirst%3DM.%26aulast%3DGuldiken%26aufirst%3DN.%26aulast%3DPujuguet%26aufirst%3DP.%26aulast%3DAuberval%26aufirst%3DM.%26aulast%3DMarsais%26aufirst%3DF.%26aulast%3DShoji%26aufirst%3DK.%2BF.%26aulast%3DSaniere%26aufirst%3DL.%26aulast%3DTrautwein%26aufirst%3DC.%26aulast%3DLuedde%26aufirst%3DT.%26aulast%3DStrnad%26aufirst%3DP.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DClement-Lacroix%26aufirst%3DP.%26aulast%3DTacke%26aufirst%3DF.%26atitle%3DThe%2520medium-chain%2520fatty%2520acid%2520receptor%2520GPR84%2520mediates%2520myeloid%2520cell%2520infiltration%2520promoting%2520steatohepatitis%2520and%2520fibrosis%26jtitle%3DJ.%2520Clin.%2520Med.%26date%3D2020%26volume%3D9%26issue%3D4%26spage%3DE1140%26doi%3D10.3390%2Fjcm9041140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saniere, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jagerschmidt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meurisse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuzic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clement-Lacroix, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Osselaer, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Vos, S.</span></span> <span> </span><span class="NLM_article-title">Characterization of GLPG1205 in mouse fibrosis models: a potent and selective antagonist of GPR84 for treatment of idiopathic pulmonary fibrosis</span>. <i>Am. J. Respir. Crit. Care Med.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>199</i></span>,  <span class="NLM_fpage">A1046</span>, <span class="refDoi"> DOI: 10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A1046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1164%2Fajrccm-conference.2019.199.1_MeetingAbstracts.A1046" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2019&pages=A1046&author=L.+Saniereauthor=F.+Marsaisauthor=C.+Jagerschmidtauthor=S.+Meurisseauthor=S.+Cuzicauthor=K.+Shojiauthor=P.+Clement-Lacroixauthor=N.+Van+Osselaerauthor=S.+De+Vos&title=Characterization+of+GLPG1205+in+mouse+fibrosis+models%3A+a+potent+and+selective+antagonist+of+GPR84+for+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.1164%2Fajrccm-conference.2019.199.1_MeetingAbstracts.A1046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1164%2Fajrccm-conference.2019.199.1_MeetingAbstracts.A1046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1164%252Fajrccm-conference.2019.199.1_MeetingAbstracts.A1046%26sid%3Dliteratum%253Aachs%26aulast%3DSaniere%26aufirst%3DL.%26aulast%3DMarsais%26aufirst%3DF.%26aulast%3DJagerschmidt%26aufirst%3DC.%26aulast%3DMeurisse%26aufirst%3DS.%26aulast%3DCuzic%26aufirst%3DS.%26aulast%3DShoji%26aufirst%3DK.%26aulast%3DClement-Lacroix%26aufirst%3DP.%26aulast%3DVan%2BOsselaer%26aufirst%3DN.%26aulast%3DDe%2BVos%26aufirst%3DS.%26atitle%3DCharacterization%2520of%2520GLPG1205%2520in%2520mouse%2520fibrosis%2520models%253A%2520a%2520potent%2520and%2520selective%2520antagonist%2520of%2520GPR84%2520for%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DAm.%2520J.%2520Respir.%2520Crit.%2520Care%2520Med.%26date%3D2019%26volume%3D199%26spage%3DA1046%26doi%3D10.1164%2Fajrccm-conference.2019.199.1_MeetingAbstracts.A1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mancini, S.J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Mahmud, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkins, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolognini, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edye, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMahon, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, G.</span></span> <span> </span><span class="NLM_article-title">On-target and off-target effects of novel orthosteric and allosteric activators of GPR84</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>9</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1861</span>, <span class="refDoi"> DOI: 10.1038/s41598-019-38539-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=10.1038%2Fs41598-019-38539-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=30755705" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;key=1%3ACAS%3A280%3ADC%252BB3cfis1amsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2019&pages=1861&issue=1&author=S.J.+Manciniauthor=Z.+Al+Mahmudauthor=L.+Jenkinsauthor=D.+Bologniniauthor=R.+Newmanauthor=M.+Barnesauthor=M.+E.+Edyeauthor=S.+B.+McMahonauthor=A.+Tobinauthor=G.+Milligan&title=On-target+and+off-target+effects+of+novel+orthosteric+and+allosteric+activators+of+GPR84&doi=10.1038%2Fs41598-019-38539-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">On-target and off-target effects of novel orthosteric and allosteric activators of GPR84</span></div><div class="casAuthors">Mancini Sarah J; Mahmud Zobaer Al; Jenkins Laura; Bolognini Daniele; Tobin Andrew B; Milligan Graeme; Newman Robert; Barnes Matt; Edye Michelle E; McMahon Stephen B</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1861</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Many members of the G protein-coupled receptor family, including examples with clear therapeutic potential, remain poorly characterised.  This often reflects limited availability of suitable tool ligands with which to interrogate receptor function.  In the case of GPR84, currently a target for the treatment of idiopathic pulmonary fibrosis, recent times have seen the description of novel orthosteric and allosteric agonists.  Using 2-(hexylthiol)pyrimidine-4,6 diol (2-HTP) and di(5,7-difluoro-1H-indole-3-yl)methane (PSB-16671) as exemplars of each class, in cell lines transfected to express either human or mouse GPR84, both ligands acted as effective on-target activators and with high co-operativity in their interactions.  This was also the case in lipopolysaccharide-activated model human and mouse immune cell lines.  However in mouse bone-marrow-derived neutrophils, where expression of GPR84 is particularly high, the capacity of PSB-16671 but not of 2-HTP to promote G protein activation was predominantly off-target because it was not blocked by an antagonist of GPR84 and was preserved in neutrophils isolated from GPR84 deficient mice.  These results illustrate the challenges of attempting to study and define functions of poorly characterised receptors using ligands that have been developed via medicinal chemistry programmes, but where assessed activity has been limited largely to the initially identified target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSQc62oWEy_4Oqrn-c4Of3KfW6udTcc2eZF73GIxCpMELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cfis1amsA%253D%253D&md5=1bd20c2443890cb3691d558cb8511c5f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fs41598-019-38539-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-019-38539-1%26sid%3Dliteratum%253Aachs%26aulast%3DMancini%26aufirst%3DS.J.%26aulast%3DAl%2BMahmud%26aufirst%3DZ.%26aulast%3DJenkins%26aufirst%3DL.%26aulast%3DBolognini%26aufirst%3DD.%26aulast%3DNewman%26aufirst%3DR.%26aulast%3DBarnes%26aufirst%3DM.%26aulast%3DEdye%26aufirst%3DM.%2BE.%26aulast%3DMcMahon%26aufirst%3DS.%2BB.%26aulast%3DTobin%26aufirst%3DA.%26aulast%3DMilligan%26aufirst%3DG.%26atitle%3DOn-target%2520and%2520off-target%2520effects%2520of%2520novel%2520orthosteric%2520and%2520allosteric%2520activators%2520of%2520GPR84%26jtitle%3DSci.%2520Rep.%26date%3D2019%26volume%3D9%26issue%3D1%26spage%3D1861%26doi%3D10.1038%2Fs41598-019-38539-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00272">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_81835"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00272?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00272</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">General methods and synthetic routes used in the investigation of compounds; synthetic procedures and analytical data for all compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00272/suppl_file/jm0c00272_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00272/suppl_file/jm0c00272_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00272/suppl_file/jm0c00272_si_001.pdf">jm0c00272_si_001.pdf (1.06 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00272/suppl_file/jm0c00272_si_002.csv">jm0c00272_si_002.csv (8.92 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00272&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00272%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00272" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a561682ad1d7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
